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Abstract	  	  There	   is	   an	   increasing	   need	   to	   treat	   bone	   defects	   that	   arise	   from	   disease	   or	  trauma	   and	   bone	   tissue	   engineering	   offers	   an	   alternative	   solution	   to	   the	  limitations	   that	   are	   present	   in	   current	   treatments.	   Until	   now,	   regenerative	  medicine	  strategies	  rely	  on	  the	  static	  culture	  of	  human	  mesenchymal	  stem	  cells	  (hMSC)	  on	  a	  three-­‐dimensional	  (3D)	  scaffold	  in	  the	  presence	  of	  biochemical	  cues	  in	   order	   to	   stimulate	   cell	   differentiation.	   However,	   this	   approach	   neglects	   the	  importance	   of	  mechanical	   stimuli	   in	   the	   homeostasis	   of	   bone	   tissue.	   Perfusion	  bioreactors	   have	   been	   designed	   to	   improve	   the	   nutrient	   supply	   and	   induce	   a	  mechanical	   stress	   in	   in	   vitro	   cell	   culture.	   Within	   a	   bioreactor	   system,	   many	  important	   parameters	   including	   flow	   type,	   insertion	   of	   rest	   periods,	   duration,	  frequency	  and	  magnitude	  of	  shear	  stress	  can	  create	  different	  biomechanical	  and	  cellular	  microenvironments	  which	  can	  accelerate	  the	   formation	  of	  bone	  matrix.	  Therefore,	  the	  ultimate	  aim	  of	  this	  project	  was	  to	  study	  the	  effects	  of	  a	  perfusion	  bioreactor	  (with	  particular	  emphasis	  on	  flow	  parameters)	  to	  achieve	  progenitor	  cell	   commitment	   towards	   an	   osteogenic	   lineage	   and	   accelerate	   the	   biological	  process	  of	  bone	  formation.	  	  	  In	  order	   to	  achieve	   this,	  hES-­‐MP	  cells	  were	   seeded	  on	   to	  a	  novel	   glass	   scaffold	  and	   subjected	   to	   oscillatory	   and	   unidirectional	   flow.	   It	   was	   shown	   that	   direct	  perfusion	   in	   combination	   with	   oscillatory	   flow	   improved	   cell	   growth	   and	  enhanced	   genes	   associated	   with	   osteogenic	   differentiation	   of	   hES-­‐MPs	   in	  comparison	  to	  static	  cultures.	  	  	  The	   methods	   developed	   were	   also	   used	   to	   study	   the	   cell’s	   response	   to	   a	  combination	   of	   peptide	   coated	   scaffolds	   and	   bioreactor	   culture.	   Scaffolds	  were	  received	  as	  coated	  by	  Orla	  Protein	  Technologies	  with	  peptides	  from	  Tenascin	  C,	  Osteopontin	   and	   BMP-­‐2.	   It	  was	   shown	   that	   the	   combination	   of	   peptide	   coated	  scaffolds	   and	   oscillatory	   flow	   resulted	   in	   an	   improved	   cell	   distribution	   and	   an	  upregulation	  in	  early	  and	  late	  markers	  of	  bone	  formation.	  	  	  
	   	   7	  
Finally,	   the	  3D	  model	  was	  used	   to	   investigate	   the	   role	  of	   the	  primary	  cilia	  as	  a	  mechanosensory	   organelle.	   It	   was	   demonstrated	   that	   MLO-­‐A5	   cells	   were	   less	  responsive	  and	   synthesized	   less	  matrix	   in	   response	   to	   fluid	   shear	   stress	   in	   the	  absence	  of	  the	  primary	  cilium.	  Suggesting	  that	  presence	  of	  intact	  primary	  cilia	  is	  essential	   for	   load	   sensing	   and	   absence	   of	   the	   cilium	   (or	   changes	   in	   its	  morphology),	  inhibit	  the	  ability	  of	  cells	  to	  respond	  to	  fluid	  flow	  in	  a	  3D	  scaffold.	  	  	  The	  work	  in	  this	  thesis	  indicated	  that	  short	  bouts	  of	  oscillatory	  fluid	  flow	  may	  be	  sufficient	  to	  stimulate	  bone	  differentiation	  and	  maintain	  cell	  viability	  in	  an	  open	  pored	   scaffold	   such	   as	   used	   here.	   Initial	   data	   suggested	   that	   a	   combination	   of	  coating	   the	   scaffolds	   with	   peptides	   from	   ECM	   proteins	   or	   osteogenic	   growth	  factors	  can	  act	  synergistically	  with	  fluid	  flow.	  Finally	  it	  was	  demonstrated	  for	  the	  first	   time	   that	   the	   primary	   cilia	   of	   bone	   cells	   can	   be	   a	  mechanosensor	   in	   a	   3D	  porous	   scaffold	   culture	   system.	   	   This	  work	   contributes	   to	   the	  ongoing	  work	   in	  the	  field	  of	  bone	  tissue	  engineering	  to	  optimise	  in	  vitro	  culture	  conditions	  for	  the	  creation	   of	   3D	   bone	   matrix	   that	   could	   be	   used	   for	   future	   tissue	   engineering	  strategies.	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Chapter	  1:	  Literature	  review	  	  
1.1	   Anatomy	  and	  physiology	  
	  Bone	  is	  a	  dynamic,	  highly	  vascularised	  tissue	  that	  provides	  structural	  support	  for	  the	   body.	   It	   also	   supports	   muscular	   contraction	   (resulting	   in	   motion),	   stores	  minerals,	  bears	  load	  and	  protects	  internal	  organs.	  Bone	  can	  be	  divided	  into	  two	  categories;	   spongy/trabecular/cancellous	   bone	   and	   lamellar/compact/cortical	  bone	   [1-­‐3].	   The	  different	   architectures	   arise	   depending	   on	   anatomical	   site	   and	  loading	  conditions.	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  Cortical	   bone	   is	   located	  on	   the	   external	   region	  of	  bone	  and	  appears	  dense	  and	  solid,	  whereas	  trabecular	  bone	  is	  located	  in	  the	  internal	  region	  and	  appears	  as	  a	  honeycomb-­‐like	   network	   of	   interconnected	   trabecular	   plates	   [5-­‐8].	   These	  structures	  serve	  to	  provide	  mechanical	  stability	  to	  the	  global	  structure	  of	  bone.	  
Fig	  1.1;	  Drawing	  of	  the	  proximal	  end	  of	  a	  human	  femur	  showing	  the	  location	  of	  compact	  and	  spongy	  bone	  [4].	  	  	  
Spongy	  bone	  
Compact	  bone	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This	   contribution	   to	   total	   bone	   volume	   differs	   at	   various	   locations	   across	   the	  body.	   Cortical	   bone	   is	   only	   10%	   porous	   containing	   just	   microarchitectural	  channels	  for	  blood	  vessels	  and	  bone	  cells.	  Trabecular	  bone	  has	  a	  higher	  porosity	  ranging	   from	   50-­‐90%	   that	   contain	   bone	   marrow,	   making	   its	   compressive	  strength	  20	  times	  less	  than	  that	  of	  cortical	  bone	  [9,	  10].	  	  	  Trabecular	   bone,	   contained	   in	   the	   ends	   of	   long	   bones	   and	   the	   site	   of	   bone	  marrow	  synthesis,	  exhibits	  anisotropy	  (having	  a	  different	  value	  when	  measured	  in	  different	  directions)	  as	  a	   result	  of	  being	   composed	  of	   rod-­‐shaped	  and	  plate-­‐shaped	  elements.	  Cortical	  bone	  is	  highly	  compact	  and	  orthotropic	  (having	  elastic	  properties	   in	   two	   or	   three	   planes	   perpendicular	   to	   each	   other)	   due	   to	   the	  cylindrical,	   lamellae	   that	   make	   up	   the	   osteonal	   structure.	   One	   example	   of	   the	  micro-­‐architectural	  differences	  between	  the	  two	  bone	  types	  is	  that	  cortical	  bone	  contains	  only	  microscopic	   channels	   through	   the	   centre	  of	   the	  osteons	  whereas	  trabecular	  bone	  is	  highly	  porous	  [11].	  	  At	   the	  microscopic	   level,	  bone	  can	  be	   found	   in	   two	   forms;	  woven	  and	   lamellar.	  Woven	  bone	   is	   immature	  bone	  and	   is	   characterised	  by	   fibre	  arrangement	  with	  no	  orientation	  and	  contains	  more	  randomly	  arranged	  cells	  per	  unit	  volume	  than	  lamellar	  bone	  [12].	  This	  network	  of	  randomly	  oriented	  fibres	  results	  in	  isotropic	  mechanical	   properties	   (properties	   of	   bone	   are	   the	   same	   in	   all	   directions).	  Lamellar	   bone	   contains	   a	   high	   number	   of	   organised,	   stress	   oriented	   collagen	  fibres	  which	  give	  it	  its	  anisotropic	  mechanical	  behaviour	  [13].	  	  	  The	  Haversian	  system	  is	  the	  fundamental	  functional	  unit	  of	  adult	  human	  cortical	  bone.	   Osteons	   are	   cylindrical	   structures	   that	   are	   normally	   several	   millimetres	  long	   and	   roughly	   0.2	   mm	   in	   diameter.	   Each	   osteon	   consists	   of	   lamellae	   that	  surround	  a	  central	  canal	  (the	  Haversian	  canal),	  which	  contains	  the	  bone’s	  nerve	  and	  blood	  supply.	  Within	  bone,	  osteocytes	   live	  within	  individual	  spaces,	  known	  as	  lacuna.	  Osteocytes	  make	  contact	  with	  cytoplasmic	  processes	  via	  a	  network	  of	  canals	  called	  canaliculi	  which	  facilitate	  the	  exchange	  of	  nutrients	  and	  metabolic	  waste	  (fig	  1.2).	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1.2	   Cell	  biology	  
	  
Osteoblasts	  are	  the	  bone	  cells	  that	   form	  bone	  (fig	  1.6).	  They	  are	  responsible	  for	  the	   production	   of	   the	   organic	   matrix	   of	   bone	   and	   secrete	   products	   such	   as	  collagen	   type	   1	   and	   also	   noncollagenous	   proteins	   such	   as	   osteopontin	   and	  osteocalcin	   (table	   1.1).	   Osteoblasts	   arise	   from	   pluripotent	   mesenchymal	  progenitor	   cells	   that	   can	   also	   develop	   into	   adipocytes,	   myocytes,	   and	  chondrocytes	  [15].	  Figure	  1.3	  is	  an	  SEM	  micrograph	  of	  osteoblasts	  cultured	  on	  a	  Lithium-­‐Hydroxyapatite	  (LiHA)	  matrix.	  	  	  	  	  	  	  	  	  	  
Fig	  1.2;	  Diagram	  of	  a	  ground	  section	  of	  compact	  bone	  showing	  the	  transverse	  section	  of	  long	  bone’s	  cortex	  [14].	  	  
Fig	  1.3;	  SEM	  micrograph	  of	  osteoblasts	  cultured	  on	  LiHA	  matrix	  [16].	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While	  osteoblastic	   cells	   are	  perhaps	   the	  most	  widely	   studied	  bone	   cells,	   by	   far	  the	  most	  abundant	  bone	  cells	  are	  the	  osteocytes	  (fig	  1.6).	  Roughly	  90%	  of	  all	  cells	  in	   bone	   are	   osteocytes.	   However,	   due	   to	   the	   difficulties	   in	   isolating	   these	   cells	  and	  culturing	  them	  in	  vitro,	  osteocytes	  are	  the	  least	  studied	  bone	  cells.	  They	  arise	  from	  osteoblasts	  that	  have	  become	  entrapped	  in	  the	  mineralised	  matrix	  that	  they	  have	  formed.	  	  Figure	  1.4	  is	  an	  image	  of	  cells	  from	  an	  octeocyte-­‐like	  cell	  line	  MLO-­‐Y4	  [17].	  	  	  	  	  	  	  	  	  	  
	  
	  
Osteoclasts	  are	  large	  multinucleated	  cells	  and	  are	  responsible	  for	  the	  dissolution	  and	   absorption	   of	   bone	   (fig	   1.6).	   They	   are	   multinucleated	   and	   derive	   from	  hematopoietic	   cells	   (fig	   1.5).	   They	   have	   the	   ability	   to	   secrete	   lysosmalenzyme	  which	   break	   down	   mineralized	   bone.	   An	   active	   osteoclast	   can	   resorb	   20,000	  
µm3/day	  of	  bone	  matrix	  [17].	  	  	  	  	  	  	  	  	  	  	  
Fig	  1.4;	  Light	  micrograph	  of	  MLO-­‐Y4	  osteocytic	  cells	  cultured	  on	  tissue	  culture	  plate	  [18].	  	  	  
Fig	  1.5;	  Image	  of	  an	  osteoclast	  in	  cell	  culture	  [19].	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1.3	   Extracellular	  matrix	  components	  	  Bone	   matrix	   has	   a	   mineral	   inorganic	   component,	   composed	   of	   mostly	  hydroxyapatite	   (65-­‐70%)	   and	   an	   organic	   part,	   which	   is	   composed	   of	   collagen,	  proteoglycans,	  glycoproteins,	  bone	  gla	  proteins	  and	  sialoproteins,	  that	  comprises	  the	   remaining	   25-­‐30%	   of	   the	   total	  matrix.	   The	   newly	   formed	  matrix	   (osteoid)	  consists	   roughly	  94%	  collagen	   [21].	  Type	   I	   collagen	   is	   the	  principle	  collagen	   in	  mineralized	  bone,	  together	  with	  type	  V	  collagen.	  The	  collagen	  fibrils	  in	  bone	  are	  stabilized	   by	   intermolecular	   cross-­‐linking	   which	   leads	   to	   the	   high	   tensile	  strength	  of	  collagen	  fibres	  [22].	  	  Osteocalcin	  (OCN),	  also	  known	  as	  gla	  protein,	  is	  a	  5.8-­‐kDa	  acidic	  protein	  which	   is	  modified	  by	  vitamin-­‐dependent	  carboxylating	  enzymes	   that	   convert	   glutamic	   acids	   into	   γ-­‐carboxyglutamic	   acids	   (gla	   group)	  interacting	  with	  hydroxyapatite	  [23].	  	  Osteopontin	  (OPN)	  and	  Bone	  sialoprotein	  (BSP)	   are	   34-­‐kDa	   proteins	   with	   highly	   glycosylated	   and	   phosphorylated	   sites	  binding	   with	   Hyaluronic	   acid	   (HA).	   BSP	   is	   restricted	   to	   mineralizing	   tissues,	  whereas	   OPN	   has	   been	   shown	   to	   play	   an	   important	   role	   in	   both	   the	   cell	  attachment	   and	   mechanotransduction	   responses	   of	   osteoblasts	   in	   vitro	   [24].	  
Fig	  1.6;	  Micrograph	  image	  of	  bone	  cells.	  Osteoblasts	  lie	  alongside	  the	  surface	  of	   the	  channel	  and	  are	  responsible	  for	  the	  production	  of	  the	  organic	  matrix	  of	  bone.	  Osteocytes	  arise	  from	  osteoblasts	  and	  become	  entrapped	  in	  the	  mineralised	  matrix	  they	  form.	  Osteoclasts	  remove	  bone	  matrix	  [20].	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Bone	  Extracellular	  Matrix	  
constituent	  
Functions	  and	  properties	   Reference	  
Collagen	  I	  	   Provides	  framework	  for	  skeletal	  structure;	  matrix	  calcification	   25	  Byglican	  	  	  Decorin	  	  
Proteoglycan;	  affect	  collagen	  fiber	  growth	  and	  diameter,	  involved	  in	  the	  process	  of	  matrix	  mineralization	  	  
26	  	  	  27	  Osteonectin	  	   Glycoprotein,	  binds	  Ca2+	  and	  collagen;	  nucleates	  hydroxyapatite	   28,29	  Thrombospondin	  	   Glycoprotein;	  binds	  calcium,	  hydroxyapatite,	  osteonectin	  and	  other	  cell	  surface	  proteins;	  mediates	  cell	  adhesion	  in	  a	  RGD-­‐independent	  fashion	  
30	  
Fibronectin	  	   Osteoblast	  attachment	  to	  substrate	   31	  Osteopontin	  	  	   Sialoprotein;	  constituent	  of	  cement	  line	  involved	  in	  bone	  remodeling	   32,33	  	  Bone	  Sialoprotein	  	   Sialoprotein;	  constituent	  of	  cement	  line	   34	  Osteocalcin	  	   Skeletal	  gla	  protein;	  late	  marker	  of	  osteogenic	  phenotype;	  involved	  in	  bone	  remodeling;	  it	  may	  also	  be	  involved	  in	  the	  control	  of	  mineralization	  through	  its	  inhibition	  
35	  
Table	  1.1;	  Components	  of	  the	  organic	  phase	  of	  bone	  matrix	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Signaling	  factors	  	   Functions	   Reference	  	  Bone	  Morphogenic	  Proteins	  (BMP)	   Stimulates	  osteoblast	  proliferation	  	  Causes	  increased	  matrix	  production	  Induces	  MSC	  differentiation	  into	  osteoblasts	  
36	  
Fibroblast	  Growth	  Factors	  (FGF)	   Stimulates	  proliferation	  of	  MSCs	  and	  osteoblasts	   13	  Dentin	  matrix	  protein-­‐1	  (DMP1)	   Induces	  MSC	  differentiation	  into	  osteoblasts	  	  Mineralization	  regulator	   17	  Platelet-­‐derived	  growth	  factors	  (PDGF)	   Stimulates	  proliferation	  of	  osteoblasts	  	   17	  Insulin-­‐like	  growth	  factors	  (IGF)	   Stimulates	  proliferation	  of	  osteoblasts	  	   36	  Transforming	  growth	  factor-­‐β	  (TGF-­‐	  β)	   Induces	  proliferation	  of	  osteoblasts	  Enhances	  bone	  resorption	   37	  Prostaglandin	  E2	  (PGE2)	   Induces	  osteoblast	  differentiation,	  alkaline	  phosphatase	  activity,	  collagen	  synthesis	  Stimulates	  osteoblast	  proliferation	  
38	  
Dexamethasone	  (DEX)	   Promotes	  osteoblast	  differentiation	   17	  Nitric	  oxide	  (NO)	   Enhances	  PGE2	  release	  Stimulates	  osteoblast	  proliferation	   39	  Adenosine	  3’,5’-­‐cyclic	  monophosphate	  (cAMP)	   Stimulates	  osteoblast	  proliferation	   17	  Extracellular	  signal-­‐regulated	  kinase	  (ERK)	   Induces	  osteoblast	  differntation	  Enhances	  calcium	  deposition	   40	  
	  
	  
1.4	   Bone	  formation,	  bone	  modelling	  and	  bone	  remodelling	  
	  Bone	   is	   initially	   developed	   by	   the	   process	   of	   ossification	   as	   a	   specialised	  connective	  tissue.	  During	  the	  process	  of	  ossification,	  osteoblastic	  cells	  secrete	  an	  
Table	  1.2;	  Signaling	  factors	  and	  their	  functions	  during	  bone	  development.	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amorphous	  material	  gradually	  becoming	  osteoid,	   this	   is	  a	  mixture	  of	  collagen	  1	  (COL1)	   and	   non	   collagenous	   matrix	   proteins.	   Calcium	   phosphate	   crystals	  (synthesised	   by	   osteoblasts)	   are	   deposited	   in	   the	   osteoid	   resulting	   in	   bone	  matrix.	   As	   the	   osteoblastic	   cells	   become	   surrounded	   by	   the	   matrix,	   they	  differentiate	  into	  osteocytes	  [41].	  Chemical	  and	  mechanical	  factors	  influence	  the	  rate	  of	  ossification.	  	  	  Bone	  modeling	  is	  the	  process	  by	  which	  bone	  is	  shaped	  or	  reshaped	  by	  the	  action	  of	  the	  osteoblast-­‐osteoclast	  complex.	  For	  example,	  the	  radius	  in	  the	  playing	  arm	  of	  a	  tennis	  player	  has	  a	  greater	  diameter	  and	  thicker	  cortex	  in	  comparison	  to	  the	  other	   arm	   as	   a	   result	   of	   bone	   modeling.	   In	   the	   human	   body,	   bone	   modeling	  occurs	   less	   frequently	   than	  bone	   remodeling.	  Bone	  modeling	  differs	   from	  bone	  remodeling	  in	  that	  bone	  formation	  does	  not	  follow	  bone	  resorption.	  	  The	  remodeling	  process	  begins	  at	  a	  quiescent	  bone	  surface	  when	  the	  osteoclasts	  attach	  to	  the	  bone	  tissue	  matrix	  and	  form	  a	  ruffled	  border	  at	  the	  bone	  interface	  [42].	   Thus	   the	   osteoclast	   creates	   an	   isolated	   microenvironment	   and	  subsequently	   the	   osteoclast	   acidifies	   the	   microenvironment	   and	   dissolves	   the	  organic	  and	  inorganic	  matrices	  of	  the	  bone.	  Briefly	  after	  this	  resorptive	  process	  stops,	   osteoblasts	   appear	   at	   the	   same	   surface	   site	   and	   deposit	   osteoid	   and	  mineralize	  it	  and	  hence	  forming	  new	  bone.	  Remaining	  osteoblastic	  cells	  continue	  to	  synthesize	  bone	  until	   they	  eventually	  stop	  and	  transform	  to	  quiescent	   lining	  cells	  that	  completely	  cover	  the	  newly	  formed	  bone	  surface	  [43].	  
	  
1.5	   Cell	  model	  for	  in	  vitro	  research	  	  Various	   cell	   culture	  models	   have	   been	   employed	   for	   studying	  MSC,	   osteoblast	  and	   osteocyte	   cell	   biology,	   including	   primary	   cells	   from	   different	   species,	  induced	  osteoblasts	  from	  pluripotent	  stem	  cells,	  immortalised	  and	  malignant	  cell	  lines.	   The	   main	   advantage	   to	   using	   primary	   human	   cells	   is	   their	   clinical	  applicability,	   they	  should	  better	  represent	  a	   ‘typical’	  human	  osteoblast	  and	  one	  does	   not	   need	   to	   take	   into	   account	   any	   interspecies	   differences,	   as	   is	   the	   case	  when	   other	   animal	   cell	   sources	   are	   used.	   Furthermore,	   primary	   human	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osteoblasts	   tend	   to	   retain	   their	   differentiated	   phenotype	   in	  vitro.	   On	   the	   other	  hand,	   human	   isolated	   cells	   represent	   a	   heterogeneous	   cell	   population,	   and	  therefore	   exhibit	   phenotypic	   differences	   relating	   to	   the	   skeletal	   location	   from	  which	   they	   were	   isolated	   [44,	   45].	   Many	   factors	   influence	   primary	   human	  osteoblast	   cell	   behaviour;	   age,	   site	   of	   isolation	   and	   gender	   differences	   are	   the	  most	   common.	  Thus,	   the	   time	   frames	   for	  phenotypic	   changes	   in	  vitro	   differ	   for	  cells	  isolated	  from	  different	  origins.	  Some	  studies	  indicate	  that	  nodule	  formation	  in	  mineralization	  of	  human	  bone	  cell	  cultures	  may	  not	  occur	  [46].	  	  However	  primary	  osteocytes	  are	  extremely	  difficult	  to	  work	  with,	  firstly	  they	  are	  difficult	   to	   isolate	   form	   bone	   since	   the	   methods	   used	   also	   release	   osteoblasts	  form	   the	   same	   bone.	   Therefore,	   osteocytes	   must	   be	   separated	   via	   antibody	  selection.	  In	  addition	  they	  do	  not	  proliferate	  well	  in	  culture	  and	  die-­‐differentiate,	  loosing	   their	   characteristic	   morphology	   of	   numerous	   cell	   processes	   after	  prolonged	   time	   in	   plastic.	   Therefore	   most	   of	   the	   early	   work	   that	   aimed	   at	  understanding	   the	   responses	   of	   bone	   cells	   to	   fluid	   flow	   in	   fact	   worked	   with	  osteoblast	  in	  culture	  rather	  than	  osteocytes.	  A	  few	  specialized	  laboratories	  have	  worked	  with	  human	  primary	  osteocytes	  and	  shown	  that	  one	  hour	  pulsating	  fluid	  flow	  resulted	  in	  a	  rapid	  increase	  in	  nitric	  oxide	  production	  and	  mRNA	  levels	  for	  ecNOS	  [47].	  	  Cell-­‐line	  osteoblasts	  provide	  a	  more	  homogenous	  population	  of	   cells	  and	  allow	  the	  study	  of	  particular	  stages	  of	  osteoblast	  phenotype.	  They	  are	  very	  useful	  at	  the	  early	  stages	  of	  assessing	  the	  therapeutic	  agents	  or	  for	  cytocompatibility	  testing;	  however,	  they	  do	  not	  fully	  reflect	  the	  behaviour	  of	  primary	  cells.	  The	  advantages	  of	  using	  immortalized	  cell	   lines	  include	  ease	  of	  maintenance,	  unlimited	  number	  of	  cells	  without	  the	  need	  for	  isolation	  and	  relative	  phenotypic	  stability.	  However,	  some	  reports	  present	  evidence	  of	  progressing	  phenotypic	  heterogeneity	  among	  cell	   lines,	   which	   is	   correlated	   with	   prolonged	   passaging	   of	   cells	   [48-­‐50].	  Additionally,	  both	  transformed	  and	  non-­‐transformed	  cell	  lines,	  as	  they	  are	  stage-­‐arrested,	   do	   not	   reflect	   the	   whole	   range	   of	   phenotypic	   features	   of	   normal	  osteoblast	   cells.	   In	   the	   last	  10	  years	   a	  mouse	  osteocyte	   cell	   line	   (MLO-­‐Y4)	  was	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developed	  by	  the	  Bonewald	  group	  and	  this	  has	  become	  a	  popular	  cell	   line	  with	  which	  to	  study	  osteocyte	  mechanoresponsiveness	  in	  vivo	  [51-­‐53]	  	  Mesenchymal	  stem	  cells	  (MSCs)	  from	  the	  bone	  marrow	  are	  multipotent	  and	  are	  capable	   of	   differentiating	   into	   several	   lineages	   including	   chondrocytes	   [54],	  adipocytes	   [55],	   fibroblasts	   [56]	   and	   osteoblasts	   [57].	   In	   order	   to	   develop	   an	  osteoblastic	   phenotype,	   MSCs	   are	   cultured	   in	   medium	   supplemented	   with	  ascorbic	  acid	  (AA),	  β-­‐	  glycerophosphate	  (βGP),	  and	  dexamethasone	  (DEX)	   [58].	  

















Fig	   1.7;	   MSC	   differentiation	   in	   vitro	   can	   be	   marked	   by	   the	   three	   phases	  including	   proliferation,	   ECM	   maturation	   and	   ECM	   mineralisation.	   This	  development	   sequence	   is	   very	   useful	   in	   monitoring	   osteoblastic	  differentiation.	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1.6	   Bone	  mechanobiology	  	  It	  is	  known	  that	  cells	  and	  tissues	  in	  the	  human	  body	  are	  constantly	  subjected	  to	  a	  wide	  variety	  of	  external	   forces,	  which	  can	   influence	   their	  growth,	  development	  and	   maintenance.	   In	   tissues	   such	   as	   muscles,	   tendon,	   skin	   and	   vessels,	   cells	  continuously	   recognise	   alterations	   in	   mechanical	   forces	   and	   adapt	   their	  biological	   function	   accordingly	   [62].	   	   For	   example	  mechanical	   strain	   has	   been	  found	   to	   induce	   cardiac	   myocyte	   hypertrophy	   [63].	   Similarly	   bone	   adapts	   to	  increased	  loading	  by	  modeling,	  for	  example	  there	  is	  greater	  bone	  density	  in	  the	  femurs	  of	  weightlifters	  compared	  to	  non-­‐weightlifters.	  Jones	  et	  al.,	  compared	  the	  dominant	   arms	   of	   professional	   tennis	   players	  with	   the	   contralateral	   bone	   and	  found	   that	   cortical	   thickness	   was	   increased	   by	   34.9%	   in	   men	   and	   28.4%	   in	  women.	   In	   contrast,	   reduced	   loading	   e.g.	   due	   to	   bed	   rest,	   or	  microgravity	   can	  lead	  to	  bone	  loss	  [64].	  	  It	   has	   been	   advocated	   over	   the	   last	   several	   years	   that	   the	   osteocytes	   are	   the	  mechanosensory	   cells	   of	   bone,	   and	   the	   lacuno-­‐canalicular	   porosity	   is	   the	  structure	  that	  allows	  mechanosensing	  [65].	  The	  current	  widely	  accepted	  theory	  of	   bone	   mechanotrasnduciton	   is	   as	   follows:	   mechanical	   loads	   in	   vivo	   cause	  deformation	   in	   bone	   that	   induce	   fluid	   flow	   within	   the	   bone	   canaliculae	   and	  create	  shear	  stresses	  on	   the	  cells	   (osteocytes)	  embedded	  deep	  within	   the	  bone	  matrix	   [43].	   Osteocytes	   produce	   second	   messengers,	   which	   can	   cause	  osteoprogenitor	   cells	   to	   differentiate	   into	   osteoblasts	   resulting	   in	   new	   bone	  formation	   and/or	   inhibit	   osteoclast	   function	   resulting	   in	   reduced	   bone	  resorption.	  The	  cyclic	  loading	  of	  bone	  such	  as	  the	  femur	  or	  tibia	  during	  walking	  produces	   oscillating	   fluid	   shear	   forces	   in	   the	   lacunocanalicular	   network.	   This	  mechanically	   induced	   loading	  not	  only	   subjects	  osteocytes	   to	   fluid	   shear	   stress	  but	  also	  pumps	  wastes	  products	  out	  of	  the	  network	  and	  directs	  oxygenated	  and	  nutrient-­‐containing	   fluid	   from	   the	   blood	   back	   to	   the	   network.	   Figure	   1.8	  illustrates	  this	  hypothesis	  [66,	  67].	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  It	   has	   been	   shown	   that	   fluid	   shear	   stress	   plays	   an	   important	   role	   in	   normal	  physiology,	   e.g.	   in	   the	   adaptation	   of	   blood	   vessels	   to	   changes	   in	   blood	   flow.	  Regular	  flow	  of	  blood	  results	   in	  shear	  stress,	  which	  act	  on	  the	  inner	  wall	  of	  the	  blood	   vessel.	   During	   exercise,	   enhanced	   blood	   flow	   results	   in	   widening	   of	   the	  vessel,	  to	  ensure	  a	  constant	  blood	  pressure.	  Endothelial	  cells	  sense	  the	  increased	  blood	   flow	   (higher	   shear	   stress)	   and	  produce	   intercellular	  messengers	   such	   as	  nitric	  oxide	  (NO)	  and	  prostaglandins,	  which	  enable	  the	  blood	  vessel	  to	  adapt	  to	  fluid	   flow.	   In	   response	   to	   these	   signaling	   molecules,	   the	   smooth	   muscle	   cells	  around	  the	  vessel	  relax,	  to	  allow	  the	  vessel	  to	  increase	  in	  diameter.	  The	  capacity	  of	  endothelial	  cells	  to	  produce	  NO	  in	  response	  to	  fluid	  flow	  is	  related	  to	  a	  specific	  enzyme	  called	  endothelial	  NO	  synthase	  (eNOS).	  In	  endothelial	  cells,	  eNOS	  activity	  is	  predominantly	  associated	  with	   the	  plasma	  membrane	  and	   the	   localisation	  of	  this	   enzyme	  may	   be	   related	   to	   the	   transduction	  mechanism	  by	  which	   physical	  forces	  bring	  forth	  the	  formation	  of	  NO	  [69-­‐71].	  	  
Fig	  1.8;	  Transduction	  of	  mechanical	   strain	  to	  osteocytes	   in	  bone.	  Loading	  results	  in	  flow	  of	  interstitial	  fluid	  in	  the	  canalicular	  complex	  as	  indicated	  by	  the	  horizontal	  arrows.[68].	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Similarly	   in	   bone,	   in	   vivo	   studies	   suggest	   that	   NO	   is	   involved	   in	   mechanically	  induced	  bone	   formation.	  eNOS	  was	   found	   in	  rat	  osteocytes	  and	   in	  human	  bone	  cells	   and	   was	   found	   that	   treatment	   with	   pulsating	   fluid	   flow	   increased	   eNOS	  mRNA	   levels	   in	   bone	   cells	   [72].	   The	   kinetics	   of	   this	   adaptive	   response	   are	  different	   for	   the	   two	   systems	   however,	   it	   is	   interesting	   that	   two	   different	  biological	   structures	   would	   use	   a	   similar	   mechanism	   to	   detect	   mechanical	  signals.	   It	  has	  been	  speculated	  that	  the	  detection	  and	  signal	  transduction	  of	  NO	  upregulation	   (in	   bone	   cells	   and	   endothelial	   cells)	   involves	   opening	   of	   cation	  channels	  and	  an	  increase	  in	  intracellular	  calcium.	  	  Cell	   response	   to	   mechanical	   loading	   depends	   on	   various	   factors	   including;	  magnitude,	   frequency	  and	   rate	  of	   applied	   force.	  High	   rates	  of	   loading	  and	  high	  impact	  physical	  activity	  including	  jumps	  in	  unusual	  directions	  have	  been	  shown	  to	  have	  a	  great	  osteogenic	  potential	  in	  humans	  [39,	  73].	  Bacabac	  et	  al.,	  suggested	  the	  bone	  cell	  response	  to	  shear	  stress	  is	  rate	  dependent	  and	  demonstrated	  that	  increasing	   shear	   stress	   amplitude	   or	   frequency	   on	   cultured	   MC3T3-­‐E1	  osteoblastic	  cells,	  resulted	  in	  increased	  NO	  production	  [74].	  	  	  Other	   in	  vitro	  studies	  have	  also	  shown	  that	  osteocytes	  respond	  to	   fluid	   flow	  by	  increasing	   NO	   levels	   and	   stimulating	   osteoblast	   proliferation,	   leading	   to	  prostaglandin	  E2	   (PGE2)	   release	   [72].	   In	  vivo,	   PGE2	  plays	   an	   important	   role	   in	  the	   functional	   adaptation	   of	   bone	   to	   mechanical	   load	   by	   inducing	   cell	  proliferation,	  alkaline	  phosphate	  activity	  and	  collagen	  synthesis.	  	  
1.7	   Mechanically	  responsive	  bone	  cells	  
	  Bone	   cells	   sense	   and	   respond	   to	   mechanical	   forces	   by	  at	   least	  four	   cell	   types:	  osteoclasts,	   osteoblasts,	   osteocytes,	   and	  mesenchymal	   stem	  cells.	  Each	  of	   these	  cell	   types	   is	   independently	   sensitive	   to	   mechanical	   signals	   through	   their	  interaction	  with	  each	  other	  and	  their	  precursors,	  can	  serve	  as	  critical	  regulatory	  elements	  in	  the	  recruitment,	  proliferation	  and	  differentiation	  of	  osteoclasts	  and	  osteoblasts.	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This	   regulation	   is	   evident	   in	   studies	   which	   demonstrate	   that	   application	   of	  mechanical	  strain	  to	  murine	  marrow	  derived	  stromal	  cells,	  significantly	  reduced	  mRNA	   expression	   of	   receptor	   activator	   of	   NF	   kappa	   B	   ligand	   (RANKL),	   a	  signalling	   factor	   that	   induces	   osteoclast	   differentiation	   [75].	   These	   studies	  demonstrate	  the	  temporal	  and	  spatial	  coordination	  between	  multiple	  cell	   types	  in	  bone,	  which	  together	  regulate	  adaptive	  changes	   in	  response	  to	  alterations	   in	  the	  mechanical	  environment.	  	  Mechanical	   control	   of	   osteoclast	   function	   appears	   to	   occur	   largely	   through	  regulation	  of	  osteoclast	  recruitment,	  which	  is	  achieved	  through	  osteoprogenitor	  lineage	   expression	   of	   RANKL	   [76].	   Cells	   of	   the	   osteoprogenitor	   lineage	   are	  located	   in	   mechanically	   active	   environments,	   and	   respond	   to	   mechanical	   cues	  with	  alteration	  in	  proliferation,	  differentiation	  and	  differentiated	  function.	  	  	  MSC	   cells,	   which	   share	   a	   hematopoietic	   niche	   with	   blood	   stem	   cells,	   are	   also	  sensitive	   to	   mechanical	   stimulation	   and	   respond	   by	   altering	   the	   output	   of	  differentiated	  cell	  types	  [77]	  and	  increase	  rates	  of	  clonal	  proliferation	  [78].	  As	  mentioned	  previously,	  osteocytes	  are	  uniquely	  situated	   in	  cortical	  bone	  and	  are	   connected	   through	   a	   network	   of	   sister	   cells	   [79]	  which	   contributes	   to	   the	  perception	   of	   these	   cells	   to	   sense	   and	   respond	   to	   mechanical	   loading.	   During	  unloading	   (or	   a	   decrease	   in	   mechanical	   signals)	   this	   network	   of	   cells	   tend	   to	  respond	   with	   an	   upregulation	   in	   sclerostin	   and	   RANKL	   that	   control	   bone	  remodelling	  at	  multiple	   levels	   [80,	  81].	  The	   long	  osteocytic	  processes	  also	  pass	  information	  between	  cells	  and	  it	  is	  likely	  that	  they	  generate	  soluble	  factors	  that	  modulate	  MSC	  differentiation	  as	  well	  as	  osteoprogenitor	  recruitment	  to	  areas	  of	  bone	  remodelling.	  	  
1.8	   Bone	  mechanotransduction	  
	  Mechanotransduction	   is	   described	   as	   the	   process	   by	   which	   cells	   convert	   an	  external	   mechanical	   force	   into	   biochemical	   signals.	   As	   mentioned	   previously,	  osteocytes	   are	   found	   in	   the	   lacunae	   and	   form	   an	   interconnected	  network	  with	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one	   another	   and	   also	   with	   osteoblasts	   at	   the	   bone	   surface	   through	   canaliculi.	  
Burger	   et	   al,	   described	  mechanotransduction	   in	   bone	   in	   three	   different	   stages	  [82];	  	   1) Mechanical	   loading	   must	   induce	   a	   cell-­‐level	   physical	   signal	   that	   can	   be	  sensed	  by	  osteocytes,	  2) The	   physical	   signal	   must	   be	   translated	   to	   a	   biochemical	   signal	   by	  osteocytes,	  3) The	  biochemical	  signal	  must	  be	  communicated	  to	  effector	  cells	  including	  osteoblasts	  and	  osteoclasts.	  Subjecting	   osteocytes	   to	   mechanical	   loading	   activates	   multiple	   signaling	  pathways	   that	   can	   result	   in	   osteogenic	   and	   antiresorptive	   responses.	   Shortly	  after	   exposure	   to	   a	   mechanical	   load,	   osteocytes	   respond	   with	   the	   release	   of	  adenosine	  triphosphate	  (ATP),	  Ca2+	  and	  PGE2.	  These	  responses	  lead	  to	  the	  down	  stream	  effects	  that	  mediate	  bone	  remodeling,	  including	  increases	  in	  cytochrome	  oxidase	   subunit	   2	   (COX-­‐2)	   and	   PGE2	  [83-­‐86].	   COX-­‐2	   is	   an	   enzyme	  maintaining	  homeostatic	   levels	   of	   prostaglandins	   and	   is	   induced	   by	   an	   array	   of	   stimuli	  including	  injury,	  inflammation	  and	  mechanical	  stress.	  	  	  
	  
1.9	   Candidate	  mechanoreceptors	  	  	  The	   ability	   of	   cells	   to	   sense	   the	   mechanical	   signals	   from	   the	   environment	  requires	   that	   mechanoreceptors	   either	   directly	   contact	   with	   the	   extracellular	  space,	   or	   that	   a	   mechanoreceptor	   can	   distinguish	   changes	   in	   a	   physical	  intermediary	   such	   as	   pressure	   or	   fluid	   shear	   on	   the	   plasma	   membrane.	  Suggested	  mechanotransduction	  mechanisms	  include	  junctions	  between	  the	  cell	  and	  ECM	  (integrins	  and	  focal	  adhesions),	  cell-­‐cell	  adhesions	  (cadherins	  and	  gap	  junctions),	   the	   cell	   cytoskeleton	   (microfilaments,	   microtubulules,	   and	  intermediate	   filaments)	   and	   membranes	   (ion	   channels	   and	   caveolae).	   Other	  suggested	  mechanisms	  include	  the	  pericellular	  glycocalyx	  and	  the	  primary	  cilia.	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   1.9.1	   Integrins	  	  	  Integrins	  are	  protein	  complexes	  that	  couple	  the	  cell	  to	  the	  external	  environment	  by	   spanning	   the	   plasma	   membrane	   and	   forming	   attachments	   with	   the	   ECM.	  Integrins	   serve	   a	  mechanosensory	   role	   in	   a	   variety	   of	   cells	   including	   platelets	  [87],	   endothelial	   cells	   [88],	   fibroblasts	   [89],	  myocytes	   [90],	   chondrocytes	   [91],	  and	  bone	  cells	  [92].	  The	  binding	  of	  extracellular	  ligands	  to	  integrins	  may	  initiate	  intracellular	   signaling	   events.	   Experiments	   have	   shown	   that	   integrin	  manipulation	   activates	   RhoA,	  which	   induces	   formation	   of	   new	   focal	   adhesions	  which	  can	  contribute	  to	  remodelling	  of	  the	  cytoskeleton	  [93].	  	  	   	  	   1.9.2	   The	  Cytoskeleton	  	  The	   actin,	   intermediate	   filaments,	   and	   microtubules	   produce	   a	   structural	  framework	  (the	  cytoskeleteon)	  by	  which	  the	  cells	  can	  mediate	  functions	  such	  as	  cellular	   and	   molecular	   transport,	   cell	   division,	   and	   cellular	   structure.	   The	  cytoskeleton	   provides	   an	   inherent	   means	   of	   perceiving	   and	   responding	   to	  mechanical	  signals.	   It	  has	  been	  shown	  that	  fluid	  shear	  stress	  across	  osteoblasts	  induces	  reorganization	  of	  actin	  filaments	  into	  contractile	  stress	  fibers	  [75]	  while	  disruption	  of	   the	  actin	   cytoskeleton	  reduces	   the	   response	  of	  bone	  cells	   to	   fluid	  shear	   stress	   [94,	   95].	   It	   has	   been	   suggested	   that	   cell	   response	   to	   mechanical	  stimuli	  is	  mediated	  by	  its	  cytoskeleton	  [96].	  The	  stiffness	  of	  the	  cytoskeleton	  has	  shown	  to	  increase	  in	  response	  to	  an	  increase	  in	  mechanical	  stress.	  Pavalko	  et	  al.,	  demonstrated	   MC3T3-­‐E1	   actin	   cytoskeleton	   rearranges	   in	   response	   to	   fluid	  shear	  stress	  [97].	  
	   	  
	   1.9.3	   Ion	  channels	  and	  Connexins	  	  	  Ion	   flow	   through	   non-­‐ciliary	   associated	   ion	   channels	   are	   responsible	   for	  maintaining	   proper	   electrochemical	   gradients	   and	   thus	   are	   sensitive	   to	  membrane	   depolarization.	   Connexins	   are	   membrane	   spanning	   protein	  complexes	   that	   form	  pores	  within	   the	  plasma	  membrane	  of	   cells.	  Alignment	  of	  connexons	  with	  their	  counterpart	  on	  an	  adjacent	  cell	  creates	  gap	  junctions	  that	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allows	   for	   intracellular	   communication	   isolated	   from	   the	   extracellular	  environment,	  and	  can	  pass	  small	  molecules	  (<1kDA)	   including	  calcium,	   inositol	  phosphates,	   ATP,	   and	   cAMP	   [98,	   99].	   It	   has	   been	   shown	   that	   mechanical	  stimulation	   increased	   expression	   of	   connexins	  in	   vitro	  and	  in	   vivo,	  suggesting	  that	  cells	  generate	  enhanced	  connections	  with	  their	  neighbours	  enabling	  proper	  transmission	  of	  mechanical	  information	  within	  the	  skeletal	  network.	  	  















	   Fig	  1.9;	  (A)	  An	  electron	  micrograph	  of	  the	  primary	  cilium	  of	  a	  canary	  brain	  radial	  glia.	  (B)	  Schematic	  diagram	  showing	  structure	  of	  the	  basal	  body	  and	  primary	  cilium	  [103].	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The	  primary	  cilium	   is	  a	  microtubule-­‐based	  structure	   that	  extends	   from	  the	  cell	  membrane	  into	  the	  extracellular	  space.	  The	  basal	  body/mother	  centriole	  is	  well	  known	  for	  its	  role	  as	  a	  microtubule	  organising	  center	  of	  mitotic	  spindles	  (fig	  1.9).	  When	   not	   involved	   in	   mitosis,	   the	   mother	   centriole	   migrates	   to	   the	   cell	  membrane	   and	   acts	   an	   anchor	   for	   the	   primary	   cilium	   and	   as	   a	   template	   of	  ciliogenseis	   [104].	   Since	   the	   primary	   cilium	   does	   not	   contain	   the	   complex	  machinery	  to	  synthesis	   its	  own	  proteins,	  ciliary	  proteins	  are	  synthesized	   in	   the	  cell	   body	   and	   targeted	   to	   the	   cilia	   through	   intraflagellar	   transport	   (IFT,	   a	  bidirectional	   system	   that	   directs	  movement	   along	   the	  microtubules	   of	   the	   cilia	  body).	  	  	  A	  typical	  cilia	  is	  approximately	  5	  μm	  in	  length	  but	  can	  be	  up	  to	  30	  μm	  as	  seen	  on	  cells	  from	  a	  kangkaroo	  rat	  kidney	  [105].	  Both	  motile	  and	  non	  motile	  cilia	  contain	  a	  microtubule	  doublet	  that	  provide	  structure	  and	  stability.	  Non	  motile	  cilia	  lack	  a	  central	   pair	   of	  microtubules	   (hence	  designated	  9+0	   cilia)	   and	  other	  machinery	  found	   in	  motile	   cilia	   including	  radial	   spokes,	   central	  pair	  projections	  and	   inner	  and	  outer	  dynein	  arms.	  Unlike	  motile	  9+2	  cilia,	  there	  is	  only	  one	  primary	  cilium	  per	  cell	  [103].	  	  
	  
1.11	   Role	  of	  primary	  cilia	  in	  bone	  
	  Primary	   cilia	  were	   first	   discovered	   over	   a	   century	   ago	   and	   until	   recently	   their	  function	  has	  been	  a	  mystery.	  They	  have	  been	  shown	  to	  have	  an	  important	  role	  in	  a	   number	   of	   developmental	   processes	   including	   the	   establishment	   of	   the	   left-­‐right	   axis	   in	   the	   embryonic	  node	   [106].	  Haycraft	  and	  Serra	   showed	   that	   ciliary	  dysfunction	  resulted	   in	  extensive	  polydactyly	  with	   loss	  of	  anteroposterior	  digit	  patterning	  and	  shortening	  of	  the	  proximodistal	  axis	  [107].	  	  Most	   previous	   work	   that	   focused	   on	   primary	   cilia	   as	   a	   mechanosensor	   has	  focused	   on	   the	   kidney	   and	   liver.	  Praetorius	  and	  Spring	   revealed	   that	   fluid	   flow	  within	  the	  kidney	  resulted	   in	  a	  deflection	  of	   the	  primary	  cilia,	  which	  caused	  an	  extracellular	   calcium	   dependent	   increase	   in	   intracellular	   calcium	   [108].	   This	  response	  was	   lost	  after	   the	   removal	  of	   the	  primary	  cilia.	   It	  was	   found	   that	  this	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calcium	  response	  is	  mediated	  by	  a	  mechanosensory	  complex,	  which	  is	  located	  at	  the	   base	   of	   the	   cilium	   [109].	   This	   complex	   is	  made	   up	   of	   polycystin	   1	   (PC1,	   a	  large	   transmembrane	  protein)	  and	  polycystin	  2	  (PC2,	  a	  cationic	  channel	   that	   is	  part	   of	   the	   transient	   receptor	   potential	   channel	   family	   (TRP)).	   This	  mechanosesning	  mechanism	   has	   also	   been	   reported	   in	   liver	   cholangiocytes.	   It	  was	  found	  that	  the	  PC1/2	  complex	  and	  the	  stretch	  activated	  ion	  channel	  TRPV4	  are	   situated	   at	   the	   primary	   cilium	   and	   sense	   fluid	   shear	   stress	   and	   osmotic	  pressure	  respectively	  [110].	  The	  application	  of	  flow	  not	  only	  resulted	  in	  an	  influx	  of	  calcium	  but	  also	  suppression	  of	  a	  forskolin	  stimulated	  increase	  in	  cAMP.	  	  	  Recent	  studies	  have	  shown	  that	  the	  primary	  cilia	  also	  acts	  as	  a	  mechanosensor	  in	  bone	   cells	   [111].	   Cilia	   bends	   under	   in	  vitro	   fluid	   flow	   and	   recent	   reports	   have	  found	   that	   disruption	   of	   the	   cilia	   inhibits	   COX-­‐2	   gene	   expression	   and	   PGE2	  release	   in	   response	   to	   fluid	   flow	   in	   osteoblasts	   [112].	   Further	   studies	   suggest	  that	   the	   application	   of	   flow	   leads	   to	   a	   cilia-­‐dependent	   decrease	   in	   the	   second	  messenger	   cAMP	   [113].	   Interestingly,	   flow	   induced	   cilia-­‐dependent	   responses	  were	   independent	   of	   intracellular	   calcium	   [112]	   suggesting	   that	   the	  mechantransduction	  pathway	  for	  bone	  cells	  differs	  from	  the	  kidney	  and	  liver.	  	  	  
Hoey	   et	   al.,	   showed	   that	   signaling	   molecules	   released	   into	   culture	   media	   by	  osteoblasts	  subjected	  to	  fluid	  flow	  were	  primary-­‐cilia	  dependent,	  suggesting	  that	  primary	   cilia	   plays	   a	   key	   role	   in	   osteogenic	   responses	   to	   flow	   in	   osteoblasts	  [114].	   In	   a	   similar	   study	   the	   primary	   cilium	  was	   shown	   to	  mediate	   fluid	   flow-­‐increases	   in	   osteogenic	   genes	   in	   human	   MSCs.	   Results	   from	   this	   study	  demonstrate	  that	  targeting	  the	  primary	  cilium	  using	  oscillatory	  fluid	  flow	  may	  be	  beneficial	   for	   bone	   tissue	   engineering	   applications	   and	   could	   provide	   insight	  regarding	  ciliopathies	  and	  cystic	  diseases	  [111].	  	  	  	  Although	  the	  PC1/2	  complex	  has	  been	  shown	  to	  play	  a	  vital	  role	  in	  cilia-­‐related	  mechanotransduction	   in	   the	   liver	  and	  kidney,	   its	   role	   in	  bone	   is	   still	  unclear.	  A	  recent	   study	   showed	   that	   heterozygous	   pkd1	  mutant	   mice	   (a	   mutation	   in	   the	  gene	   that	   encodes	   for	   PC1)	   have	   decreased	   trabecular	   bone	   volume,	   bone	  mineral	  density	  and	  cortical	  thickness	  [115].	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1.12	   	  	  	  Bone	  tissue	  engineering	  
	  It	  is	  estimated	  that	  nearly	  1	  million	  cases	  of	  skeletal	  defects	  a	  year	  require	  bone-­‐graft	  procedures	   to	  achieve	  union	  [13].	  Bone	  disease	   is	  a	  major	  health	  concern	  for	  both	  USA	  and	  the	  EU,	  and	  its	  incidence	  will	  increase	  in	  the	  next	  years	  due	  the	  ageing	  of	  their	  populations.	  Current	  treatments	  include	  the	  use	  of	  autologous	  and	  autogenous	  bone	  grafts	  or	  as	  an	  alternative	  to	  these,	  polymers	  and	  ceramics.	  
Autologous	  bone	  graft,	  that	  is,	  bone	  taken	  from	  another	  part	  of	  the	  patients	  own	  body,	  has	  been	  the	  gold	  standard	  of	  bone	  replacement	  for	  many	  years	  because	  it	  provides	  osteogenic	  cells	  as	  well	  as	  essential	  osteoinductive	   factors	  needed	   for	  bone	   healing	   and	   regeneration.	   The	  major	   disadvantage	   of	   this	   method	   is	   the	  limited	  amount	  of	  autograft	  that	  can	  be	  obtained	  and	  donor	  site	  morbidity	  [116].	  
Allograft,	   bone	   taken	   from	   somebody	   else’s	   body,	   could	   be	   an	   alternative	  solution.	   However,	   the	   rate	   of	   graft	   incorporation	   is	   lower	   than	   with	   the	  autograft	  and	  the	  bone	  could	  also	  introduce	  the	  possibilities	  of	  immune	  rejection	  and	   of	   pathogen	   transmission	   from	   donor	   to	   host.	   Furthermore	   infections	  sometimes	   occur	   in	   the	   recipient’s	   body	   due	   to	   the	   transplantation	   [117].	   For	  this	  reason	  allograft	   is	  usually	  decellularised	  and	  sterilised	  which	  compromises	  both	  its	  bioactivity	  and	  mechanical	  properties.	  
As	  a	  result	  of	  the	  limitations	  of	  different	  bone	  grafts,	  bone	  tissue	  engineering	  is	  emerging	   as	   a	   potential	   alternative	   [118].	   To	   quote	   Langer	   and	   Vacanti	   et	   al.,	  tissue	   engineering	   is	   “an	   interdisciplinary	   field	   of	   research	   that	   applies	   the	  principles	   of	   engineering	   and	   the	   life	   sciences	   towards	   the	   development	   of	  biological	   substitutes	   that	   restore,	  maintain,	   or	   improve	   tissue	   function”	   [119].	  Unlike	  other	  approaches	  (rather	  than	  just	  to	  implanting	  new	  spare	  parts),	  tissue	  engineering	  is	  based	  on	  the	  understanding	  of	  tissue	  formation	  and	  regeneration,	  and	  aims	  to	  induce	  new	  functional	  tissues.	  Researchers	  hope	  to	  reach	  this	  goal	  by	  combining	   knowledge	   from	   various	   fields	   including	   physics,	   engineering,	  chemistry,	  biology	  and	  materials	  science.	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1.13	   	  	  Scaffolds	  for	  bone	  tissue	  engineering	  
	  Scaffolds	  are	  commonly	  used	   in	  bone	  tissue	  engineering,	  acting	  as	  a	  vehicle	   for	  the	  delivery	  of	   cells,	   genetic	  material	   and	  growth	   factors	   to	   the	   site	  of	   interest	  (table	  1.3).	  The	  aim	  is	   that	  a	  scaffold	  would	  also	  support	  vascular	   invasion	  and	  retain	  a	  uniform	  distribution	  of	  cells	  throughout	  its	  3D	  lattice.	  	  Ideally	  a	  scaffold	  for	  bone	  tissue	  engineering	  should	  have	  the	  following	  characteristics:	  	  
Fig	   1.10;	   Bone	   tissue	   engineering	   technique	   tends	   to	  replicate	  the	  natural	  process	  of	  cell	  signaling	  involved	  in	  cell	  growth	  and	  differentiation.	  This	  can	  be	  achieved	  by	  placing	  the	   cells	  and	  growth	  factors	   in	  synthetic	  and	  biocompatible	  scaffolds	  in	  order	  to	  act	  as	  temporary	  extracellular	  matrices	  [120].	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-­‐	  Porosity:	  Scaffolds	  must	  possess	  an	  open	  pore,	  fully	  interconnected	  geometry	  in	   a	   highly	   porous	   structure	  with	   large	   surface	   to	   area	   volume	   ratio.	   This	  will	  allow	   cell	   in-­‐growth	   and	   a	   uniform	   cell	   distribution	   throughout	   the	   porous	  structure.	   Furthermore,	   the	   scaffolds	   should	   also	   exhibit	   adequate	   porosity	   for	  capillary	  in-­‐growth.	  	  	  
Porosity	  and	  interconnectivity	  are	  important	  for	  diffusion	  of	  nutrients	  and	  gases	  and	   for	   the	   removal	   of	  metabolic	  waste	   resulting	   from	   the	   activity	   of	   the	   cells	  that	  have	  grown	  into	  the	  scaffold.	  However,	  the	  degree	  of	  porosity	  will	  influence	  other	   properties	   of	   the	   scaffolds	   such	   as	   its	   mechanical	   stability,	   so	   it	   should	  always	   be	   balanced	   with	   the	  mechanical	   needs	   of	   the	   particular	   tissue	   that	   is	  going	  to	  be	  replaced.	  
-­‐	  Permeability:	  Permeability	   is	  a	   term	  used	   to	  measure	   the	  ease	  with	  which	  a	  ﬂuid	  can	  ﬂow	  through	  the	  scaffold.	  A	  high	  permeability	  indicates	  good	  diffusion	  within	  the	  scaffold,	  which	  would	  improve	  the	  inflow	  of	  nutrients	  and	  the	  disposal	  of	   waste	   products.	   Fluid-­‐material	   interactions	   can	   influence	   the	   viscoelastic	  response	  of	  a	  scaffold	  and	  hence	  change	  its	  permeability.	  This	  is	  important	  when	  designing	   scaffolds	   for	   bone	   and	   articular	   cartilage	   repair,	   since	  mechanotransduction	  is	  affected	  by	  fluid	  flow.	  	  
-­‐	  Pore	  Size:	  Pore	  size	  is	  also	  a	  very	  important	  issue.	  If	  the	  pore	  size	  is	  too	  small,	  pore	   occlusion	   by	   the	   cells	   will	   prevent	   cellular	   penetration	   and	   extracellular	  matrix	  production.	  It	  has	  been	  stated	  that	  for	  bone	  tissue	  engineering	  purposes,	  pore	  size	  should	  be	  between	  the	  200-­‐900	  μm	  [121-­‐123].	  	  
	  
Holy	  et	  al.,	  reported	  bone	   formation	  on	  a	  3D	   temporary	  matrix	   (PLGA	  scaffold)	  with	  large	  macroporous	  interconnected	  structure	  with	  macro	  pore	  size	  ranging	  from	  1.5-­‐2.2	  mm	  [124].	  This	  approach	  has	  advantages	  due	  to	  its	  high	  surface	  to	  volume	  ratios	  that	  will	  facilitate	  cell,	  tissue	  and	  blood	  vessels	  ingrowth.	  However	  scaffolds	   with	   large	   pores	   will	   have	   lower	   mechanical	   properties	   for	   a	   given	  material	   so	   many	   large	   pored	   scaffolds	   would	   not	   be	   appropriate	   for	   load	  bearing	  areas.	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-­‐	   Surface	  Properties:	  Surface	  properties,	  both	  chemical	  and	  topographical,	  are	  important	  for	  cellular	  adhesion	  and	  proliferation	  [125-­‐127].	  Chemical	  properties	  affect	   the	   ability	  of	  proteins	   and	   cells	   to	   adhere	   to	   the	  material.	  Topographical	  properties	   are	   of	   particular	   interest	   when	   considering	   osteoconduction.	   As	  defined	  by	  Davies	  et	  al,	  osteoconduction	  “is	  the	  process	  by	  which	  osteogenic	  cells	  migrate	  to	  the	  surface	  of	   the	  scaffold	  through	  a	   fibrin	  clot,	  which	   is	  established	  immediately	  after	  the	  material	  implantation”	  [128].	  
-­‐	   Mechanical	   Properties:	   Due	   to	   the	   high	   levels	   of	   pressure	   that	   cells	   are	  subjected	   to	   in	  vivo,	   the	   scaffold	   should	   have	   sufficient	  mechanical	   strength	   to	  withstand	  this	  and	  to	  maintain	  the	  spaces	  required	  for	  cell	  ingrowth	  and	  matrix	  production.	   Many	   researchers	   suggest	   that	   the	   mechanical	   properties	   of	   the	  implanted	  scaffold	  should	  ideally	  match	  those	  of	  living	  bone	  [129-­‐131].	  
-­‐	  Biodegradability:	  The	  scaffolds	  degradation	  rate	  must	  be	  tuned	  appropriately	  with	   the	   growth	   rate	   of	   the	   neotissue,	   so	   by	   the	   time	   the	   injury	   site	   is	   totally	  regenerated	  the	  scaffold	  is	  completely	  degraded	  [132].	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Material	  	   	  Origin	   Characteristics	   Outcome	  of	  study	   Reference	  Collagen	   Natural	   -­‐	  Low	  immune	  response	  -­‐	  Low	  mechanical	  properties	  
-­‐	  Good	  substrate	  for	  cell	  adhesion	  	  -­‐	  Active	  bone	  formation	   133-­‐136	  Fibrin	   Natural	   -­‐	  osteoconduction	  properties	   -­‐	  Promotes	  migration	  of	  vascular	  	  endothelial	  cells	  -­‐	  improved	  regeneration	  of	  mature	  epidermal	  structure	  	  
137-­‐140	  
Chitosan	   Natural	   -­‐	  osteoconduction	  properties	  -­‐	  Hemostatic	   -­‐	  Promotes	  wound	  healing	  -­‐	  Enhanced	  periodontal	  bone	  regeneration	  
141,	  142	  
Starch	  	   Natural	  	   -­‐ -­‐	  Thermoplastic	  behavior	  -­‐ -­‐	  Good	  mechanical	  properties	  
-­‐	  Enhanced	  cell	  adhesion	   23	  
Hyaluronic	  acid	  (HA)	   Natural	  	   -­‐ -­‐	  Low	  mechanical	  properties	   -­‐ -­‐	  Minimal	  immunogenicity	  	   143	  Demineralised	  bone	   Natural	  	   -­‐ -­‐	  Good	  mechanical	  properties	  -­‐ 	   -­‐ -­‐	  Promotes	  osteogenic	  differentiation	  of	  bone	  marrow	  stromal	  cells	   144	  Poly(a-­‐hydroxy	  acid)	  	   Synthetic	   -­‐	  Degradation	  by	  hydrolysis	  	   -­‐	  New	  bone	  formation	  -­‐	  no	  evidence	  of	  significant	  inflammatory	  reaction	  or	  local	  tissue	  damage	  
145,	  146	  
Polyurethane	  	   Synthetic	   -­‐	  Excellent	  mechanical	  properties	  -­‐	  Degradable	  and	  non	  degradable	  
-­‐	  Enhanced	  cell	  adhesion	  -­‐	  Promotes	  tissue	  ingrowth	  	  
147	  
Titanium	  	   Synthetic	   -­‐	  Excellent	  mechanical	  properties	   -­‐	  Promotes	  bone	  ingrowth	  both	  in	  vivo	  and	  in	  vitro	   148	  Bioactive	  glass	  	   Synthetic	   -­‐	  Degradable	  and	  non	  degradable	  -­‐	  Creates	  a	  strong	  bone/implant	  interface	  
-­‐	  Good	  bone	  bonding	  properties	  	  -­‐	  Enhances	  bone	  apposition	  
149	  
Table	  1.3;	  Natural	  and	  synthetic	  biocompatible	  scaffolds	  used	  in	  bone	  tissue	  engineering.	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poly(L-­‐lactide-­‐co-­‐D,L-­‐lactide)	  	   Synthetic	   -­‐	  Controllable	  biodegradability	  -­‐	  Low	  mechanical	  properties	  	  
-­‐	  Improves	  the	  distribution	  of	  calcified	  ECM	  -­‐	  Enhanced	  bone	  ingrowth	  
150	  
Poly(e-­‐caprolactone)	   Synthetic	  	  -­‐ -­‐	  Aliphatic	  polyester	  -­‐ -­‐	  Degraded	  by	  hydrolysis	  -­‐ -­‐	  Slow	  degrading	  -­‐ -­‐	  Good	  mechanical	  properties	  
-­‐	  Adhesion	  of	  bone	  marrow	  mesenchymal	  stem	  cells	   151	  
	  
	  
	   1.13.1	   Calcium	  phosphate	  (CaPs)	  based	  bioactive	  ceramic	  scaffolds	  	  CaPs	   have	   been	   extensively	   studied	   as	   scaffold	   material	   for	   bone	   tissue	  engineering	   since	   they	   are	   a	  major	   constituent	   of	   bone.	   Among	   different	   CaPs,	  the	  majority	  of	  research	  has	  been	  focused	  on	  hydroxyapatite	  (HA),	  β-­‐tricalcium	  phosphate	   (β-­‐TCP)	   or	   mixture	   of	   HA	   and	   β-­‐TCP	   otherwise	   known	   as	   biphasic	  calcium	   phosphate	   (BCP)	   [152].	  Recent	   studies	   have	   shown	   that	   BCP	   scaffolds	  (80	  ±	  3%	  HA	  and	  20	  ±	  3%	  β-­‐TCP)	  with	  70%	  interconnected	  porosity	  (68%	  pores	  are	   400	  μm,	   and	   ∼3%	   are	   0.7	  μm	   in	   size),	   can	   successfully	   support	   new	   bone	  formation	  in	  immune-­‐deﬁcient	  male	  mice	  [153].	  	  	   1.13.2	   Bioglass	  based	  bioresorbable	  scaffolds	  	  Bioglass	  scaffolds	  are	  silica	  that	  contain	  bioresorbable	  substances	  and	  have	  been	  used	   as	   an	   alternative	   to	   conventional	   bioinert	   materials	   for	   bone	   healing.	  Studies	  have	  shown	  that	  a	  bioglass	  scaffolds	  with	  70%	  porosity	  and	  300–400	  μm	  pore	   size,	   exhibited	   hydroxy	   carbonate	   apatite	   (HCA)	   layer	   formation	   on	   its	  surface	   that	   significantly	   enhanced	   osteoblast	   activity.	   The	  HCA	   layer	  was	   also	  shown	   to	   adsorb	   protein	   and	   growth	   factors	   that	   facilitated	   new	   bone	  formation	  in	   vivo	   [154].	   Various	   alterations	   to	   bioglass	   composition	   have	   been	  utilised	  to	  enhance	  it’s	  activity,	  just	  one	  recent	  example	  is	  a	  recent	  study	  in	  which	  cobalt	  (Co)	  was	  introduced	  in	  meso-­‐porous	  bioglass	  scaffolds	  to	  induce	  hypoxia	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that	   increased	   bone	   marrow-­‐derived	   stem	   cell	   (BMSC)	   proliferation,	  differentiation,	  and	  bone-­‐related	  gene	  expression	  [155].	  	  	   1.13.3	   Polymeric	  scaffolds	  	  Polymers	   can	   be	   both	   bioactive	   and	   biodegradable.	   Commonly	   used	   natural	  polymers	   for	   bone	   tissue	   engineering	   include	   collagen,	   ﬁbrin,	   alginate,	   silk,	  hyaluronic	  acid,	  and	  chitosan.	  One	  of	   the	  advantages	  of	  using	   these	  scaffolds	   is	  the	  flexibility	  in	  processing	  and	  ability	  to	  tailor	  the	  chemistry	  of	  polymers.	  	  
O’Brien	  et	  al.,	  used	  a	   collagen-­‐	  glycosaminoglycan	  scaffold	   to	  provide	  a	   suitable	  3D	   environment	   on	   which	   to	   culture	   adult	   rat	   mesenchymal	   stem	   cells	   and	  induce	   differentiation	   along	   the	   osteogenic	   and	   chondrogenic	   lineages.	   The	  results	   from	   the	   study	   demonstrated	   that	   the	   combination	   of	   adult	   rat	  mesenchymal	   stem	   cells	   and	   collagen-­‐glycosaminoglycan	   scaffold	   can	   induce	  osteogenesis	  and	  can	  be	  stimulated	  with	  osteogenic	   factors	  as	   indicated	  by	   the	  temporal	  induction	  of	  the	  bone-­‐specific	  proteins,	  collagen	  I	  and	  osteocalcin,	  and	  subsequent	  matrix	  mineralisation	  [156].	  	  Synthetic	  polymers	  are	  an	  alternauve	   to	  natural	  polymes	  as	  a	   scaffold	  material	  and	   have	   advantage	   that	   their	   properties	   can	   be	   more	   closely	   tailored	   and	  manipulated.	   Degradation	   of	   appropriate	   synthetic	   polymers	   can	   produce	  monomers	   which	   are	   readily	   removed	   by	   the	   natural	   physiological	   pathway.	  Some	   polymers	   such	   as	   poly	   (propylene	   fumarate)	   (PPF)	   have	   been	   shown	   to	  have	   high	   compressive	   strength	   that	   is	   comparable	   to	   cortical	   bone	   and	   their	  degradation	  time	  can	  be	  controlled.	  However,	  one	  of	  the	  disadvantages	  of	  using	  polymeric	   scaffolds	   is	   that	   they	   show	   rapid	   strength	   degradation	   in	   vivo	   even	  with	   high	   initial	   strength	   [157].	   It	   has	   been	   demonstrated	   that	   biodegradable	  porous	  poly(DL-­‐lactide-­‐co-­‐glycolide)	  (PDLLGA)	  hollow	  fibres	  in	  combination	  with	  human	   bone	  marrow	   stromal	   cells	   (HBMSC)	  was	   able	   to	   initiate	   natural	   bone	  repair.	   The	   results	   indicated	   that	   a	   high	   proportion	   of	   HBMSC	   survived	   when	  expanded	  on	  PDLLGA	  fibres	  for	  6	  days	  and	  in	  response	  to	  osteogenic	  stimuli,	  the	  cells	   differentiated	   along	   the	   osteogenic	   lineage	   with	   associated	   alkaline	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phosphatase	  activity.	  Following	  implantation	  into	  SCID	  mice,	  the	  combination	  of	  PDLLGA	  fibre–HBMSC	  resulted	  in	  type	  I	  collagen	  deposition	  and	  associated	  bone	  mineralisation	  and	  osteoid	  formation	  [158].	  	  	   1.13.4	  Metallic	  scaffolds	  	  	  Porous	  metallic	  scaffolds,	  predominantly	  made	  of	  titanium	  (Ti)	  and	  tantalum	  	  (Ta),	   have	   been	   studied	   as	   bone	   replacement	   materials	   since	   they	   have	   have	  high	  compressive	  strengths	  and	  excellent	  fatigue	  resistance	  [159,	  160].	  Xue	  et	  al.,	  processed	  17–58	   vol%	  porous	  Ti	  with	   an	   average	  pore	   size	   of	   800μm	  allowed	  strong	  osteoblast	   cell	   attachment	   and	  proliferation	   [161].	  However,	   unlike	  CaP	  or	   polymeric	   scaffolds,	   biomolecules	   cannot	   be	   integrated	   into	   these	   scaffolds	  and	   they	  are	  not	  biodegradable.	  Moreover,	   there	  are	   concerns	   related	   to	  metal	  ion	  release	  and	  surface	  modiﬁcation	  techniques	  are	  often	  employed	  to	  improve	  bioactivity	  of	  Ti	  scaffolds	  [162].	  	  	  Polyurethanes	   are	   becoming	   a	   popular	   biomaterial	   for	   use	   in	   bone	   tissue	  engineering.	  This	  is	  because	  of	  their	  excellent	  biocompatibility,	  great	  mechanical	  properties	   and	   easy	   handling	   during	   in	   vitro	   culture	   and	   in	   vivo	   implantation	  [163].	   They	   also	   have	   been	   shown	   in	   vivo	   to	   support	   cell	   growth	   and	  proliferation	   and	   the	   in-­‐growth	   of	   blood	   vessels.	   However,	   the	   major	  disadvantage	  of	  using	  PU	  as	  a	  biomaterial	  for	  long	  term	  implants	  is	  their	  low	  rate	  of	  biodegradation.	  Once	  implanted,	  several	  sources	  were	  found	  to	  contribute	  to	  their	  degradation.	  One	  example	  of	  this	  is	  the	  aliphatic	  ester	  linkage	  in	  polyester-­‐urethanes.	  These	  are	  known	  to	  be	  susceptible	  to	  hydrolytic	  degradation,	  whereas	  polyether-­‐urethane	   materials	   are	   known	   to	   be	   susceptible	   to	   degradative	  phenomenon	  involving	  crack	  formation	  and	  propagation.	  Furthermore,	  enzymes	  in	  the	  physiological	  environment	  such	  as	  hydrolytic	  enzymes	  are	  another	  factor	  contributing	   to	  PU	  degradation	   [164].	  Biodegradable	  PUs	   can	  be	  manufactured	  through	   a	   variety	   of	   techniques	   including	   carbon	   dioxide	   foaming,	  electrospinning,	   wet	   spinning,	   salt	   leaching	   and	   thermally	   induced	   phase	  separation.	   Studies	   have	   shown	   that	   biodegradable	   PUs	   can	   support	   cell	   in-­‐growth	   and	   hence	   tissue	   formation,	   and	   can	   also	   undergo	   controllable	  
	   	   44	  
degradation	  to	  noncytotoxic	  decomposition	  products.	  	  Since	  PUs	  can	  be	  modified	  in	   terms	   of	   their	   biological,	   mechanical	   and	   chemical	   properties,	   they	   present	  compelling	   future	   opportunities	   as	   scaffolds	   for	   bone	   tissue	   engineering	   [165-­‐168].	  
	  
1.14	   Peptide-­‐coated	  scaffolds	  
	  Since	  3D	  scaffolds	  have	  a	  larger	  interconnected	  porous	  structure	  compared	  to	  2D	  slides,	   modification	   of	   their	   surface	   to	   improve	   interaction	   between	   cell	   and	  surface	   would	   have	   potential	   to	   accelerate	   tissue	   formation.	   	   Cells	   in	   tissues	  constantly	  sense	  their	  environment	  by	  binding	  to	  molecules	  of	  the	  ECM	  and	  cell	  surface	   receptors	   that	   interact	   with	   ligands	   on	   neighboring	   cells.	   These	  interactions	   control	   cellular	   behavior	   and	   morphology	   and	   can	   therefore	  influence	  cell	  growth	  and	  differentiation.	  	  	  Cell	  adhesion	  to	  a	  surface	  is	  dependent	  on	  many	  factors	  including,	  the	  collection	  of	  extracellular	  matrix	  (ECM)	  proteins,	  the	  composition	  of	  ECM	  absorbed	  to	  the	  surface	  and	  also	  the	  intrinsic	  chemistry	  of	  the	  surface.	  How	  a	  cell	  attaches	  to	  the	  ECM	  will	  depend	  on	  its	  competition	  of	  integrins.	  Integrins	  are	  widely	  expressed	  and	  are	  involved	  in	  many	  biological	  functions	  including	  embryonic	  development,	  wound	  repair	  and	  homeostasis	  [169-­‐171].	  Integrin	  receptors	  consist	  of	  an	  alpha	  and	  a	  beta	  subunit	  and	  bind	  to	  many	  ECM	  proteins	  such	  as	  osteopontin	  (OPN),	  collagen	  type	  I	  (CoI),	  fibronectin	  (FN)	  and	  laminin	  (LN).	  This	  binding	  to	  the	  ECM	  occurs	  at	  specific	  sites	  known	  as	  focal	  adhesions	  (fig	  1.11).	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  Within	  a	  focal	  adhesion,	  the	  cytoplasmic	  domain	  of	  the	  integrins	  is	  linked	  to	  the	  actin	  cytoskeleton	  via	  a	  complex	  array	  of	  protein-­‐protein	  interactions.	  Integrin-­‐ECM	   binding	   has	   the	   ability	   to	   activate	  multiple	   signal	   transduction	   pathways	  and	  regulate	  gene	  expression.	  	  	   1.14.1	   Osteopontin	  
	  There	   are	   many	   integrins	   expressed	   on	   the	   surface	   of	   human	   osteoblastic	  cultured	   cells,	   but	   the	  major	   subunits	   include	  α3	  β1,	  α4	  β1	   and	  αv	  β1	   [173-­‐175].	  	  Osteopontin	  is	  a	  bone	  extracellular	  matrix	  protein	  as	  mentioned	  in	  section	  1.3.	  It	  is	  an	  acidic	  protein	  which	   is	  highly	  phosphorylated	  and	  glycosylated	  and	  has	  a	  arginine-­‐glycine-­‐aspartic	  acid	  (RGD)-­‐binding	  domain	  [176].	  Osteopontin	  binds	  to	  cells	  via	  the	  RGD	  cell	  adhesion	  sequence	  that	  recognises	  the	  αv	  β1	  integrin.	  OPN	  influences	  bone	  homeostatis	  in	  vivo	  by	  inhibiting	  mineral	  deposition,	  promoting	  differentiation	   of	   osteoclasts	   and	   by	   enhancing	   osteoclast	   activity.	   	   It	   is	  hypothesised	   that	   activated	  osteoblasts	   secrete	  ECM	  components	   such	   as	  OPN,	  
Fig	  1.11;	  The	  contact	  areas	  between	  the	  plasma	  membrane	  and	  the	  extracellular	  matrix	   (ECM)	  are	   called	  focal	   adhesions.	  Cell-­‐surface	   integrin	   molecules	   associate	   with	   intracellular	  cytoskeleton-­‐	  proteins	  and	  with	  ECM	  components	  [172].	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which	   are	   recognised	   and	   bound	   to	   by	   integrins	   on	   other	   osteoblasts	   to	   be	  activated	   (autocrine).	   However,	   osteoclasts	   also	   recognise	   OPN	   and	   use	   it	   to	  adhere	  to	  the	  bone	  surface	  and	  resorb	  bone	  matrices	  (paracrine)	  [177].	  	  	   1.14.2	   Tenascin	  C	  
	  Tenascins	   are	   a	   family	   of	   glycoproteins,	   which	   are	   present	   in	   many	   ECMs	  throughout	   our	   bodies.	   They	   are	   synthesised	   primarily	   by	   cells	   in	   connective	  tissue	   [178].	   Tenascin	   C	   (TNC)	   is	   an	   ECM	   protein	   that	   displays	   a	   restricted	  pattern	   of	   expression	   in	   vivo.	   Furthermore,	   it	   is	   highly	   expressed	   during	  embryonic	   development	   and	   organogenesis,	   it	   is	   reduced	   in	   developed	   organs	  but	   reappears	  under	  pathological	   conditions	   caused	  by	   infection,	   inflammation	  or	   during	   tumor	   development	   [178].	   	   The	   fact	   that	   TNC	   is	   significantly	  upregulated	  in	  tissues	  adjacent	  to	  injury	  sites,	  suggests	  it	  may	  play	  an	  important	  role	   in	   regulating	   cellular	   response	   to	   the	   provisional	   matrix.	   	   Many	   growth	  factors	   have	   been	   shown	   to	   promote	   the	   expression	   of	   TNC	   and	   another	  important	   mechanism	   to	   induce	   TNC	   expression	   is	   by	   applying	   a	   mechanical	  stress	  to	  cells	  in	  culture	  or	  tissues	  in	  vivo	  [178].	  In	  recent	  experiments	  employing	  osteoblast-­‐like	  cell	  lines,	  TNC	  was	  shown	  to	  stimulate	  alkaline	  phosphatase	  and	  anti-­‐TNC	   caused	   a	   reduction	   in	   alkaline	   phosphatase	   and	   collagen	   synthesise	  [179],	  suggesting	  that	  TNC	  plays	  an	  important	  role	  in	  bone	  cell	  differentiation.	  	  
	  
1.15	   Growth	  factors	  
	  Growth	   factors	   are	   proteins	   that	   serve	   as	   signaling	   agents	   for	   cells	   and	   they	  influence	   critical	   functions	   such	   as	   matrix	   synthesis,	   cell	   division,	   and	   tissue	  differentiation.	  Experimental	  results	  suggest	  that	  growth	  factors	  play	  a	  vital	  role	  in	   bone	   and	   cartilage	   formation,	   repair	   and	   healing	   of	   other	   musculoskeletal	  tissues.	   A	   wide	   variety	   of	   growth	   factors	   including	   fibroblast	   growth	   factors	  (FGFs),	  bone	  morphogenetic	  proteins	   (BMPs)	  and,	  parathyroid	  hormone	   (PTH)	  have	   been	   shown	   to	   be	   expressed	   during	   different	   phases	   of	   experimental	  fracture	   healing.	   Therefore,	   growth	   factors	   have	   been	   advocated	   as	   a	   potential	  clinical	   treatment	   for	   bone	   repair	   for	   example,	   Joyce	   et	   al.,	  demonstrated	   that	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injections	   of	   TGF-­‐1	   in	   a	   rat	   model	   could	   stimulate	   periosteal	   cells	   to	   undergo	  endochondral	  ossification	  [180].	  In	  another	  study	  Kato	  et	  al.,	  analysed	  the	  effect	  of	   various	   doses	   (0,	   50,	   100,	   200,	   and	   400	   μg)	   of	   rhFGF-­‐2	   on	   the	   healing	   of	  segmental	  tibial	  defects	  in	  rabbits.	  It	  was	  shown	  that	  concentrations	  of	  >100	  μg	  had	   significant	   effect	   on	   healing,	   bone	   volume	   and	   mineral	   content	   in	  comparison	   to	   controls.	   It	  was	   suggectsedt	   that	   a	   single	   injection	  of	  FGF-­‐2	  had	  the	   ability	   to	   enhance	   bone	   formation	   [181].	   In	   addition	   to	   full-­‐length	   growth	  factors,	   truncated	  peptides	  of	  BMP-­‐2	  have	  also	  demonstrated	  promising	  results	  [182,	   183].	   Saito	   et	   al.,	   reported	   that	   a	   BMP-­‐2-­‐derived	   peptide	   in	   combination	  with	  a	  porous	  alpha-­‐tricalcium	  phosphate	  (TCP)	  scaffold	  promoted	  calcification	  and	   induced	   connection	   in	   rabbit	   bone	   defects	   (20-­‐mm	   long)	   12	   weeks	   after	  implantation	  [182].	  
	  1.15.1	   Bone	  Morphogenetic	  Proteins	  (BMP)	  
	  Although	   many	   growth	   factors	   have	   shown	   potential	   for	   use	   in	   bone	  regeneration	  and	  repair,	  BMPs	  are	  the	  most	   investigated	  osteoinductive	  factors	  described	   to	   date	   [184].	   BMPs	   are	   cytokines	   with	   important	   roles	   during	  embryonic	  patterning	  and	  early	  skeletal	  formation.	  The	  various	  individual	  BMPs,	  of	   which	   there	   are	   more	   than	   30	   members,	   have	   been	   shown	   to	   induce	  differentiation	  of	  mesenchymal	  stem	  cells	   into	  cells	  of	  osteoblast	   lineage	  [185].	  However	  interest	  has	  been	  focused	  on	  BMP-­‐2	  and	  -­‐4	  in	  the	  potential	  treatment	  of	  segmental	  bone	  defects,	  fracture	  repair	  and	  in	  the	  fixation	  of	  prosthetic	  implants	  [186].	   Nowadays,	   recombinant	   human	   BMPs	   (rhBMPs)	   are	   widely	   used	   in	  several	   tissue-­‐engineering	   products	   that	   might	   serve	   for	   the	   complete	  regeneration	  of	  bone	  or	  cartilage.	  Current	  applications	  include	  rhBMPs	  loaded	  in	  delivery	  systems	  made	  of	  synthetic	  or	  natural	  polymers	  and	  the	  differentiation	  of	  transplanted	   stem	   cells	   from	   the	   patient	   with	   rhBMPs	   for	   later	   body	  implantation.	  	  	  Biodegradable	   polymers	   have	   been	  widely	   used	   as	   a	   carrier	   for	   BMP	   delivery	  including	   poly(lactic	   acid)	   (PLA)	   [187],	   polylactic	   acid–p-­‐dioxanone–polyethylene	   glycol	   (PLA–DX–PEG)	   [188]	   and,	   Poly(lactic-­‐co-­‐glycolic	   acid)	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(PLGA)	   [189].	   PLGA	   has	   shown	   successful	   results	   in	   delivering	   rhBMP-­‐2	   and	  inducing	  the	  repair	  of	  bone	  defects	  several	  weeks	  after	  implantation	  in	  alveolar	  cleft	  repair	   in	  dogs	  [180],	   in	  gelatine	  sponge	  composites	   in	  a	  rabbit	  ulna	  model	  [190],	  in	  tooth	  defects	  of	  dogs	  [191]	  and	  in	  combination	  with	  bone	  marrow	  cells	  in	  a	  rabbit	  segmental	  bone	  defect	  model	  [192].	  Similarly,	  an	  acrylated	  hyaluronic	  acid	  hydrogel	  was	  used	  in	  combination	  with	  human	  mesenchymal	  stem	  cells	  and	  rhBMP-­‐2	   for	   healing	   of	   rat	   calvarial	   defects	   [193].	   Higher	   levels	   of	   osteocalcin	  expression	  and	  bone	   formation	  occurred	  when	   the	  BMP-­‐2	  and	  stem	  cells	  were	  tested.	  	  Natural	   polymers	   have	   also	   been	   used	   as	   carriers	   for	   BMP	   delivery	   [194].	  Recently,	   rhBMP-­‐2	  was	   immobilised	   directly	   on	   chitosan	   nanoﬁbres	   (a	   guided	  bone-­‐regenerative	  membrane	  surface)	   that	   functioned	  as	  a	  bioactive	  surface	   to	  enhance	   bone	   healing	   [195].	   It	   was	   demonstrated	   that	   the	   BMP-­‐2-­‐conjugated	  membrane	   surface	   retained	   bioactivity	   for	   up	   to	   4	   weeks	   of	   incubation,	  promoting	   cell	   attachment,	   proliferation,	   ALP	   activity	   and	   calciﬁcation.	   In	  another	   study,	   it	   was	   shown	   that	   electrospun	   silk	   fibroin-­‐based	   scaffolds	  supported	   hMSC	   growth	   and	   differentiation	   towards	   an	   osteogenic	   lineage.	  Results	   from	   the	   study	   indicated	   that	   scaffolds	   with	   the	   co-­‐processed	   BMP-­‐2	  supported	  higher	  calcium	  deposition,	  higher	   transcript	   levels	  of	  collagen	   type	   I	  and	   enhanced	   transcript	   levels	   of	   bone-­‐specific	   markers	   on	   day	   31	   of	   static	  culture	  [196].	  	  	  Similarly,	  rhBMP-­‐2	  was	  directly	   immobilised	  on	  silk	  ﬁbroin	  ﬁlms	  and	  the	  effect	  of	   the	   delivery	   system	   studied	   in	   human	   bone	   marrow	   stromal	   cells	   and	   in	  critical-­‐sized	  cranial	  defects	  in	  mice	  [197]	  and	  the	  rhBMP	  retained	  its	  biological	  activity.	  In	  another	  report,	  silk	  scaffold	  ﬁbres,	  prepared	  by	  electrospinning,	  were	  used	   to	   deliver	   rhBMP-­‐2	   and	   hydroxyapatite	   nanoparticles	   for	   in	   vitro	   bone	  formation	   [196].	   The	   rhBMP-­‐2	   induced	   osteogenesis	   in	   cultures	   of	   human	  mesenchymal	  stem	  cells.	  The	  group	  also	  tested	  BMP-­‐2	  delivered	  via	  silk	  ﬁbroin	  scaffolds	   in	   critical	   size	   defects	   in	   mice	   [198].	   In	   both	   studies,	   the	   delivered	  rhBMP-­‐2	  increased	  levels	  of	  ALP	  activity	  and	  calcium	  deposition	  and	  transcript	  levels	  for	  bone	  sialoprotein,	  osteopontin,	  osteocalcin	  and	  RUNX2.	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1.16	   	  	  	  	  Cells	  for	  bone	  tissue	  engineering	  
	  An	   ideal	   cell	   source	   should	   be	   easily	   expandable	   to	   higher	   passages,	   non-­‐immunogeneic	  and	  have	  a	  protein	  expression	  pattern	  similar	  to	  the	  tissue	  to	  be	  regenerated.	  
	   1.16.1	   Osteoblasts	  
The	   isolation	   of	   osteoblasts	   from	   biopsies	   taken	   from	   the	   patient	   is	   the	   most	  obvious	   choice	   of	   cells	   because	   of	   their	   non-­‐immugenicity.	   However	   there	   are	  several	   limitations	   to	   using	   these	   cells	   including:	   the	   additional	   surgery	   time	  required,	   few	   cells	   are	   available	   after	   the	   dissociation	   of	   the	   tissue	   and	   their	  expansion	   rates	   are	   relatively	   low.	   Furthermore,	   for	   a	   patient	   with	   a	   bone	  disease,	   their	  osteoblasts	  may	  not	  be	  appropriate	   for	   transplantation	   [199].	  An	  alternative	  to	  this	  method	  is	  the	  use	  of	  cells	  obtained	  from	  other	  animals	  which	  could	   solve	   the	   problem	   of	   low	   cell	   numbers.	   However	   there	   are	   also	   some	  limitations	   to	   this	   procedure	   including:	   the	   possibilities	   of	   the	   transmission	   of	  infectious	  agents	  and	  immunogenicity	  of	  the	  cells.	  The	  ethical	  problems	  related	  with	  use	  of	  animal	  cells	  have	  reduced	  the	  enthusiasm	  for	  this	  approach	  [200].	  A	  more	  promising	  solution	  is	  the	  use	  of	  stem	  cells.	  
	   1.16.2	   Stem	  Cells	  
Stem	   cells	   are	   undifferentiated	   cells	   with	   a	   high	   proliferation	   capability,	   the	  ability	   to	   self-­‐renew	   and	   the	   ability	   to	   differentiate	   to	   multiple	   cell	   lineages	  [201].	   Stem	   cells	   have	   varying	   degrees	   of	   differentiation	   potential.	   The	   most	  primitive	  one	  being	  derived	   from	   the	   zygote	   in	   the	  embryonic	   stage	  which	  are	  also	   known	   as	   embryonic	   stem	   cells	   (ESCs).	   Adult	   stem	   cells	   (ASCs)	   are	   those	  found	  in	  fully	  differentiated	  tissues.	  
	   	   -­‐	  Embryonic	  Stem	  Cells	  
Undifferentiated	   ESCs	   (fig	   1.12)	   have	   the	   potential	   to	   differentiate	   into	   many	  kinds	  of	  tissues	  including	  cardiomyocytes,	  haematopoietic	  cells,	  endothelial	  cells,	  neurons,	   chondrocytes,	   adipocytes,	   hepatocytes	   and	   pancreatic	   islets	   [202].	   In	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the	  bone	  tissue	  engineering	  field	  Buttery	  et	  al,	  reported	  how	  osteoblasts	  can	  be	  differentiated	   from	  ES	   cells	   in	   the	  presence	  of	  dexamethasone	   [203].	  However,	  the	   criticism	   against	   their	   use	   because	   of	   ethical	   and	   social	   issues	   is	   the	  most	  difficult	  barrier	  to	  overcome.	  	  
	  
	   	   	  
	   	   -­‐	  Adult	  Stem	  Cells	  	  
ASCs	   are	   found	   in	   the	   bone	   marrow,	   periosteum,	   muscle,	   fat,	   brain	   and	   skin	  [205].	   In	   the	   bone	   tissue	   engineering	   field	   there	   has	   been	   a	   special	   interest	   in	  bone	  marrow	  stromal	  cells	  	  (stem	  cells	  located	  in	  the	  bone	  marrow),	  also	  known	  as	   Mesenchymal	   Stem	   Cells	   (MSC).	   These	   are	   the	   cells	   that	   differentiate	   into	  osteoblasts	   in	  vivo.	  The	  bone	  marrow	  site	   is	   the	  most	  exploited	  source	  of	   these	  cells,	   however	   MSCs	   have	   also	   been	   found	   in	   other	   tissues	   such	   as	   the	  periosteum	  and	  adipose	   tissue.	  Apart	   from	  their	  differentiation	  potential,	  MSCs	  present	   other	   important	   properties.	   Bruder	   et	   al,	   described	   that	   they	   can	   be	  
Fig	  1.12;	  Pluripotent	  of	  embryonic	  stem	  cells.	  The	  cells	  can	  become	  into	  many	  types	  of	  tissues	  in	  the	  body	  [204].	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extensively	   expanded	   in	   vitro	   [206].	   Pittinger	   et	   al,	   also	   showed	   that	   with	   an	  increased	   number	   of	   passages,	   they	   did	   not	   spontaneously	   differentiate.	  Furthermore	   it	   has	   been	   suggested	   that	   these	   cells	   may	   possess	  immunosuppressive	   effects.	   This	  may	   allow	   them	   to	   have	   immunosuppressive	  roles	   in	   vivo,	   which	   would	   make	   them	   suitable	   for	   allogeneic	   or	   xenogeneic	  transplantation	  [207].	  	  
Although	   MSCs	   have	   several	   advantages	   regarding	   their	   use	   for	   tissue	  engineering,	   there	   are	   some	   limitations	   to	   their	   use.	   It	   is	   known	   that	   the	  percentage	   of	  MSCs	   present	   in	   the	   bone	  marrow	   is	   roughly	   1	   in	   each	   100,000	  cells,	   which	  makes	   the	   expansion	   time	   consuming.	   It	   was	   also	   shown	   that	   the	  number	  as	  well	   as	   the	  differentiation	  potential	  of	  MSCs	   is	   lower	  when	   isolated	  from	  elderly	  patients.	  Similar	  to	  ESCs,	  the	  knowledge	  regarding	  the	  mechanisms	  and	  pathways	  that	  lead	  to	  the	  final	  osteogenic	  differentiation	  is	  still	  limited	  and	  further	  research	  into	  this	  field	  is	  required	  [208].	  The	  limitations	  associated	  with	  hMSCs	   can	   be	   overcome	   by	   using	   human	   embryonic	   stem	   cell-­‐derived	  mesodermal	  progenitors	  (hES-­‐MPs).	  It	  has	  been	  demonstrated	  that	  under	  proper	  stimulation,	   hES-­‐MP	   cells	   can	   undergo	   osteogenic	   differentiation	   and	   have	  shown	  to	  have	  much	  higher	  mineralisation	  ability	  in	  comparison	  to	  hMSCs	  [209].	  Several	  studies	  have	  suggested	  hES-­‐MPs	  hold	  great	  potential	  for	  the	  construction	  of	  bone	  substitutes	  and	  can	  be	  a	  suitable	  alternative	  cell	   source	   to	  hMCS	   [210-­‐212].	   The	   osteogenic	   differentiation	   potential	   of	   hES-­‐MP	   cells	   is	   further	  investigated	  in	  chapters	  3,	  4	  and	  5	  of	  this	  project.	  	  
1.17	   Bioreactors	  for	  bone	  tissue	  engineering	  
	  Throughout	  the	  past	  decade,	  research	  has	  shown	  that	  traditional	  2D	  cell	  culture	  techniques	  are	   inadequate	   for	   three-­‐dimensional	  3D	   tissue	  engineering.	  This	   is	  primarily	   due	   to	   the	   fact	   that	   in	   2D	   culture,	   a	   monolayer	   of	   cells	   are	   in	  continuous	  contact	  with	  the	  culture	  medium	  and	  because	  of	  this,	  simple	  diffusion	  is	   sufficient	   to	   maintain	   cell	   viability.	   However	   when	   we	   are	   considering	   3D	  scaffolds,	   the	   diffusion	   of	   nutrients	   and	   removal	   of	   waste	   from	   the	   inner	   core	  becomes	  very	  limited	  and	  as	  a	  result	   it	  will	   lead	  to	  central	  core	  necrosis	  with	  a	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layer	  of	   live	  cells	  on	  the	  surface	  crust	  of	   the	  scaffold	  [213,	  214].	  These	  findings	  have	   lead	   researchers	   to	   design	   various	   hydrodynamic	   bioreactors	   to	   promote	  chemotransport	   for	   in	  vitro	  3D	  culture.	  Although	   the	  main	  aim	  of	  perfusing	  3D	  scaffold	  is	  chemotransport	  it	  is	  likely	  that	  fluid	  flow	  will	  also	  subject	  the	  cells	  to	  a	  mechanical	   signal.	   As	   discussed	   above	   (section	   1.7)	   bone	   cells	   are	   highly	  sensitive	  to	  fluid	  flow	  and	  therefore	  it	  is	  not	  surprising	  that	  MSCs	  differentiating	  to	   osteoblasts	   are	   also	   highly	   sensitive	   to	   fluid	   flow.	   	   Many	   of	   the	   same	  mechanisms	  by	  which	  osteoblasts	  and	  osteocytes	  respond	  to	  fluid	  flow	  seem	  to	  be	  also	  present	  in	  MSCs	  [215].	  Various	  experimental	  setups	  have	  been	  utilised	  to	  apply	  flow	  in	  2D	  systems	  including	  parallel	  plate	  flow	  chambers,	  rotating	  disc,	  jet	  impingement,	   and	   microfluidic	   apparatus.	   A	   number	   of	   bioreactor	   types	   have	  also	   been	   designed	   for	   3D	   tissue	   engineering	   applications	   including	   spinner	  flasks,	   rotating	  wall	   bioreactors	   and	   perfusion	   rigs.	   These	   studies	   have	   used	   a	  range	  of	  bone	  cell	  types	  from	  immature	  MSCs	  to	  mature	  osteoblasts.	  	  
	  
Warren	   et	   al.,	   used	   a	   flow-­‐perfusion	   bioreactor	   to	   provide	   chemotransport	   to	  thick	   (6	   mm)	   polyurethane	   scaffolds	   (fig	   1.13),	   seeded	   with	   murine	  preosteoblasts.	   Samples	   were	   subjected	   to	   flow	   on	   days	   2,	   4,	   6	   and	   8	   and	  analysed	   for	   cellular	   distribution,	   viability	   and	  metabolic	   activity	   compared	   to	  static	   conditions.	  Results	  demonstrated	   that	  constructs	   subjected	   to	   flow	  had	  a	  peripheral	  cell	  density	  of	  94%	  and	  a	  core	  density	  of	  76%,	  whilst	  those	  cultured	  in	   static	   conditions	   had	   a	   peripheral	   cell	   density	   of	   67%	  and	   a	   core	   density	   of	  0.3%	  [216].	  	  	  	  	  	  	  	  	  	  	  
(a)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  (b)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Fig	  1.13;	  (a)	  Schematic	  of	  the	  8-­‐chamber	  flow-­‐perfusion	  bioreactor	  within	  a	  standard	  cell	  culture	  incubator.	  (b)	  Schematic	  chamber	  within	  the	  flow-­‐perfusion	  bioreactor	  whereby	  media	  is	  forced	  through	  the	  entire	  structure	  of	  the	  scaffold.	  Arrows	  indicate	  direction	  of	  flow	  [216].	  	  
	   	   53	  
In	  a	  similar	  study	  Sikavitsas	  et	  al.,	  seeded	  rat	  bone	  marrow	  cells	  onto	  a	  titanium	  fiber	   mesh	   and	   cultured	   them	   under	   static	   conditions	   or	   in	   a	   flow	   perfusion	  bioreactor	   for	   4,	   8	   and	   16	   days	   [217].	   Constructs	   were	   examined	   for	   DNA	  content,	   calcium	   deposition	   and	   alkaline	   phosphatase	   activity.	   Results	  demonstrated	   an	   increase	   in	   DNA	   content	   from	   day	   4	   to	   day	   8	   for	   constructs	  under	  perfusion	  flow	  and	  a	  significant	  enhancement	  in	  DNA	  on	  day	  8	  compared	  to	   static	   conditions.	   Calcium	   content	  was	   also	  higher	   for	   scaffolds	   subjected	   to	  fluid	  flow	  on	  day	  16.	  
	  
Jaasma	  et	  al,	  investigated	  the	  short	  term	  (1-­‐49h)	  effects	  of	  various	  flow	  regimens	  including	   intermittent	   steady	   (1	   ml/min),	   pulasatile	   (0-­‐1	   ml/min,	   2	   Hz)	   and	  oscillatory	   fluid	   flow	  (1	  ml/min,	  1	  Hz)	  on	  MC3T3-­‐E1	  osteoblastic	   cells	  on	  a	  3D	  collagen-­‐glycosaminoglycan	  scaffold	  (fig	  1.14).	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  The	  results	  showed	  that	  intermittent	  flow	  (high	  flow	  rate)	  significantly	  increased	  COX-­‐2	  expression,	  PGE2	  production	  and	  osteopontin	  expression	  when	  compared	  to	   steady	   flow	   conditions	   (continuous	   low	   flow	   rate).	   Pulsatile	   and	   oscillatory	  flow	   tripled	   COX-­‐2	   expression,	   whereas	   under	   steady	   flow	   PGE2	   production	  
Fig	   1.14;	   Cross	   section	   of	   the	   scaffold	   chamber.	   O-­‐rings	   hold	  cell-­‐seeded	   scaffold	   in	   place	  whilst	   media	   is	   pumped	   through	  the	  tubing.	  Arrows	  indicate	  direction	  of	  flow	  [85].	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Fig	   1.15;	   Schematic	   drawing	   of	   the	   chamber	  within	   the	   flow-­‐perfusion	  bioreactor.	   Media	   is	   forced	   through	   the	   calcium	   phosphate	   scaffold	  providing	   fresh	   media	   and	   subjecting	   cells	   to	   a	   mechanical	   stimuli.	  Arrows	  indicate	  direction	  of	  flow	  [84]	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Kim	  and	  Ma.,	  demonstrated	  the	  importance	  of	  media	  flow	  in	  bioreactor	  systems	  and	  how	  it	  can	  create	  a	  different	  cellular	  and	  biomechanical	  environment	  in	  3D	  porous	   polyethylene	   terephthalate	   (PET)	   constructs	   [218].	   The	   influence	   of	  different	   flow	   patterns	   (transverse	   flow	   and	   parallel	   flow)	   on	   hMSC’s	   cellular	  microenvironment	   was	   investigated.	   Results	   suggested	   that	   parallel	   flow	  configuration	   retained	   ECM	   proteins	   however	   transverse	   flow	   induced	  osteogenic	   differentiation	   with	   higher	   ALP,	   higher	   calcium	   deposition,	   and	   up	  regulation	  of	  bone	  markers	  e.g.	  BMP-­‐2,	  RUNX2	  and	  OC.	  	  Taking	  these	  results	  into	  account,	  it	  can	  be	  concluded	  that	  the	  application	  of	  fluid	  flow	  can	  enhance	  early	  proliferation	  and	  minerlised	  matrix	  production	  of	  bone	  marrow	   stromal	   osteoblasts	   as	   well	   as	   mature	   osteoblasts	   and	   also	   induce	  osteogenic	  differentiation	  in	  hMSC.	  	  
	  
1.18	   Fluid	  Shear	  Stress	  
	  There	   have	   been	   a	   vast	   number	   of	   studies	   for	   non-­‐human	   and	   human	   cell	  lines/primary	   cells,	   detailing	   the	   effects	   of	   fluid	   shear	   stress	   on	   directing	  commitment	   towards	   an	   osteogenic	   lineage	   for	   2D	   systems.	   Fluid	   shear	   stress	  has	  increased	  the	  expression	  levels	  of	  OPN,	  OC,	  PGE2,	  Col1	  and	  NO	  [219-­‐232].	  In	  2D	   systems	   it	   appears	   that	   a	   range	   of	   0.1-­‐0.5	   Pa	   [233]	   is	   sufficient	   to	   induce	  osteogenic	   differentiation	   and	   in	   some	   cases	   values	   as	   high	   as	   2	   Pa	   have	  produced	   a	   positive	   response.	   These	   values	   show	   a	   good	   correlation	   with	   the	  levels	   of	   shear	   stress	   expected	   to	   occur	   in	  vivo	  (0.8-­‐3	   Pa)	   on	   osteocytes	   [234],	  however	   it	   is	   not	   known	   whether	   the	   optimum	   shear	   stress	   for	   fully	  differentiated	   cells	   would	   be	   the	   same	   as	   for	   undifferentiated	   MSCs.	   Recent	  studies	   have	   also	   investigated	   the	   complex	   mechanical	   environment	   of	  osteocytes	   in	   vivo	   in	   order	   to	   predict	   average	   interstitial	   fluid	   velocities	   and	  average	   maximum	  shear	  stresses	   [235,	   236],	   which	   are	   in	   agreement	   with	  previous	  studies.	  	  	  In	   3D	   culture	   systems,	   the	   application	   of	   fluid	   shear	   stress	   has	   resulted	   in	   an	  increase	   in	   expression	   of	   ALP,	   PGE2,	   OPN,	   OC,	   COX-­‐2,	   RunX2,	   Col1	   and	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Table	  1.4;	  Shear	  stress	  values	  for	  experimental	  investigations.	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1.19	   Aims	  &	  Objectives	  	  The	   combination	   of	   mesenchymal	   stem	   cells	   and	   3D	   scaffolds	   has	   become	   an	  active	   area	   of	   research	   into	   creating	   functional	   bone	   constructs.	   Cell-­‐seeded	  scaffolds	  cultured	  in	  static	  conditions	  have	  shown	  to	  have	  major	  limitations	  with	  respect	  to	  cell	  proliferation	  and	  cell	  function.	  This	  has	  lead	  researchers	  to	  design	  various	   bioreactors	   in	   order	   to	   provide	   a	   controlled	   physiochemical	   and	  biomechanical	   microenvironment	   to	   maintain	   the	   quality	   of	   the	   3D	   construct.	  Fluid	  flow	  within	  bioreactors	  is	  important	  not	  only	  for	  the	  delivery	  of	  oxygen	  and	  nutrients	  on	  cells	  within	  scaffolds	  but	  also	  exerts	  a	  hydrodynamic	  shear	  stress,	  which	   has	   been	   shown	   to	   enhance	   genes	   associated	   with	   osteogenesis.	   In	  particular,	   oscillatory	   and	   unidirectional	   flow	   have	   demonstrated	   to	   direct	  commitment	   towards	   an	   osteogenic	   lineage	   for	   2D	   systems	   but	   the	   signaling	  mechanisms	   by	  which	   cells	   convert	   shear	   stress	   into	   biochemical	   signals	   have	  not	  been	   fully	   investigated	   in	   a	  3D	  model.	  Therefore,	   the	  ultimate	  main	   aim	  of	  this	   project	   was	   to	   investigate	   the	   ability	   of	   a	   perfusion	   bioreactor	   to	   achieve	  progenitor	   cell	   commitment	   towards	   an	   osteogenic	   lineage	   and	   accelerate	   the	  biological	   process	   of	   osteogenesis	   with	   a	   particular	   focus	   on	   short	   bouts	   of	  perfusion	  and	  the	  effect	  of	  oscialltory	  verses	  unidirectional	  flow.	  	  In	  order	  to	  achieve	  this	  aim,	  the	  project	  was	  broken	  down	  into	  a	  list	  of	  objectives:	  	  
1. Setup	  a	  model	  system	  to	  investigate	  the	  in	  vitro	  culture	  of	  MSCs	  in	  a	  
3D	  environment:	  
• Study	   the	  osteogenic	  differentiation	  of	  mouse	  MSCs	  and	  a	  Mesenchymal	  progenitor	   derived	   from	  human	   embryonic	   stem	   cell	   (hES-­‐MP)	   in	   static	  culture	  
• Study	  the	  effects	  of	   fluid	   flow	  on	  the	  osteogenic	  response	  of	  mouse	  MSC	  and	  hES-­‐MP	  cells	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2. Investigate	  the	  effects	  of	  different	  flow	  type	  with	  respect	  to	  hES-­‐MP	  
osteogenesis:	  
• Study	  the	  biological	  outcome	  of	  hES-­‐MP	  cells	  subjected	  to	  unidirectional	  and	  oscillatory	  fluid	  flow	  
	  
3. Investigate	  the	  response	  of	  hES-­‐MP	  cells	  on	  different	  peptide-­‐coated	  
scaffolds:	  
• Study	   hES-­‐MP	   cell	   viability	   and	   matrix	   production	   in	   serum-­‐containing	  and	  serum-­‐free	  media	  	  
• Study	   the	   effects	   of	   peptide-­‐coated	   scaffolds	   and	   fluid	   flow	   on	   the	  osteogenic	  differentiation	  of	  hES-­‐MP	  cell	  	  
4. Investigate	  the	  response	  of	  primary	  cilium	  to	  fluid	  flow	  in	  3D	  porous	  
scaffolds:	  
• Identify	  the	  primary	  cilia	  of	  mature	  bone	  cells	  seeded	  on	  glass	  scaffolds	  
• Study	   the	   removal/inhibition	   of	   primary	   cilia	   using	   chloral	   hydrate	  treatment	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   dose-­‐dependent	   manner.	   Proc	   Natl	   Acad	   Sci	   USA.	   2002,	   99,	  12600-­‐5.	  
	   	   80	  











	   	   81	  
Chapter	  2:	  Materials	  and	  Methods	  
	  
2.1	   Materials	  
	   1. Polyether	   polyurethane	   (PU)	   foam	   grade	   XE1700V	   (department	   of	  chemistry,	  University	  of	  Sheffield,	  UK)	  2. Glass-­‐based	   3D	   cell	   matrix	   (kindly	   donated	   by	   Dr.	   Sion	   Philips,	   Orla	  Protein	  Technologies	  Ltd,	  Newcastle,	  UK)	  3. BM1	   murine	   bone	   marrow	   derived	   MSC	   (donated	   by	   University	   of	  Sheffield,	  Medical	  School,	  Sheffield,	  UK)	  4. BM1	   murine	   bone	   marrow	   derived	   MSC	   culture	   media:	   DMEM	  supplemented	   with	   10%	   (v/v)	   fetal	   bovine	   serum	   (FBS),	   1%	  penicillin/streptomycin	  (P/S)	  and	  1%	  Glutamine	  (G)	  5. MLO-­‐A5	  osteoblastic	  cell	   (kindly	  donated	  by	  Professor	  Lynda	  Bonewald,	  University	  of	  Missouri,	  Kansas	  City,	  USA)	  6. MLO-­‐A5	  basal	  culture	  media:	  Alpha	  minimum	  essential	  medium	  (α-­‐MEM)	  supplemented	   with	   5%	   FBS,	   5%	   bovine	   calf	   serum	   (BCS),	   1%	   P/S	   and	  0.25%	  fungizone	  (F)	  7. Human	   embryonic	   stem	   cell	   mesenchymal	   progenitor	   cells	   (hES-­‐MP	  0025)	  (Cellartis,	  Gothenburg,	  Sweden)	  8. hES-­‐MP	  serum-­‐free	  media:	  Stemline®	  Pluripotent	  Stem	  Cell	  Culture	  Medium	  (Sigma	  Aldrich,	  Roset,	  UK).	  9. hES-­‐MP	   basal	   culture	   media:	   α-­‐MEM	   supplemented	   with	   10%	   FCS,	   1%	  P/S	  and	  1%	  Glutamine	  	  10. hES-­‐MP	   osteogenic	   differentiation	   media:	   hES-­‐MP	   basal	   culture	   media	  supplemented	  with	  dexamethasone	  at	  final	  concentration	  10	  nM,	  ascorbic	  asic-­‐2-­‐phosphate	  (AA)	  50	  μg/ml	  and	  5mM	  of	  β-­‐glycerophosphate	  (βGP)	  11. Loading	   media:	   α-­‐MEM	   supplemented	   with	   10%	   FCS,	   1%	   P/S	   and	   1%	  Glutamine	  12. Medical	  grade	  stainless	  steel	  rings	  (internal	  diameter	  1	  cm)	  13. Porcine	  gelatine	  (Sigma,	  UK)	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14. MTT	  (Sigma	  Aldrich,	  Roset,	  UK)	  15. MTS	  (Promega,	  Southampton,	  UK)	  16. DAPI	  [4’-­‐6-­‐Diamidino-­‐2-­‐phenylindole]	  (Sigma	  Aldrich,	  Roset,	  UK)	  17. ALP	   Yellow	   (pNPP)	   Liquid	   Substrate	   system	   for	   ELISA	   (Sigma,	   UK)	   for	  measuring	  alkaline	  phosphatase	  (ALP)	  activity	  in	  cells.	  	  18. Oscillatory	  fluid	  flow	  pump	  (ibidi,	  Germany)	  	  19. Peristaltic	  fluid	  pump	  (fisher,	  UK)	  20. Silicone	  tubing/conduit	  (cole-­‐parmer,	  UK)	  21. Sirius	  Red	  (Sigma	  Aldrich,	  Roset,	  UK)	  22. Alizarin	  red	  (Sigma	  Aldrich,	  Roset,	  UK)	  23. PGE2	  Assay	  kit	  (Parameter,	  R&D	  Systems,	  Abingdon,	  UK)	  for	  quantitative	  determination	  of	  Prostaglandin	  E2	  in	  cell	  culture	  supernates.	  	  24. Mouse	  antibody	   to	  Acetylated	  alpha	   tubulin	   [6-­‐11B-­‐1]	   (2mg/ml)	   (Sigma	  Aldrich,	  Roset,	  UK)	  25. FITC-­‐conjugated	   rabbit	   anti-­‐mouse	   immunoglobulins	   (green)	   or	  rhodamine-­‐conjugated	   goat	   anti-­‐mouse	   immunoglobulins	   (red)	  (400mg/L)	  (Sigma	  Aldrich,	  Roset,	  UK)	  26. Micro	  CT	  scanner	  (SKYSCAN)	  27. ImageJ	  software	  (National	  institute	  of	  Health,	  Maryland,	  USA)	  28. Simpleware	  software	  (Exeter,	  UK)	  29. All	  other	  chemicals	  were	  from	  Sigma	  Aldrich	  (Dorset,	  UK)	  unless	  stated.	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2.2	   Methods	  
	  
2.2.1	  Cell	  preparation	  	  All	  cells	  were	  examined	  daily	  to	  observe	  their	  morphology,	  colour	  of	  media	  and	  density	  of	  cells.	  To	  passage	  cells,	  cell	  media	  was	  removed	  and	  cells	  were	  washed	  with	  PBS	  twice	  before	  adding	  2	  ml	  of	  trypsin-­‐EDTA	  and	  incubated	  for	  5	  minutes	  to	  detach	  cells.	  Media	  was	  added	  to	  halt	  the	  trypsin-­‐EDTA	  reaction	  and	  detached	  cells	   in	   suspension	  were	   centrifuged	   at	   1000	   rpm	   for	   5	  minutes	   to	   form	  a	   cell	  pellet.	  The	  supernatant	  was	  poured	  off	  and	  cells	  were	  resuspended	  in	  a	  known	  volume	  of	  media.	  A	  cell	  count	  was	  performed	  using	  a	  haemocytometer	  and	  cells	  were	  then	  split	  1:10	  to	  new	  flasks.	  
	   2.2.1.1	  	  	  Murine	  bone	  marrow	  derived	  MSC	  (BM1)	  
	  Murine	   bone	   marrow	   derived	   MSCs,	   previously	   isolated	   in	   the	   lab	   from	   5-­‐8	  weeks	  old	  Balb/c	  mice	  by	  our	  collaborator	   Ilaria	  Bellantuono,	  were	  cultured	   in	  DMEM	  media	  supplemented	  with	  10%	  (v/v)	  FBS,	  1%	  Penicillin	  (P)	  and	  2	  mM	  L-­‐Glutamine	  (G)	  in	  a	  370C	  incubator	  with	  a	  humidified	  atmosphere	  of	  95%	  air	  and	  5%	   CO2	   in	   0.1%	   gelatin	   coated	   T75	   flasks.	   Cells	   were	   used	   for	   experiments	  between	  passages	  3-­‐10	  in	  most	  cases.	  
	  2.2.1.2	  	  	  Osteoblastic	  cell	  line	  (MLO-­‐A5)	  
	  MLO-­‐A5	   cells	   are	   postosteoblast-­‐preosteocyte	   cells	   and	   are	   thought	   to	   behave	  similarly	  to	  the	  cells	  that	  are	  responsible	  for	  mineralisation	  in	  bone.	  Kato	  et	  al.,	  have	   also	   described	   these	   cells	   as	   spontaneously	   producing	   more	   bone	   like	  matrix	  faster	  in	  culture	  than	  other	  osteoblastic	  cell	  lines,	  even	  in	  the	  absence	  of	  additional	   chemical	   factors	   normally	   added	   to	   induce	   cell	   differentiation	   and	  matrix	  production	  [1].	  MLO-­‐A5	  cells	  utilised	  in	  this	  study	  were	  cultured	  in	  media	  supplemented	   with	   α-­‐MEM	   (Alpha	   Modified	   Eagles	   Medium),	   10%	   Fetal	   Calf	  Serum	  (FCS)	  on	  0.1%	  gelatin	  coated	  surfaces	  and	  used	  between	  passages	  25-­‐30.	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2.2.1.3	  	  	  Human	   embryonic	   stem	   cell	   derived	   mesenchymal	   progenitors	  (hES-­‐MP)	  	  hES-­‐MP	   cells	   were	   shown	   to	   be	   very	   similar	   to	   mesenchymal	   stem	   cells	   with	  regards	   to	   morphology	   and	   expression	   of	   markers.	   These	   cells	   also	   have	   the	  potential	   to	  differentiate	   towards	  the	  osteogenic,	  adipogenic,	  and	  chondrogenic	  lineage	   in	   vitro	   [2].	   These	   cells	   were	   cultured	   in	  media	   supplemented	  with	  α-­‐MEM	   (Alpha	  Modified	   Eagles	   Medium),	   10%	   Fetal	   Calf	   Serum	   (FCS)	   on	   0.1	  %	  gelatine	   coated	   surfaces	   and	   expanded	   in	   4nM	   fibroblast	   growth	   factor-­‐basic	  recombinant	  human	  (bFGF)	  as	  stated	  by	  the	  manufacturer	  (Cellartis).	  Cells	  were	  used	   for	   experiments	   between	   passages	   3-­‐10	   in	   most	   cases.	   Cells	   could	   be	  expanded	  up	  to	  passage	  20	  but	  were	  observed	  to	  begin	  to	  lose	  their	  fibroblastic	  morphology	  after	  passage	  12	  and	  ALP	  activity	  and	  mineral	  depositing	  ability	  also	  reduced.	  	  	  	  
2.2.2	   Scaffold	  Preparation	  	  	   2.2.2.1	  Polyurethane	  Scaffolds	  (PU)	  	  A	  previous	  study	  [3]	  measured	  the	  average	  pore	  size	  and	  strut	  width	  of	  the	  PU	  foams	   using	   imageJ	   (an	   image	   analysis	   package).	   The	   average	   pore	   size	   was	  shown	  to	  be	  400	  µm	  (varies	  between	  150-­‐1000	  µm)	  and	  the	  average	  strut	  width	  was	   shown	   to	   be	   65	   µm	   (varies	   between	   43-­‐96	   µm).	   In	   the	   same	   study	   the	  mechanical	  properties	  were	  tested	  by	  a	  single	  cycle	  of	   loading	  to	  50%	  strain	  at	  0.2	  mm/sec.	  Properties	  of	  the	  PU	  scaffolds	  are	  shown	  in	  the	  following	  table;	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Table	  2.1;	  Properties	  of	  Polyurethane	  used	  in	  this	  study	  
10mm	  
	  10mm	  
Fig	  2.1;	  (a)	  The	  dimensions	  of	  a	  single	  PU	  scaffold	  and	  (b)	  PU	  scaffolds	  were	  hole-­‐punched,	   sterilized	   and	   washed	   with	   PBS.	   Steel	   rings	   held	   the	   PU	  scaffolds	  in	  place	  for	  the	  for	  initial	  cell	  seeding	  which	  contained	  100	  μl	  media	  with	  500,000	  cells	  per	  scaffold.	  
(a)	   	   	   	  	  	  	  	  	  	  (b)	  
	   	   86	  
	   2.2.2.2	  Nippon	  Sheet	  Glass	  (NSG)	  scaffolds	  
	  















Properties	  of	  glass	  scaffold	  Pore	  volume	  (%)	   60	  Glass	  volume	  (%)	   40	  Density	  (g/mL)	   2.5	  Pore	  size	  (µm)	   100-­‐500	  
12mm	   3mm	  
(a)	   	   	   	   	   	  	  	  	  (b)	  	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
(c)	  
Fig	   2.2;	   (a)	   Image	   of	   cylindrical	   glass	   rods,	   which	   are	   sintered	   to	   create	   randomly	   oriented	   glass	  scaffolds.	  The	  result	  is	  a	  highly	  porous	  material,	  with	  pores	  of	  variable	  size	  making	  up	  approximately	  60%	  of	  the	  total	  volume.	  (b)	  image	  of	  a	  single	  glass	  scaffold	  (c)	  dimensions	  of	  a	  single	  glass	  scaffold	  (12	  mm	  x	  3	  mm).	  
Table	  2.2;	  Properties	  of	  glass	  scaffolds	  used	  in	  this	  study	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2.2.3	   Cell	  seeding	  in	  3D	  scaffolds	  
	  Initially	  cells	  were	  passaged	  under	  standard	  culture	  conditions	  in	  basal	  medium	  and	  at	  80%	  confluency,	  cells	  were	  enzymatically	  released	  using	  Trypsin/EDTA.	  Cells	   were	   pelleted	   by	   centrifugation	   at	   1000	   rpm	   for	   5	   minutes	   and	  resuspended	   in	   1	   ml	   media	   and	   cell	   number	   was	   determined	   using	  hemocytometer.	  From	  a	  previous	  study	  the	  optimum	  cell	  density	  and	  volume	  of	  cell	  suspension	  for	  PU	  scaffolds	  was	  determined	  at	  5x105	  cells	  in	  100	  μl	  of	  media.	  Having	  a	  smaller	  volume,	   it	  was	   found	   that	  2.5x105	  cells	   in	  50	  µl	  of	  media	  was	  sufficient	  to	  seed	  glass	  scaffolds.	  The	  cell	  suspension	  volume	  was	  able	  to	  spread	  throughout	  the	  scaffold	  structure,	  cells	  were	  retained	  and	  had	  the	  opportunity	  to	  attach.	  After	  incubating	  for	  1	  hour,	  sufficient	  media	  was	  added	  to	  cover	  scaffolds	  and	   stainless	   steel	   rings.	   Cells	   were	   allowed	   to	   attach	   for	   3-­‐4	   hours,	   removed	  from	  stainless	  steel	  or	  silicone	  rings	  and	  held	  in	  place	  using	  stainless	  steel	  wires	  (if	   PU).	   Cell	   seeded	   scaffolds	   were	   cultured	   in	   the	   incubators	   for	   the	  experimental	   period	   and	   supplied	   with	   fresh	  media	   every	   3	   days.	   Cell	   seeded	  scaffolds	  were	  assessed	  for	  cell	  viability,	  osteogenesis	  or	  further	  investigated	  at	  specific	  time	  points	  depending	  on	  experimental	  design.	  
	  
2.2.4	   Fluorescent	  staining	  of	  cell	  nucleus	  and	  cytoskeleton	  
	  DAPI	  (4′,6-­‐Diamidino-­‐2-­‐phenylindole	  dihydrochloride)	  is	  a	  tool	  used	  for	  various	  cytochemical	  investigations.	  DAPI	  is	  known	  to	  form	  fluorescent	  complexes	  with	  natural	  double-­‐stranded	  DNA.	  When	  DAPI	  binds	  to	  DNA,	   it	   is	   fluorescent	  under	  the	  blue	  wavelength.	  Cell	  cytoskeletal	  staining	  was	  performed	  using	  phalloidin-­‐TRITC	   (phalloidin-­‐Tetramethylrhodamine	   B	   isothiocyanate).	   Phalloidin	   is	   a	  fungal	   toxin	   that	   binds	   to	   polymeric	   and	   oligomeric	   forms	   of	   actin.	   TRITC	  conjugate	  allows	  for	  imaging	  under	  the	  orange-­‐red	  wavelengths.	  	  Samples	  were	   carefully	  washed	  with	   PBS	   and	   fixed	  with	   10%	   formalin,	   for	   10	  minutes	   under	   room	   temperature.	   This	   was	   followed	   by	   washes	   with	   PBS	   3	  times,	  allowing	  the	  cells	  to	  keep	  their	  structures	  and	  preventing	  degradation.	  To	  increase	   cell	  membrane	   permeability,	   a	   0.5%	  Triton-­‐X	   solution	  was	   applied	   to	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samples	  for	  5	  minutes	  and	  then	  washed	  away.	  A	  solution	  of	  1	  µg/ml	  of	  DAPI	  and	  1	  µg/ml	  phalloidin-­‐TRITC	   in	  PBS	  was	  added	  to	  each	  well	   to	  cover	   the	  samples.	  The	  well	  plates	  were	  covered	  with	  aluminum	  foil	  and	  incubated	  for	  30	  minutes.	  The	  DAPI	  solution	  was	  removed	  and	  replaced	  by	  PBS,	  and	  cells	  were	  imaged	  on	  an	  epifluorescent	  or	  confocal	  microscope.	  	  
	  
2.2.5	   Assessing	  cell	  viability	  
	  There	   have	   been	   a	   number	   of	   methods	   developed	   in	   order	   to	   measure	   cell	  proliferation	   including	   direct	   counting	   of	   viable	   cells,	   measurement	   of	   DNA	  content	  and	  measurement	  of	  metabolic	  activity.	  The	  traditional	  methods	  of	  using	  trypan	  blue	   dye	   exclusion	   assay	   (using	   a	   hemacytometer)	   are	   very	   simple	   and	  inexpensive	   however,	   they	   can	   be	   time	   consuming	   and	   inaccurate	   [4].	  Mitochondrial	   metabolic	   rate	   can	   be	   measured	   using	   MTT	   (3-­‐(4,5-­‐Dimethylthiazol-­‐	   2-­‐yl)-­‐2,5-­‐diphenyltetrazolium	   bromide)	   and	   MTS	   (3-­‐(4,5-­‐dimethylthiazol-­‐2-­‐yl)-­‐5-­‐(3-­‐carboxymethoxyphenyl)-­‐2-­‐(4-­‐sulfophenyl)-­‐	   2H-­‐tetrazolium).	  These	  assays	  do	  indirectly	  reflect	  viable	  cell	  number	  and	  have	  been	  widely	  used	   [5-­‐7].	  However,	   cell	  metabolic	   activity	   can	  change	  due	   to	  different	  conditions	   or	   addition	   of	   chemical	   treatments,	   which	   can	   ultimately	   vary	   the	  results	  obtained	  from	  these	  assays.	  	  
	  
	   2.2.5.1	  	  	  MTT	  assay	  
	  MTT	   (A3-­‐(4,5-­‐dimethylthiazol-­‐2-­‐yl)-­‐2,5-­‐diphenyltetrazolium	   bomide)	   is	   a	  method	  used	  for	  measuring	  cell	  growth	  and	  viability.	  The	  yellow	  MTT	  solution	  is	  reduced	  to	  a	  dark	  blue	  formazan	  insoluble	  salt	  due	  to	  the	  active	  mitochondria	  in	  live	   cells.	   The	   optical	   density	   of	   dissolved	   salt	   is	   measured	   by	   using	   a	   plate	  reader	   at	   a	   wavelength	   of	   540	   nm.	   The	   absorbance	   is	   directly	   related	   to	   the	  amount	  of	  formazan	  salt	  formed	  and	  is	  assumed	  to	  represent	  the	  number	  of	  live	  cells.	  For	  the	  experiments	  conducted	  in	  this	  study,	  the	  cell	  seeded	  scaffolds	  were	  washed	  with	  PBS	  several	  times	  and	  incubated	  with	  1	  mg/ml	  MTT	  in	  PBS	  for	  40	  minutes	   at	   370C.	   The	   solution	   was	   then	   removed	   and	   dissolved	   with	   0.125%	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acidified	   isopropanol	   and	   the	   absorbance	   of	   the	   resulting	   solution	   was	  determined	  using	  a	  96-­‐well	  plate	  reader	  at	  570nm	  referenced	  at	  630nm.	  	  	  
	   2.2.5.2	  	  MTS	  assay	  	  Similar	   to	   MTT	   assay,	   MTS	   (3-­‐(4,5-­‐dimethylthiazol-­‐2-­‐yl)-­‐5-­‐(3carocymethoxyphenyl-­‐2-­‐4-­‐(sulfophenyl)-­‐2H-­‐tetrazolium)	   assay	   is	   another	  colorimetric	   method	   to	   determine	   the	   number	   of	   viable	   cells	   in	   culture.	   The	  yellow	  MTS	  tetrazolium	  compound	  is	  reduced	  to	  a	  pink	  formazan	  product	  that	  is	  soluble	   in	   culture	   medium.	   This	   conversion	   is	   achieved	   by	   NADPH	   which	   is	  produced	   by	   dehydrogenase	   enzymes	   in	   metabolically	   active	   cells.	   The	   cell-­‐seeded	  scaffolds	  were	  washed	  several	  times	  until	  there	  was	  no	  colour	  present	  in	  the	  solution.	  Scaffolds	  were	  placed	  in	  1cm	  diameter	  stainless	  steel	  rings	  and	  the	  assay	  was	  performed	  by	  adding	  0.5	  ml	  of	  1:10	  MTS	  in	  PBS	  mixture	  directly	  to	  the	  scaffolds.	   After	   3	   incubating	   for	   3	   hours	   at	   370C,	   two	   200	   μl	   samples	   were	  pipetted	  out	  from	  the	  scaffolds	  and	  absorbance	  was	  read	  at	  490	  nm.	  	  
	  
	  
	   2.2.5.3	  	  	  Alamar	  Blue	  staining	  	  Alamar	  blue	  is	  also	  another	  colorimetric	  method	  designed	  to	  provide	  a	  rapid	  and	  sensitive	  measure	  of	   cell	   viability,	  which	   can	  be	  used	   to	   estimate	  proliferation,	  and	  cytotoxicity	  in	  various	  human	  and	  animal	  cell	   lines,	  bacteria	  and	  fungi.	  It	   is	  simple	   to	   use	   as	   the	   indicator	   dye	   is	   water	   soluble,	   thus	   eliminating	   the	  washing/fixing	   and	   extraction	   steps	   required	   in	   other	   commonly	   used	   cell	  proliferation	  assays.	  It	  also	  produces	  a	  clear,	  stable	  and	  distinct	  change,	  which	  is	  easy	  to	  interpret.	  Alamar	  Blue	  has	  several	  characteristics	  that	  make	  this	  dye	  an	  attractive	  candidate	  for	  use	  as	  a	  quantitative	  assay	  of	  cell	  proliferation.	  This	  dye	  is	  nonradioactive,	  nontoxic,	  water-­‐soluble	  (eliminating	  the	  need	  for	  extraction),	  and	  readily	  detectable	  by	  either	  absorbance	  or	  fluorescence	  spectroscopy.	  Assay	  was	  performed	  by	  washing	  samples	  several	   times	  with	  PBS	  and	  adding	  1	  ml	  of	  0.4:1	   alamar	   blue	   in	   PBS	  mixture.	   Specimens	   were	   incubated	   for	   4	   hours	   and	  optical	  density	  was	  measured	  measured	  at	  520	  nm	  and	  630	  nm.	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2.2.6	   Total	  DNA	  assay	  	  Total	   DNA	   was	   measured	   using	   a	   fluorescent	   Quant-­‐iT™	   PicoGreen®	   dsDNA	  reagent	   assay	   kit	   (Invitrogen,	   UK).	   This	   was	   used	   as	   a	   measure	   of	   total	   cell	  number	  through	  the	  binding	  of	  a	  fluorescent	  dye	  to	  double	  stranded	  DNA	  in	  the	  cells.	  	  	  Cell-­‐seeded	  scaffolds	  were	  washed	  with	  PBS	  several	  times	  (5	  minutes	  each)	  and	  placed	   in	   a	   bijou	   that	   contained	   a	   known	   volume	   of	   buffer	   solution.	   Scaffolds	  were	  vortexed	  for	  10	  seconds	  followed	  by	  centrifugation	  at	  10,000	  rpm	  and	  left	  at	   40C	   overnight.	   To	   extract	   cellular	   DNA,	   cell-­‐seeded	   scaffolds	   were	   freeze-­‐thawed	  3	  times,	  100	  µl	  of	  cell	  lysate	  was	  added	  to	  200	  µl	  of	  Tris-­‐buffered	  EDTA	  solution	   (provided	   in	   kit,	   diluted	   1:20)	   containing	   the	   Quant-­‐iT™	   PicoGreen®	  (diluted	  1:400).	  Fluorescence	  intensity	  was	  recorded	  using	  a	  fluorescence	  reader	  (BioTek,	  UK)	  using	  485	  nm	  excitation	  and	  520	  nm	  emission.	  
 
2.2.7	  Assessment	  of	  osteogenesis	  	  
	   2.2.7.1	  	  	  Alkaline	  Phosphatase	  assay	  	  Alkaline	   phosphatase	   (ALP)	   has	   been	   shown	   to	   be	   a	   biochemical	   indicator	   of	  bone	  turnover	  and	  the	  assay	  involves	  the	  conversion	  of	  p-­‐nitrophenol	  phosphate	  substrate	   to	   p-­‐nitrophenyl	   and	   recording	   the	   rate	   of	   colour	   change	   from	  colourless	  to	  yellow.	  Cell	  lysate	  for	  ALP	  assessment	  was	  taken	  from	  the	  same	  cell	  solution	   used	   to	   extract	   total	   DNA	   using	   the	   same	   extraction	   techniques	   (See	  2.2.6).	  	  Cell	  lysate	  was	  incubated	  for	  30	  min	  before	  adding	  10	  µl	  (Vsample)	  to	  190	  µl	  of	  p-­‐nitrophenol	   phosphate	   substrate	   followed	   by	   incubation	   for	   5	   minutes.	   The	  mixture	  was	  then	  briefly	  vortexed	  and	  centrifuged.	  200	  µl	  (Vtotal)	  of	  mixture	  was	  transferred	   into	   a	  well	   of	   a	   96	  well	   plate	   and	   the	   subsequent	   conversion	   to	   p-­‐nitrophenyl	   was	   measured	   by	   recording	   the	   rate	   of	   colour	   change	   from	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colourless	   to	   yellow	   at	   405	   nm.	   ALP	   activity	   was	   expressed	   as	   nmol	   of	   p-­‐nitrophenol	   converted	   per	   minute	   where	   22.5	   nmol	   (K)	   equals	   1	   absorbance	  value	  (A405).	  ALP	  activity	  was	  calculated	  using	  the	  following	  formula:	  	  	  ALP	  activity	  (nmol	  pNPP	  converted	  per	  min)	  =	  Δ	  A405	  *	  K	  *	  Vtotal/Vsample	  	  ALP	  activity	  was	  then	  normalised	  to	  total	  DNA.	  	  
	  
	   2.2.7.2	  	  	  Prostaglandin	  E2	  (PGE2)	  assay	  
	  This	  assay	  is	  based	  on	  the	  forward	  sequential	  competitive	  binding	  technique	  in	  which	  PGE2	  present	   in	  a	  sample	  competes	  with	  horseradish	  peroxidase	  (HRP)-­‐labeled	   PGE2	   for	   a	   limited	   number	   of	   binding	   sites	   on	   a	   mouse	   monoclonal	  antibody.	  The	  PGE2	  kit	  was	  obtained	  from	  R&D	  Systems,	  UK	  and	  all	  reagents	  are	  provided	  in	  the	  kit.	  	  	  PGE2	   has	   diverse	   actions	   on	   various	   organs,	   including	   inflammation,	   bone	  healing,	  bone	  formation	  and	  embryo	  implantation.	  It	  also	  plays	  an	  important	  role	  in	   the	   functional	   adaptation	   of	   bone	   cells	   to	  mechanical	   loading.	   PGE2	   release	  into	  the	  media	  by	  MLO-­‐A5	  cells	  after	  application	  of	  flow	  was	  determined	  using	  a	  Parameter	   PGE2	   assay	   kit	   following	   the	   manufactures	   protocol.	   Media	   was	  extracted	  from	  well	  plates	  and	  a	  goat	  anti-­‐mouse	  was	  then	  used	  to	  coat	  the	  base	  of	  a	  96-­‐well	  plate.	  A	  mouse	  monoclonal	  antibody	  was	  then	  added	  to	  the	  wells	  to	  bind	   to	   the	   anti-­‐mouse	   antibody.	   Media	   samples	   were	   then	   added	   to	   the	   well	  plate	  and	  after	  2	  hours	  the	  well	  plate	  was	  washed	  3	  times	  using	  a	  wash	  buffer.	  Well	  plates	  were	  left	   in	  room	  temperature	  for	  30	  minutes,	  an	  acid	  solution	  was	  added	  to	  stop	  any	  enzymatic	  activity,	  which	  was	  seen	  by	  a	  change	  in	  colour.	  The	  plate	  were	   then	  placed	  on	  a	  plate	   reader	  and	   read	  at	   a	  wavelength	  of	  450	  nm.	  PGE2	  concentration	  was	  calculated	  from	  the	  formula	  of	  a	  plotted	  standard	  curve:	  	  PGE2	  concentration	  =	  EXP	  ((A405	  –	  0.2146)/-­‐0.025)	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This	  assay	  was	  used	  in	  chapter	  6	  and	  cells	  subjected	  to	  fluid	  flow	  were	  incubated	  in	  fresh	  medium	  for	  2	  hours	  before	  collection	  of	  the	  medium.	  	  	  	  
	   	  
	   2.2.7.3	  	  	  Alizarin	  red	  S	  staining	  
 Alizarin	  red	  S	  is	  a	  dye	  that	  binds	  to	  Ca2+	  ions	  to	  form	  a	  strong	  red	  complex	  and	  is	  commonly	  used	   as	   an	   indicator	   of	   calcium	  deposition	   in	  mineralising	   cells	   and	  tissues.	   Scaffolds	   were	   washed	   three	   times	   with	   PBS	   and	   fixed	   with	   10%	  formalin	   for	   10	  minutes	   at	   room	   temperature.	   The	   Solution	  was	   removed	   and	  again	  washed	  with	  PBS	  several	  times.	  Alizarin	  red	  S	  dye	  was	  added	  to	  dH2O	  (10	  mg/ml)	  and	  the	  pH	  adjusted	  to	  4.1	  using	  ammonium	  hydroxide	  before	  applying	  to	   fully	   cover	   each	   sample	   and	   placing	   under	   mild	   shaking	   for	   15	   minutes	   at	  room	   temperature.	   Scaffolds	  were	   removed	   and	  washed	   under	   distilled	  water.	  For	   qualitative	   analysis,	   samples	   were	   air	   dried	   in	   a	   fume	   cupboard	   and	  observed	   under	   a	   light	   microscope	   or	   normal	   magnification	   with	   a	   digital	  camera.	   For	   quantitative	   analysis,	   samples	  were	   destained	  with	   5%	  perchloric	  acid	  and	  subjected	  to	  15	  minutes	  of	  mild	  shaking.	  The	  optical	  density	  was	  then	  measured	  at	  490	  nm.	  
	  
2.2.8	   	  	  	  	  Sirius	  red	  staining	  (Collagen	  production)	  
	  Picro-­‐sirius	  red	  staining	  is	  a	  routine	  method	  for	  the	  qualitative	  identification	  of	  collagen	  in	  tissue	  sections	  or	  that	  deposited	  by	  cells.	  If	  collagen	  is	  present	  it	  will	  form	   a	   strong	   red	   staining	   complex	   that	   can	   then	   be	   destained	   for	   semi-­‐quantitative	  analysis.	  Sirius	  red	  is	  a	  strong	  anionic	  dye	  and	  aligns	  itself	  parallel	  to	  the	   long	  axis	  of	   the	  collagen	  molecules.	  The	  dye	   is	  not	  specific	  and	  so	  stains	  all	  types	   of	   collagen	   but	   it	   can	   be	   used	   as	   a	   fluorescent	   marker	   of	   collagen	   and	  suffers	   very	   little	   from	   photo-­‐bleaching.	   Cell	   seeded	   scaffolds	   were	   washed	  several	  times	  with	  PBS	  and	  fixed	  with	  10%	  formalin	  for	  15	  minutes,	  which	  was	  then	  removed	  and	  three	  PBS	  washes	  were	  performed	  again.	  Sirius	  red	  dye	  was	  mixed	  with	   saturated	   picric	   acid	   solution	   (1	  mg/ml)	   and	   added	   to	   fully	   cover	  each	   sample.	   Samples	   were	   then	   left	   to	   shake	   mildly	   for	   18	   hours	   at	   room	  temperature.	  Dye	  solution	  was	  removed	  and	  each	  well	  was	  washed	  with	  distilled	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water	   several	   times	   until	   no	   more	   red	   colouring	   was	   eluted.	   For	   qualitative	  analysis,	  samples	  were	  air	  dried	  in	  a	  fume	  cupboard	  and	  observed	  under	  a	  light	  microscope	   or	   normal	   magnification	   with	   a	   digital	   camera.	   For	   quantitative	  analysis,	   the	  scaffolds	  were	  destained	  with	  0.2M	  NaOH/Methanol	   in	  a	  1:1	  ratio	  and	  subjected	  to	  mild	  shaking	  for	  15	  minutes	  and	  optical	  density	  was	  measured	  at	  a	  wavelength	  of	  490	  nm.	  
	  
2.2.9	   	  	  Primary	  cilia	  staining	  
	  As	  mentioned	  in	  chapter	  1,	  primary	  cilia	  have	  axonemes	  containing	  alpha	  tubulin	  and	   can	   therefore	   be	   detected	   by	   immunostaining	   with	   anti-­‐acetylated	   alpha	  tubulin	   antibodies.	   Alpha	   tubulin	   immunostaining	   shows	   the	   microtubular	  cytoskeleton	   which	   is	   dense	   around	   the	   centrosome	   region	   in	   which	   primary	  cilia	  occur	  [8].	  	  	   1. Samples	  were	  washed	  with	  PBS	  3	  times	  and	  fixed	  in	  3.7%	  formaldehyde	  solution	  for	  10	  minutes,	  2. Cells	  were	  permeablised	  by	  0.1%	  triton-­‐X-­‐100	  solution	  and	   incubated	   in	  primary	   blocking	   solution	   (containing	   0.1%	   Albumin	   bovine	   serum	   and	  0.2%	  Igepal	  in	  PBS	  for	  2	  hours	  at	  room	  temperature),	  3. Samples	   were	   incubated	   with	   primary	   antibody	   solution	   (1:2000	   of	   2	  mg\ml	  mouse	   antibody	   to	   acetylated	   alpha	   tubulin	   in	   primary	   blocking	  solution)	  for	  24	  hours,	  4. Samples	  were	  then	  washed	  with	  primary	  blocking	  solution	  3	  times,	  5. Secondary	  antibody	  containing	  1:30	  of	  FITC-­‐conjugated	  rabbit	  anti-­‐mouse	  immunoglobulins	  in	  primary	  blocking	  solution	  was	  applied	  to	  samples	  for	  1	  hour	  at	  room	  temperature,	  6. Samples	  were	  then	  washed	  with	  primary	  blocking	  solution	  3	  times,	  7. DAPI	  solution	  (1:1000	  DAPI	  in	  PBS)	  was	  added	  to	  the	  samples	  and	  left	  for	  30	  minutes,	  8. Samples	  were	   then	  washed	  with	  PBS	  3	   times	  and	   imaged	  using	  confocal	  microscopy.	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2.2.10	  	  	  	  Removal	  of	  the	  primary	  cilia	  using	  Chloral	  Hydrate	  
	  It	  has	  been	  shown	  that	  long	  exposure	  to	  chloral	  hydrate	  will	  completely	  remove	  the	  cilia	   in	  MDCK	  cells,	   from	  the	  early	  embryo	  phase	  of	  the	  sea	  urchin	  and	  also	  bone	   cells.	   The	  mechanisms	  by	  which	   chloral	   hydrate	   destabilises	   the	   primary	  cilium	  is	  still	  unclear,	  however	  it	  has	  been	  proposed	  that	  it	  disrupts	  the	  junction	  between	  the	  cilium	  and	  basal	  body	  through	  disassembly	  of	  microtubules.	   It	  has	  been	   suggested	   that	   the	   primary	   cilia	   does	   weaken	   when	   exposed	   to	   chloral	  hydrate.	   Deciliation	   in	   this	   study	   (chapter	   6)	   was	   achieved	   by	   incubating	  constructs	   in	  culture	  media	  containing	  4mM	  chloral	  hydrate	   for	  48	  and	  72	  hrs.	  After	  which	  samples	  were	  washed	  with	  PBS	  3	  times	  and	  placed	  in	  normal	  culture	  medium	  for	  24	  hrs	  before	  subjecting	  them	  to	  fluid	  flow.	  	  	  
2.2.11	  	  	  	  IBIDI	  Oscillatory	  flow	  pump	  
	  The	  oscillatory	   perfusion	  bioreactor	   (fig	   2.3)	   consists	   of	   a	   pump	   system	   (Ibidi,	  Germany)	   that	   was	   controlled	   by	   a	   computer	   software	   provided	   by	   the	   same	  company.	  The	  reservoir	  pots	  were	  connected	  to	  filters	  and	  air	  pressure	  tubings,	  which	   in	   turn	   connected	   to	   a	   bottle	   containing	   silicate	   beads.	   A	   conduit	   was	  connected	  to	  this	  unit	  to	  hold	  the	  cell-­‐seeded	  scaffolds	  in	  place	  during	  the	  action	  of	  the	  fluid	  flow.	  After	  confirming	  the	  absence	  of	  air	  bubbles,	   the	  whole	  system	  was	  placed	   in	   a	   370C	   incubator	   and	   samples	  were	   subjected	   to	   1	   hour	   of	   fluid	  flow	  at	  a	  frequency	  of	  1	  Hz.	  A	  frequency	  of	  1	  Hz	  was	  chosen	  since	  it	  is	  commonly	  advocated	  as	  a	  ‘biomimetic	  loading	  frequency	  that	  represents	  walking	  pace.	  It	  is	  a	   	   standard	   loading	   frequency	  used	   to	   study	  bone	   cell	  mechanotransduction	   in	  the	  author’s	   laboratory	  and	  many	  others.	  A	  previous	  preliminary	  study	  showed	  that	  short	  bouts	  of	  oscillatory	  flow	  (5	  ml/min,	  1	  Hz,	  1	  hour	  loading	  session)	  were	  able	  to	  induce	  osteogenic	  differentiation	  of	  hMSCs	  in	  PU	  scaffolds.	  It	  was	  shown	  that	  ALP	  activity	  and	  collagen	  per	  cell	  was	  significantly	  enhanced	  in	  comparison	  to	  static	  cultures.	  Following	  from	  this	  work,	  this	  project	  examined	  a	  range	  of	  flow	  rates	   in	   order	   to	   analyse	   the	   flow-­‐induced	   shear	   stress	   on	   cell	   response	  including;	  cell	  growth	  and	  matrix	  production	  [9].	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2.2.12	  	  	  	  	  Peristaltic	  pump	  
	  The	  peristaltic	  pump	  (Watson	  Marlow,	  UK)	   is	  setup	   in	   the	  same	  manner	  as	   the	  previous	  system	  however	  it	  only	  applies	  flow	  in	  one	  direction.	  Figure	  2.4	  shows	  the	   setup	   of	   this	   system,	   whereby	   rotating	   cylinders	   squeese	   fluid	   through	   a	  cassette	  and	  finally	  deliver	  media	  to	  the	  conduit	  holding	  the	  cell	  seeded	  scaffold.	  The	  pump	  is	  connected	  to	  a	  reservoir	  pot	  which	  contains	  an	  inlet	  and	  outlet	  (for	  media	  circulation)	  and	  also	  a	  0.2	  μm	  filter	  for	  gas	  exchange.	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2.2.13	  	  	  	  Conduit	  length	  	  The	  conduit	  was	  the	  piece	  of	  silicone	  tubing	  that	  holds	  the	  cell-­‐seeded	  scaffold	  in	  place	  whilst	   being	   subjected	   to	   fluid	   flow.	   Equations	   2.1	   and	   2.2	  were	   used	   to	  verify	  its	  length	  to	  make	  sure	  that	  the	  flow	  is	  fully	  developed	  before	  it	  enters	  the	  scaffold.	   Since	   the	   highest	   flow	   rate	   for	   these	   experiments	   was	   10	   ml/min,	   a	  conduit	  length	  according	  to	  this	  flow	  rate	  was	  calculated.	  	  	  	  	  	  	  	  	  	  	  
Air	  Filter 




Figure	   2.4;	   Photograph	   of	   the	   peristaltic	   pump	   system.	  Rotating	   cylinders	   pump	   media	   from	   the	  media	   reservoir	  towards	  the	  conduit	  in	  which	  scaffolds	  were	  held	  in	  place.	  	  	  
Fig	  2.5;	  Fow	  in	  the	  entry	  region	  for	  laminar	  flow.	  http://www.mdp.eng.cam.ac.uk	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The	  following	  equation	  was	  used	  to	  calculate	  the	  entry	  length	  (fig	  2.5)	  within	  a	  pipe	  based	  on	  steady	  flow;	  	  	  	   Le	  =	  0.06	  	  Re	  	  D	   	   	   (Equation	  2.1)	  	  Where,	  Re	  =	  Reynolds	  number	  	   	  	  	  D	  =	  Tube	  diameter	  (m)	  	  In	  order	  to	  calculate	  the	  Reynolds	  number	  the	  following	  equation	  was	  used;	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  𝑅𝑒 = !"#! 	  	  	   	   	   (Equation	  2.	  2)	  	  Where,	  Re	  =	  Reynolds	  Number	  	     𝜚	  =	  Fluid	  density	  (kg/m3)	  	     𝑉	  =	  Average	  fluid	  velocity	  (m/s)	  	     𝐷	  =	  Tube	  diameter	  (m)	  	     𝜇	  =	  Fluid	  viscosity	  (kg/ms)	  	  The	  volume	  flow	  rate	  (ml/min)	  was	  first	  converted	  to	  m3/s	  and	  divided	  by	  pipe	  cross-­‐sectional	  area	  (m2)	  to	  achieve	  an	  average	  velocity	  (m/s).	  The	  values	  were	  then	  substituted	  in	  equation	  2.2	  to	  calculate	  the	  Reynolds	  number.	  	  
𝑅𝑒 =	  (!""".!  !"/!!)  (!.!!"#"  !/!)  (!.!"#)(!.!!"##  !"  !) 	  	  	  𝑅𝑒	  =	  2.36	  
	   	  Given	  the	  flow	  characteristics,	  flow	  type	  can	  be	  expected	  to	  be	  laminar	  based	  on	  the	  Reynolds	  number.	  Using	  this	  𝑅𝑒  value	  and	  equation	  2.1,	  the	  entry	  length	  (Le)	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of	  the	  system	  was	  calculated	  to	  be	  1.416	  mm	   for	  a	  flow	  rate	  of	  10	  ml/min	  and	  
0.425	  mm	   for	  a	   flow	  rate	  of	  3	  ml/min	  (0.71	  ≤	  Re	  ≤	  2.36).	  However	   for	  ease	  of	  handling	  and	   to	  reduce	   the	  risk	  of	  bacterial	   infection	   to	  cell-­‐seeded	  scaffolds,	  a	  length	   of	   120	  mm	  was	   chosen	  which	   guarantees	   a	   fully	   developed	   flow	  before	  coming	  into	  contact	  with	  the	  scaffold.	  	  
	  
2.2.14	  	  	  	  	  Glass	  scaffolds	  characterisation	  	  


















































Fig 2.7; Results	   from	  the	  time-­‐collection	  method	  were	  used	  to	  compare	  the	  actual	  flow	  rate	  (Q	  collected)	  to	  the	  flow	  rate	  applied	  by	  the	  pump	  system	  (Q	  pump).	  Scaffolds	  subjected	  to	  3	  (blue),	  5	  (red)	  and	  10	  ml/min	  (green)	  produced	  a	  flow	  rate	  of	  3.352±0.309,	  5.19±0.361	  and	  10.12±0.584	  ml/min	  respectively.	  
Fig	   2.6;	   Scaffold	   geometry	   was	   roughly	   estimated	   using	   a	   time-­‐collection	  method	  with	   the	  peristaltic	  pump.	  Individual	  scaffolds	  were	  subjected	  to	  flow	  rates	  of	  3,	  5	  and	  10	  ml/min	  for	  one	  minute.	  The	  fluid	  would	  then	  be	  collected	  in	  a	  small	  tub	  and	  weighed.	  The	  blue,	  red	  and	  green	   dots	   represent	   the	   amount	   of	   fluid	   collected	   for	   scaffolds	   subjected	   to	   3,	   5	   and	   10	  ml/min	  respectively.	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Results	  from	  figure	  2.6	  were	  used	  to	  calculate	  the	  average	  flow	  rate	  in	  the	  outlet	  tube.	   Figure	   2.7	   illustrates	   that	   scaffolds	   subjected	   to	   3,	   5	   and	   10	   ml/min	  produced	   a	   flow	   rate	   of	   3.352±0.309,	   5.19±0.361	   and	   10.12±0.584	   ml/min	  respectively	   in	   the	   outlet	   tube.	   This	   indicates	   that	   the	   actual	   flow	   rates	   (Q	  collected)	  are	  very	  close	  to	  the	  applied	  value	  (Q	  pump).	  
	  
	  
2.2.15	  	  	  Estimating	  the	  average	  shear	  stress	  for	  glass	  scaffolds	  	  The	   average	   shear	   stress	   can	   be	   calculated	   using	  Wang	   and	  Tarbell’s	   equation	  (equation	  2.3)	  [10].	  	  
 𝜏=!"!	  	   	   	   	   	   	   	   	   Equation	  2.3	  	  Where,	  𝜏	  is	   the	   mean	   shear	   stress	   value,	   μ	   is	   the	   fluid	   viscosity,	   v	   is	   the	   flow	  average	  velocity	  at	  the	  scaffold	  inlet	  and	  K	  is	  the	  permeability.	  This	  only	  applies	  for	   flows	   obeying	   Darcy’s	   law	   (equation	   2.4)	   and	   requires	   pressure	   drop	  measurements.	  	  	  	  𝑄 =   −   !"(!!!!!)!" 	   	   	   	   	   	   Equation	  2.4	  	   	   	  Where,	  Q	  is	  the	  flow	  rate,	  A	  is	  the	  scaffold	  surface	  area	  (area	  in	  which	  fluid	  flow	  first	  comes	  into	  contact	  with),	  Pb-­‐Pa	  is	  the	  pressure	  drop	  and	  L	  is	  the	  thickness	  of	  the	  scaffold.	  Figure	  2.8	  illustrates	  how	  the	  pressure	  drop	  was	  measured	  in	  order	  to	  calculate	  the	  permeability	  (k).	  A	  physiological	  pressure	  transducer	  was	  used	  to	  measure	   the	  pressure	  drop	  before	   the	   flow	  enters	   the	  scaffold	   (point	  a)	  and	  immediately	  after	  it	  leaves	  (point	  b).	  The	  measurements	  were	  taken	  for	  all	  three	  flow	  rates	  on	  6	  different	  glass	  scaffolds.	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  Equation	  2.4	  was	  rearranged	  to	  find	  the	  value	  of	  k	  for	  each	  scaffold	  at	  different	  flow	  rates	   i.e.	  6	   ‘k’	   values	   for	  each	   flow	  rate.	  These	  values	  were	   then	  placed	   in	  equation	  2.3	  to	  calculate	  the	  average	  shear	  stress.	  Cell-­‐seeded	  scaffolds	  subjected	  to	  3,	  5	   and	  10	  ml/min	   fluid	   flow	  experienced	  an	  average	   shear	   stress	   levels	  of	  peak	  flow	  of	  0.111±0.002,	  0.647±0.05	  and	  1.398±0.02	  Pa	  respectively.	  
	  
	  
2.2.16	  	  	  	  	  Statistical	  analysis	  





Fig	   2.8;	   A	   physiological	   pressure	   transducer	   was	   used	   to	   measure	   the	  pressure	   drop	   before	   the	   flow	   enters	   the	   scaffold	   (point	   a)	   and	  immediately	  after	  it	  leaves	  (point	  b)	  for	  flow	  rates	  of	  3,	  5	  and	  10	  ml/min.	  	  
	   	   102	  
2.2.17	  	  	  	  	  References	  
 [1]	  Kato	  Y,	  Boskey	  A,	  Spevak	  L,	  Dallas	  M,	  Hori	  M,	  Bonewald	  LF:	  Establishment	  of	  an	   osteoid	   preosteocyte-­‐like	   cell	   MLO-­‐A5	   that	   spontaneously	   mineralizes	   in	  culture.	  J	  Bone	  Miner	  Res.	  2001;16:1622–1633.	  [2]	   Karlsson	   C,	   Emanuelsson	   K,	   Wessberg	   F,	   Kajic	   K,	   Axell	   MZ,	   Eriksson	   PS,	  Lindahl	  A,	  Hyllner	  J,	  Strehl	  R:	  Human	  embryonic	  stem	  cell-­‐derived	  mesenchymal	  progenitors-­‐Potential	  in	  regenerative	  medicine.	  Stem	  Cell	  Research,	  2009,	  vol.	  3,	  no.	  1,	  39–50.	  [3]	   Sittichockechaiwut	   A,	   Scutt	   AM,	   Ryan	   AJ,	   Bonewald	   LF,	   Reilly	   GC:	   Use	   of	  rapidly	   mineralising	   osteoblasts	   and	   short	   periods	   of	   mechanical	   loading	   to	  accelerate	  matrix	  maturation	  in	  3D	  scaffolds.	  Bone.	  2009	  May;44(5):822-­‐9. [4]	  Kanemura	  Y,	  Mori	  H,	  Kobayashi	  S,	  Islam	  O,	  Kodama	  E.	  Evaluation	  of	  in	  vitro	  proliferative	  activity	  of	  human	  fetal	  neural	  stem/	  progenitor	  cells	  using	  indirect	  measurements	  of	  viable	  cells	  based	  on	  cellular	  metabolic	  activity.	  J	  Neurosci	  Res,	  2002,	  69:	  869–879.	  [5]	  Thangapazham	  RL,	  Singh	  AK,	  Sharma	  A,	  Warren	  J,	  Gaddipati	   JP,	  et	  al.	  Green	  tea	  polyphenols	  and	  its	  constituent	  epigallocatechin	  gallate	  inhibits	  proliferation	  of	  human	  breast	  cancer	  cells	   in	  vitro	  and	   in	  vivo.	  Cancer	  Lett,	  2007,	  245:	  232–241.	  [6]	   Yu	   HN,	   Shen	   SR,	   Yin	   JJ.	   Effects	   of	   interactions	   of	   EGCG	   and	   Cd(2+)	   on	   the	  growth	  of	  PC-­‐3	  cells	  and	  their	  mechanisms.	  Food	  Chem	  Toxicol,	  2007,	  45:	  244–249.	  [7]	   Farabegoli	   F,	   Barbi	   C,	   Lambertini	   E,	   Piva	   R.	   Epigallocatechin-­‐3-­‐gallate	  downregulates	  estrogen	  receptor	  alpha	  function	  in	  MCF-­‐7	  breast	  carcinoma	  cells.	  Cancer	  Detect	  Prev,	  2007,	  31:	  499–504	  [8]	   Wheatley	   DN,	   Wang	   AM,	   and	   Strugnell	   GE:	   Expression	   of	   primary	   cilia	   in	  mammalian	  cells.	  Cell	  Biol	  Int,	  1996.	  20(1):	  73-­‐81.	  [9]	  Matsiko	  A,	  Edwards	  J,	  Reilly	  GC.	  Human	  mesenchymal	  stem	  cell	  responses	  to	  steady	   and	   oscillatory	   fluid	   flow	   in	   a	   porous	   scaffold.	  Regenerative	  Medicine.	  2009;4:S159.	  	  
	   	   103	  

















	   	   104	  
Chapter	  3:	  Investigating	  a	  3-­‐D	  in	  vitro	  model	  
to	  study	  the	  effects	  of	  fluid	  shear	  stress	  on	  
cell	  behavior	  
	  
3.1	   Introduction	  
	  A	  bone	   tissue	   engineering	   strategy	   that	   involves	   seeding	  marrow	   stromal	   cells	  (MSCs)	  onto	  a	  porous	  biodegradable	  scaffold	  before	  implantation	  into	  the	  body	  represents	  a	  promising	  alternative	  to	  current	  clinical	  treatments	  for	  bone	  defects	  such	   as	   using	   autologous	   or	   allogeneic	   bone	   grafts	   [1,	   2].	   A	   common	   tissue	  engineering	   strategy	   involves	   cell-­‐seeded	   scaffolds	   to	   be	   cultured	   in	   vitro	   to	  increase	   cell	   number	   and	   to	   allow	   for	   cell	   differentiation	   of	   stem	   cells	   into	  osteoblasts.	  	  	  Human	   mesenchymal	   stem	   cells	   (hMSCs)	   from	   bone	   marrow	   and	   other	   adult	  tissues	   have	   been	   shown	   to	   differentiate	   in	   vitro	   and	   in	   vivo	   into	   several	   cell	  types,	  including	  the	  adipogenic,	  myogenic,	  chondrogenic,	  and	  osteogenic	  lineages	  [3]	  and	  have	  been	  suggested	  to	  be	  a	  suitable	  cell	  type	  for	  bone	  tissue	  engineering	  applications	  [3-­‐7].	  Despite	  their	  great	  potential,	  isolating	  hMSCs	  after	  aspiration	  from	   patients	   or	   donors	   has	   been	   shown	   to	   have	   its	   limitations.	   Adult	   MSCs	  exhibit	   wide	   variability	   both	   within	   a	   bone	   marrow	   population	   and	   between	  different	   people	   making	   their	   clinical	   usefulness	   unpredictable	   [8-­‐11].	  Furthermore,	  after	  protracted	  ex	  vivo	  expansion,	  hMSCs	  have	  been	  shown	  to	  lose	  their	  replicative	  capability	  [11,	  12]	  which	  limits	  their	  bulk	  production	  for	  tissue	  engineering	  applications	  and	  have	  been	  associated	  with	  signiﬁcant	  alterations	  in	  the	   pattern	   of	   gene	   expression,	   karyotypic	   instability	   [13],	   spontaneous	  malignant	  transformation	  [14,	  15],	  and	  an	  impaired	  differentiation	  capacity	  [16].	  	  Human	   embryonic	   stem	   cells	   (hESC)	   have	   been	   shown	   to	   provide	   a	  homogeneous	   and	   unlimited	   source	   of	   cells	   for	   bone	   tissue	   engineering	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applications	   [17,18].	  Unfortunately	  hESC’s	   tend	   to	   form	   teratoma	   in	  vivo	  which	  limits	   their	   potential	   use	   in	   clinical	   applications	   [19].	   On	   the	   other	   hand,	   an	  alternative	   could	   be	   the	   use	   of	   progenitor	   cells	   derived	   from	   hESCs.	   Human	  embryonic	  stem	  cell	  derived	  mesodermal	  progenitor	  cells	  (hES-­‐MPs)	  do	  not	  form	  teratoma	   in	   vivo	   and	   resemble	   adult	   hMSCs	   with	   respect	   to	   gene	   expression,	  surface	  markers	  and	  ability	  to	  differentiate	  towards	  mesodermal	  tissues	  [20,21].	  hES-­‐MPs	  display	   signiﬁcantly	   higher	   proliferation	   ability	   than	  hMSCs	   and	  have	  been	  demonstrated	  to	  display	  lower	  amount	  of	  human	  leukocyte	  antigen	  (HLA)	  class	  II	  proteins	  than	  hMSCs,	  suggesting	  that	  hES-­‐MPs	  may	  be	  well	  qualiﬁed	  for	  the	  successful	  treatment	  of	  musculoskeletal	  conditions	  [20].	  In	  a	  recent	  study,	  de	  
Peppo	   et	   al.,	   showed	   that	   under	   proper	   stimulation,	   hES-­‐MPs	   can	   be	   directed	  towards	   an	   osteogenic	   lineage	   with	   an	   increase	   in	   mineralisation	   when	  compared	  to	  hMSCs	  [21].	  In	  a	  follow	  up	  study,	  de	  Peppo	  et	  al.,	  demonstrated	  that	  dynamic	   culture	   of	   hES-­‐MPs	   in	   a	   packed	   bed/column	   bioreactor	   had	   the	  potential	   to	   induce	   proliferation,	   expression	   of	   genes	   involved	   in	   osteogenic	  differentiation,	  and	  matrix	  mineralisation,	  which	  resulted	  in	  increased	  bone-­‐like	  tissue	  formation	  [22].	  Therefore,	  hES-­‐MPs	  have	  the	  potential	   to	  be	  a	  model	  cell	  line	   with	   greater	   reproducibility	   than	   adult	   MSCs	   which	   to	   test	   a	   range	   of	  osteogenic	   stimulation.	   In	   addition	   hES-­‐MPs	   may	   in	   themselves	   have	   clinical	  applications	  should	  the	  barriers	  to	  the	  use	  of	  embryonic	  stem	  cells	   in	  medicine	  be	  removed.	  	  	  
	  Animal	  Marrow	  stromal	  cells	  are	  multipotential	  progenitor	  cells	  that	  can	  commit	  to	  the	  osteoblast	  lineage	  and	  have	  been	  used	  quite	  extensively	  for	  in	  vitro	  studies	  in	   bone	   tissue	   engineering.	   	   Rat	   and	   mouse	   MSC	   osteogenesis	   has	   been	  demonstrated	   on	   a	   number	   of	   scaffolds	   including	   PLGA	   [23-­‐25]	   and	   Calcium	  phosphate-­‐coated	  bioactive	  glass	   [26,	  27].	   In	  spite	  of	   the	  attention	  given	   to	   the	  study	   of	   mesenchymal	   stem	   cells	   derived	   from	   bone	   marrow	   of	   humans	   and	  other	   species,	   there	   is	   still	   a	   lack	   of	   information	   regarding	   murine	   MSCs.	   As	  mouse	  cells	  are	  often	  used	  in	  basic	  science	  experiments	  as	  a	  model	  cell	  type	  it	  is	  important	   to	   understand	   and	   compare	   mouse	   MSC	   responses	   to	   osteogenic	  conditions	  with	  those	  of	  human	  MSCs.	  It	  has	  been	  shown	  that	  in	  vitro	  expanded	  cells	   from	   murine	   bone	   marrow	   have	   the	   ability	   to	   differentiate	   along	   the	  
	   	   106	  
osteogenic	   and	   apidogenic	   lineages	   [28].	   In	   a	   recent	   study	   the	   differentiation	  potential	   of	   primary	  MSCs	  derived	   from	  adult	  mouse	  bone	  was	   investigated.	   It	  was	   shown	   that	   cell	   population	   was	   maintained	   over	   30	   passages	   and	   under	  proper	  stimulation	  these	  cells	  were	  able	  to	  induce	  osteoblastic	  differentiation	  as	  confirmed	   by	   the	   expression	   of	   osteopontin	   and	   accumulation	   of	   a	   bone-­‐like	  mineralised	  matrix	  [29].	  	  	  There	  are	  many	  factors	  that	  influence	  the	  expression	  of	  osteoblast	  phenotype	  in	  culture,	  including:	  cell	  source,	  culture	  medium,	  culture	  time	  and	  the	  presence	  of	  compounds	   that	   influence	   cell	   proliferation	   and	   differentiation	   [30].	  Furthermore,	  several	  systemic	  and	  local	  hormones,	  growth	  factors	  and	  cytokines	  have	   also	   been	   shown	   to	   be	   involved	   in	   the	   osteoblast	   differentiation	   process	  [31].	  The	  most	  commonly	  used	  osteogenic	  medium	  for	  MSCs	  usually	  consists	  of	  ascorbic	   acid/	   vitamin	   C	   (AA)	   or	   its	   phosphate	   salt,	   beta-­‐glycerophosphate	  (βGP),	   and	   dexamethasone	   (DEX).	   AA	   is	   essential	   for	   the	   production	   of	   stable	  collagen,	  the	  major	  matrix	  protein	  of	  bone,	  and	  plays	  a	  key	  role	  as	  a	  cofactor	  in	  the	   hydroxylation	   of	   proline	   residues	   in	   the	   collagen	   molecule	   [32].	   βGP	   is	  known	  to	  provide	  inorganic	  phosphates	  for	  synthesis	  of	  bone-­‐like	  mineral	  by	  the	  cells	  [33].	  Dexamethasone	  (DEX)	  is	  a	  synthetic	  glucocorticoid	  and	  is	  a	  component	  of	  multiple	   differentiation	  media	   formulae	   including	   osteogenic,	   chondrogenic,	  and	   adipogenic	   media.	   Data	   regarding	   the	   effects	   of	   glucocorticoids	   on	   cell	  activity	   in	   vitro	  are	   conflicting,	   as	   they	   appear	   to	   depend	   upon	   concentration,	  time	  and	  duration	  of	  exposure	  to	  the	  drug	  [34].	  Results	  of	  in	  vitro	  investigations	  using	   bone-­‐derived	   cells	   of	   adult	   human	   origin	   have	   suggested	   that	  glucocorticoids	   reduce	   cell	   proliferation	   and	   increase	   ALP	   activity	   [35]	   and	   its	  effect	  on	  collagen	  expression	  seems	  to	  be	  controversial,	  as	  both	  stimulation	  and	  inhibition	   have	   been	   reported	   depending	   on	   the	   cell	   source	   and	   culture	  conditions	  [36,	  37].	  Despite	  this,	   it	  has	  been	  well	  documented	  that	  human	  bone	  marrow	   cells,	   including	   actively	   proliferating	   osteoprogenitors,	   can	  be	   induced	  to	  differentiate	  into	  cells	  exhibiting	  the	  osteoblast	  phenotype	  by	  DEX	  at	  both	  10	  nM	  and	  100	  nM	  concentrations	  [38,	  39].	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Traditional	   static	   cultures	   of	   3D	   scaffolds	   have	   been	   shown	   to	   have	   a	   major	  limitation	  in	  that	  there	  is	  insufficient	  transport	  of	  nutrients	  into	  the	  inner	  regions	  of	  the	  construct.	  Because	  of	  this	  a	  thin	  layer	  (crust)	  of	  live	  cells	  tend	  to	  cover	  the	  exterior	   surface	   of	   the	   scaffold	   [40].	   Lyons	   et	   al.,	   evaluated	   collagen-­‐glycosaminoglycan	   (CG)	   and	   biomimetic	   collagen-­‐calcium	   phosphate	   (CCP)	  scaffolds	  (cell-­‐free	  and	  cultured	  with	  MSCs	  prior	  to	  implantation)	  for	  bone	  repair	  in	  rat	  cranial	  defects.	  They	  noted	  that	  for	  MSC-­‐seeded	  groups,	  the	  location	  of	  the	  resorption	   response	   was	   confined	   to	   the	   construct	   periphery.	   The	   authors	  suggested	  that	  the	  matrix	  produced	  by	  the	  MSCs	  in	  vitro	  may	  act	  as	  a	  barrier	  to	  bone	  healing	  [40].	  	  The	   use	   of	   bioreactors	   such	   as	   the	   spinner	   flask	   [41]	   and	   rotatory	   vessel	   [42]	  have	  not	  demonstrated	  an	   improvement	   in	  the	  distribution	  of	  bone	  cells	  on	  3D	  scaffolds	   since	   there	   is	   limited	  mass	   transport	  of	  nutrients	   to	   the	   inner	  core	  of	  the	   construct	   [43,	   44].	   Flow	   perfusion	   bioreactors	   have	   been	   shown	   to	   induce	  fluid	   flow	   throughout	   the	   entire	   structure	  of	   a	  3D	   scaffold	   allowing	   for	   a	  more	  efficient	   nutrient	   and	   waste	   exchange	   to	   take	   place,	   which	   will	   subsequently	  increase	   cell	   viability.	   Furthermore,	   perfusion	   bioreactors	   can	   mechanically	  stimulate	   cultured	   bone	   cells	   to	   accelerate	   the	   formation	   of	   increased	   bone	  matrix	  in	  constructs.	  Previous	  work	  performed	  on	  monolayers	  of	  cells	  seeded	  on	  slides	   has	   shown	   that	   the	   application	   of	   fluid	   flow	   has	   biological	   effects	   on	  cultured	   bone	   cells	   [45-­‐47]	   such	   as	   upregulating	   osteopontin	   expression,	   ALP	  activity	  and	  expression	  of	  COX-­‐2	  and	  release	  of	  PGE2.	  	  	  Highly	  porous	  scaffolds	  used	  for	  bone	  tissue	  engineering	  would	  ideally	  have	  load	  bearing	  properties	  once	  implanted	  in	  vivo.	  As	  mentioned	  previously	  (chapter	  1),	  selecting	   the	   most	   appropriate	   material	   to	   produce	   a	   scaffold	   for	   bone	   tissue	  engineering	   is	   a	   very	   important	   step	   towards	   the	   construction	   of	   a	   tissue-­‐engineered	   product.	   PU	   scaffolds	   have	   sufficient	   elasticity,	   resiliency	   and	  stiffness	   to	   deal	   with	   in	   vitro	  mechanical	   loading.	   The	   advantage	   of	   using	   this	  material	   is	   that	   it	   can	   be	   used	   to	   create	   a	   highly	   porous	   structure,	   and	   it	   is	  biocompatible	   with	   bone	   cells	   [48-­‐50].	   Furthermore,	   this	   non-­‐degradable	  industrially	   produced	   foam	   has	   been	   shown	   to	   support	   MLO-­‐A5	   osteoblast	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culture	  in	  3D	  [51].	  In	  other	  studies,	  an	  osteosarcoma	  cell	  line	  was	  shown	  to	  grow	  and	  mineralise	  on	   laboratory	  synthesised	  PU	  foams	  [52].	  Using	  non-­‐degradable	  PU	   for	   cell	   culture	   purposes	  means	   that	   it	  maintains	   its	  mechanical	   properties	  over	  time	  and	  does	  not	  leach	  degradation	  products	  into	  the	  culture	  media,	  which	  may	  complicate	  the	  experimental	  set-­‐up.	  	  	  Orla	   Protein	   Technologies	   initially	   developed	   their	   protein	   coatings	   for	   flat	  surfaces.	   To	   enable	   their	   coating	   to	   be	   relevant	   for	   biomaterials	   and	   tissue	  engineering	   purposes,	   it	   was	   important	   to	   develop	   a	   process	   for	   coating	   3D	  materials.	   The	   first	   porous	   scaffold	   on	   which	   they	   applied	   their	   coatings	   is	  manufactured	   from	  Nippon	  Sheet	  Glass	   (NSG)	  and	   is	  made	   from	  the	  same	  high	  optical	  grade	  borosilicate	  glass	  used	  for	  the	  production	  of	  2D	  microscope	  slides	  and	   cover	   slips.	   The	   glass	   scaffolds	   have	   good	   light	   transmissibility	   useful	   for	  microscopy.	  They	  can	  be	  supplied	  uncoated	  or	  peptide	  coated	  which	  provides	  a	  foundation	   for	   studying	   various	   aspects	   of	   cell	   matrix	   interaction,	  mechanotransduction	  and	  cell	  behavior	  relevant	   to	   in	  vitro	  3D	  culture	  systems.	  Ceramic	   and	   glass	   based	   scaffolds	   have	   been	   widely	   used	   in	   the	   biomedical	  engineering	   and	   bone	   regeneration	   field	   due	   to	   their	   osteoconductive	   and	  osteoinductive	  properties	  [53].	  While	  the	  glass	  for	  the	  Orla	  coated	  scaffolds	  was	  chosen	   for	   its	  bioinertness	  and	   is	  not	   intended	   to	  be	  an	   implantable	   scaffold	   it	  would	   have	   similar	  material	   properties	   to	   other	   glass	   based	   scaffolds	  made	   of	  clinical	  grade	  glasses.	  In	   this	   chapter,	   the	   intention	   is	   to	   set	   up	   a	   system	   in	  which	   the	   effect	   of	   short	  bouts	  of	  dynamic	  loading	  on	  MSCs	  in	  a	  3D	  environment	  can	  be	  investigated.	  	  The	  main	  hypothesis	  was:	  	  The	   porous	   glass	   scaffold	   supplied	   by	   Orla	   Protien	   Technologies	   would	   be	   a	  suitable	   substrate	   for	   MSC	   cell	   growth	   and	   cells	   would	   respond	   to	   fluid	   flow	  through	  the	  scaffold	  in	  a	  similar	  way	  to	  previous	  experiments	  on	  PU	  foams.	  In	   order	   to	   test	   this	   hypothesis	   a	   suitable	   cell	  model	  was	   first	   established.	   To	  date,	   little	   is	   known	   about	   the	   behaviour	   of	   hES-­‐MP	   and	   mouse	   MSC	   cells	  cultured	  on	  3D	  scaffolds.	  Furthermore,	  the	  effects	  of	  dynamic	  culture	  conditions	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3.2	   Investigating	  the	  effects	  of	  DEX	  on	  Mouse	  MSC	  cells	  
	  The	  aim	  of	  this	  experiment	  was	  to	  investigate	  the	  effects	  of	  dexamethasone (DEX,	  commonly	  used	  to	  induce	  osteogenic	  differentiation	  of	  MSCs	   in	  vitro) on	  mouse	  MSC	   and	   hES-­‐MP	   cells	   as	   analysed	   by	   alkaline	   phosphatase	   (ALP)	   activity.	   A	  simple	  2D	  static	  experiment	  was	  devised	  whereby	  50,000	  cells	  of	  each	  cell	  type	  were	  seeded	   in	  0.1%	  gelatin	  coated	  well-­‐plates	  and	  cultured	   in	  DEX	  containing	  (100	  nM)	  and	  DEX	  free	  media	  (both	  culture	  conditions	  contained	  AA	  and	  βGP).	  Fresh	  media	  was	  supplied	  every	  3	  days	  and	  on	  day	  7	  and	  14	  of	  culture,	  cells	  were	  analysed	  for	  ALP	  activity	  as	  described	  in	  chapter	  2.	  Figure	  3.1	  indicates	  that	  on	  day	  7	  and	  day	  14	  of	  static	  culture,	  mouse	  MSC	  cells	  have	  a	  higher	  ALP	  activity	  in	  the	  absence	  of	  DEX.	  However,	  ALP	  is	  upregulated	  for	  hES-­‐MP	  cells	  cultured	  in	  the	  presence	  of	  DEX.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Fig	  3.1;	  hES-­‐MP	  and	  mouse	  MSC	  cells	  cultured	  for	  7	  and	  14	  days	  on	  12	  well-­‐plates	  in	  DEX	  free	  and	  DEX	  containing	  media	  were	  assayed	   for	  ALP	  activity	   (normalized	   to	  DNA).	  All	  data	  is	  mean	  ±	  SD	  (n=4).	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3.3	   Investigating	   the	   initial	   attachment	   of	   mouse	   MSC	   cells	   on	   glass	  






















Fig	  3.2;	  Mouse	  MSC	  cells	  were	  statically	  cultured	  on	  glass	  scaffolds	  for	  5	  days	   and	   assayed	   for	   cell	   viability	   on	   each	   day	   using	   Alamar	   blue.	   All	  data	  is	  mean	  ±	  SD	  (n=4).	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3.5	   Investigating	  the	  effects	  of	  different	  static	  culture	  conditions	  for	  
mouse	  MSC	  cells	  seeded	  on	  glass	  scaffolds	  	  The	   aim	   of	   this	   experiment	   was	   to	   investigate	   the	   effects	   of	   different	   culture	  environments	  of	  Mouse	  MSC	  cells	  seeded	  on	  glass	  scaffolds	  with	  respect	   to	  cell	  viability	   and	   matrix	   production.	   In	   order	   to	   do	   this,	   Mouse	   MSC	   cells	   were	  
Fig	  3.3;	  Morphology	  of	  hES-­‐MP	  cells	  on	  glass	  scaffolds	  at	  day	  7	  of	  culture.	  Cell	  nucleus	  (DAPI-­‐blue)	  and	  actin	   cytoskeleton	   (Phalloidin	   TRITC-­‐red)	   shows	   cell	   morphology	   at	   different	   locations	   within	   the	  glass	  scaffold	  including	  the	  top,	  middle	  and	  bottom	  section.	  Representative	  images	  are	  shown	  (n=2).	  Sclae	  bar	  =	  50	  μm.	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Fig	  3.4;	  Mouse	  MSC	  cells	  seeded	  on	  glass	  scaffolds	  and	  cultured	  in	  well	  plates	  (blue	  bar)	  or	  silicon	  tubing	  (red	  bar).	  On	  day	  14	  of	  static	  culture	  samples	  were	  assayed	  for	  cell	  viability	  (MTS)	  and	  collagen	  production	  (Sirius	  red).	  All	  data	  is	  mean	  ±	  SD	  (n=4).	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3.6	   Studying	  the	  effects	  of	  fluid	  flow	  on	  matrix	  production	  and	  
expression	  of	  genes	  associated	  with	  osteogenic	  differentiation	  for	  Mouse	  
MSC	  and	  hES-­‐MP	  cells	  in	  3D	  constructs	  
	  The	  aim	  of	  these	  experiments	  was	  to	  study	  the	  effect	  of	  oscillatory	  fluid	  flow	  on	  cell	  viability,	  ALP	  activity,	  collagen	  production	  and	  calcium	  deposition	  of	  mouse	  MSC	  and	  hES-­‐MP	  cells	  in	  3D	  constructs.	  To	  study	  this	  effect,	  glass	  scaffolds	  were	  seeded	  with	  250,000	  cells	  and	  PU	  scaffolds	  (having	  a	  larger	  volume,	  10	  mm	  x	  10	  mm)	   were	   seeded	   with	   500,000	   cells	   using	   the	   seeding	   and	   culture	   methods	  described	   in	  chapter	  2.	  Samples	  seeded	  with	  mouse	  MSC	  cells	  were	  cultured	   in	  standard	   culture	   media	   and	   supplemented	   with	   AA	   and	   βGP.	   Samples	   seeded	  with	   hES-­‐MP	   cells	  were	   cultured	   in	   standard	   culture	  media	   and	   supplemented	  with	   AA,	   βGP	   and	   DEX.	   Fluid	   flow	   was	   applied	   using	   the	   oscillatory	   pump	  (chapter	  2,	  figure	  2.3)	  at	  a	  frequency	  of	  1Hz	  for	  a	  loading	  period	  of	  1	  hour.	  	  	  In	  short-­‐term	  dynamic	  culture,	  samples	  were	  subjected	  to	  oscillatory	   fluid	   flow	  (3	  ml/min,	  1	  Hz,	  1	  hour	  loading	  session)	  on	  day	  4	  and	  analysed	  for	  cell	  viability,	  total	  DNA	  content	  and	  ALP	  activity	  on	  day	  7	  (figure	  3.5a).	   In	   long-­‐term	  culture,	  samples	   were	   subjected	   to	   fluid	   flow	   on	   day	   4,	   7,	   10	   and	   analysed	   collagen	  production	   and	   calcium	   deposition	   on	   day	   14	   (figure	   3.5b).	   Between	   loading	  sessions,	   cell-­‐seeded	   scaffolds	   were	   cultured	   statically	   in	   an	   incubator	   in	  standard	  conditions.	  The	  experiment	  was	  conducted	  once	  (N=1)	  with	  3	  scaffolds	  (n=3)	  for	  each	  condition.	  Therefore,	  statistical	  analysis	  was	  not	  performed	  due	  to	  the	  low	  number	  of	  repeats.	  























Figure	   3.5;	   The	   experimental	   time	   line.	   (a)	   Short	   term	   dynamic	   culture,	   samples	   were	  subjected	  to	  flow	  on	  day	  4	  of	  culture	  and	  analysed	  for	  cell	  viability,	  total	  DNA	  content,	  and	  ALP	  activity	  on	  day	  7.	  (b)	  Long	  term	  dynamic	  culture,	  samples	  were	   subjected	  to	   flow	  on	  days	  4,	  7	  and	  10	  and	  analysed	  for	  cell	  viability,	  collagen	  and	  calcium	  content	  on	  day	  14.	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   3.6.1	   Short	  term	  dynamic	  culture	  -­‐	  Cell	  viability	  (MTS)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  From	  figure	  3.6	  it	  appears	  that	  regardless	  of	  scaffold	  or	  cell	  type,	  the	  application	  of	   flow	  caused	  higher	   cell	   viability	   compared	   to	   static	   conditions.	  hES-­‐MP	  cells	  seeded	  on	  glass	  scaffolds	  and	  subjected	  to	  5	  ml/min	  had	  the	  highest	  cell	  viability,	  whereas	   mouse	   MSC	   cells	   seeded	   on	   the	   same	   scaffold	   showed	   highest	   cell	  viability	   when	   subjected	   to	   3	   ml/min	   fluid	   flow.	   Moreover,	   mouse	   MSC	   cells	  seeded	  on	  PU	  foam	  demonstrated	  the	  highest	  cell	  viability	  when	  subjected	  to	  10	  ml/min	  oscillatory	  fluid	  flow.	  	  	   3.6.2	   Short-­‐term	  dynamic	  culture	  -­‐	  Total	  DNA	  content	  and	  ALP	  activity	  	  Total	  DNA	  and	  ALP	  activity	  of	  cell-­‐seeded	  scaffolds	  subjected	  to	  oscillatory	  fluid	  flow	  was	  analysed	  on	  day	  7	  of	  culture.	  DNA	  content	  of	  Mouse	  MSC	  cells	  seeded	  on	   glass	   scaffolds	   (fig	   3.7a)	  was	   higher	   for	   all	   scaffolds	   subjected	   to	   fluid	   flow	  when	  compared	  to	  static	  culture.	  It	  appears	  that	  scaffolds	  subjected	  to	  5	  ml/min	  had	   the	   highest	   DNA	   content.	   ALP	   activity	   (fig	   3.7b)	   appears	   to	   be	   relatively	  
Fig	  3.6;	  Cell-­‐seeded	  scaffolds	  were	  subjected	  to	  three	  different	  flow	  rates	  on	  day	  4	  and	   analyzed	   for	   cell	   viability	   (MTS)	   on	   day	   7	   of	   culture.	   All	   data	   is	   mean	   ±	   SD	  (n=2).	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consistent	  between	  flow	  groups	  and	  static	  culture	  except	  for	  scaffolds	  under	  10	  ml/min,	  where	  the	  activity	  of	  ALP	  was	  lowest.	  	  The	  total	  DNA	  content	  for	  Mouse	  MSCs	  seeded	  on	  PU	  scaffolds	  (fig	  3.7c)	  appears	  to	   be	   consistent	   throughout	   all	   flow	   and	   static	   conditions,	   whereby	   scaffolds	  subject	   to	   3	   ml/min	   had	   a	   slightly	   higher	   DNA	   content	   than	   other	   groups.	   In	  general,	  ALP	  activity	  (fig	  3.7d)	  was	  lower	  for	  all	  scaffolds	  subjected	  to	  fluid	  flow	  when	  compared	  to	  static	  conditions.	  
	  DNA	  content	  for	  hES-­‐MP	  cells	  seeded	  on	  glass	  scaffolds	  (fig	  3.7e)	  and	  subjected	  to	  3	  ml/min	  appears	  to	  be	  lowest	  compared	  to	  other	  flow	  conditions	  and	  static	  cultures.	  Furthermore,	  scaffolds	  subjected	  to	  5	  ml/min	  and	  10	  ml/min	  fluid	  flow	  have	  a	  higher	  DNA	  content	  than	  static	  culture.	  ALP	  activity	  (fig	  3.7f)	  also	  appears	  to	  be	  consistent	  throughout	  all	  flow	  and	  static	  conditions.	  	  
	   	  


































Fig	   3.7;	   Affect	   of	   fluid	   flow	   on	   (a)	   total	   DNA	   content	   and	   (b)	   ALP	   activity	   (normalized	   to	  DNA)	   for	  mouse	  MSCs	   cultured	   on	   glass	   scaffolds	   (c)	   total	   DNA	   content	   and	   (d)	   ALP	   activity	   (normalized	   to	  DNA)	  for	  mouse	  MSCs	  cultured	  on	  PU	  scaffolds	  (e)	  total	  DNA	  content	  and	  (f)	  ALP	  activity	  (normalized	  to	  DNA)	  for	  hES-­‐MP	  cells	  cultured	  on	  glass	  scaffolds	  at	  day	  7.	  All	  data	  is	  mean	  ±	  SD	  (n=2).	  	  	  
(a)	  Total	  DNA	  content	   (b)	  ALP	  Mouse	  MSC	  on	  Glass	  
(c)	  Total	  DNA	  content	   (d)	  ALP	  Mouse	  MSC	  on	  PU	  
(e)	  Total	  DNA	  content	   (f)	  ALP	  hES-­‐MP	  on	  Glass	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  Late	  markers	   of	   osteogenic	   differentiation	  were	   also	   analysed	   using	   Sirius	   red	  (for	   collagen	  production)	  and	  alizarin	   red	   (calcium	  deposition)	   staining	  on	  day	  14	   of	   culture	   (Figure	   3.8).	   In	   general,	   it	   seems	   that	   the	   application	   of	   flow	  increased	  matrix	  production	  in	  comparison	  to	  static	  culture.	  	  Scaffolds	  subjected	  to	  5	  ml/min	  flow	  deposited	  the	  most	  calcium	  whereas	  scaffolds	  subjected	  to	  10	  ml/min	  flow	  produced	  the	  highest	  collagen.	  
	  	  	  	  	  	  
Fig	  3.8;	  hES-­‐MP	  cells	  cultured	  on	  glass	   scaffolds	  and	  subjected	  to	   three	  different	   flow	  rates	   on	   day	   4,	   7	   and	   10.	   Collagen	   production	   (Sirius	   red)	   and	   calcium	   deposition	  (Alazarin	  red)	  were	  analyzed	  on	  day	  14.	  All	  data	  is	  mean	  ±	  SD	  (n=2).	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  Static	  	   	   	  	  	   	  	  	  	  	  	  	  	  	  	  	  3ml/min	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  10ml/min	  
Fig	  3.9;	  Mouse	  MSCs	  cultured	  on	  glass	  scaffolds	  and	  subjected	  to	  fluid	  flow	  on	  day	  4,7	  and	  10.	  On	  day	  14,	  images	  produced	  using	  confocal	  microscopy	  reveal	  a	  higher	  number	  of	  cells	  on	  the	  surface	  of	  scaffolds	  in	  static	  culture	  in	  comparison	  to	  samples	  subjected	  3	  and	  10	  ml/min	  oscillatory	  flow.	  Representative	  images	  are	  shown	  (n=2).	  Sclae	  bar	  =	  100	  μm.	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3.7	   Discussion	  	  In	   this	   chapter	   it	  was	   demonstrated	   that	  mouse	  MSC	   and	   hES-­‐MP	   cells	   can	   be	  cultured	   on	   an	   industrially	   produced	  PU	   and	  novel	   glass	   based	   scaffold,	  which	  has	   not	   previously	   been	   reported	   for	   use	   in	   3D	   tissue	   culture.	   A	   non-­‐dynamic	  method	   to	   culture	   cells	   in	   a	   3D	   static	   environment	   was	   designed,	   allowing	   to	  further	   investigate	   selected	   mechanical	   stimuli	   and	   mechanotransduction	   in	  bone	  tissue	  constructs.	  Culturing	  cells	  on	  a	  3D	  scaffold	  can	  better	  mimic	  the	  bone	  environment	   providing	   a	   better	   physiological	   model	   than	   cells	   cultured	   in	   2D	  monolayer.	  The	  model	  in	  this	  study	  can	  be	  used	  to	  better	  understand	  bone	  tissue	  constructs	  and	  other	  in	  vitro	  studies	  of	  bone	  cells	  in	  a	  3D	  environment.	  	  In	  has	  been	  well	  demonstrated	  that	  MSCs	  can	  be	  stimulated	  towards	  ostogenesis	  
in	   vitro	   by	   addition	   of	   ascorbic	   acid,	   dexamethasone,	   and	   β-­‐glycerophosphate.	  For	   example	   MSC	   proliferation	   and	   the	   number	   of	   colony	   forming	   units	   were	  increased	   by	   the	   addition	   of	   ascorbic	   acid.	   DEX	   was	   shown	   to	   enhance	   ALP	  activity	  and	  was	  critical	  for	  mineral	  deposition	  [54].	  However	  hES-­‐MPs	  are	  a	  new	  commercially	  available	  mesenchymal	  progenitor	  cell	  for	  which	  there	  was	  limited	  literature	  available	  at	  the	  beginning	  of	  this	  study,	  other	  than	  papers	  authored	  by	  the	   company	   that	  market	   the	   cells.	   Therefore,	   experiments	  were	   conducted	   to	  verify	   the	   ostoegneic	   potential	   of	   these	   cells	   using	   standard	   laboratory	  conditions.	  	  	  	  In	  this	  study	  it	  was	  shown	  that	  hES-­‐MP	  cells	  treated	  with	  100	  nM	  DEX,	  increased	  ALP	   activity	   on	   day	   7	   and	   day	   14	   of	   static	   culture	   (fig	   3.1).	   Interestingly,	   this	  effect	  was	  not	   seen	   for	   the	  mouse	  MSCs	  obtained	   from	   the	   collaborator	  where	  the	  addition	  of	  DEX	  reduced	  ALP	  activity	  on	  day	  14	  of	  culture.	  Dr.	  Delaine-­‐Smith	  also	  investigated	  the	  osteogenic	  differentiation	  of	  hES-­‐MP	  cells	  when	  exposed	  to	  different	  DEX	  concentrations	  (0,	  10	  nM	  and	  100	  nM)	  and	  showed	  that	  lower	  DEX	  concentration	  corresponded	  to	  higher	  total	  DNA,	  indicating	  that	  DEX	  affects	  cell	  number.	   ALP	   activity	   of	   samples	   treated	   with	   10	   nM	   and	   100	   nM	   showed	   no	  difference	  at	  days	  7-­‐14.	  However,	  on	  day	  21	  of	  culture,	  samples	  treated	  with	  100	  nM	  DEX	  displayed	   1.5-­‐fold	   higher	  ALP	   activity	   than	   those	   treated	  with	   10	   nM.	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Cells	  with	  0	  nM	  dex	  exhibited	  a	  much	  lower	  ALP	  activity	  at	  all	  time	  points.	  Sirius	  red	   staining	   of	   collagen	   at	   day	   14	   indicated	   that	   increasing	  DEX	   concentration	  resulted	   in	   less	   staining	   [55].	  Beresford	   et	   al.	  also	   demonstrated	   that	   DEX	   can	  inhibit	  expression	  of	  collagen	  type	  I	  (COL	  1)	  and	  enhance	  maturation	  adipocytes	  in	  culture	  [56].	  	  	  The	  results	  from	  this	  investigation	  showed	  an	  inhibition	  of	  ALP	  activity	  of	  mouse	  MSC	  cells	  treated	  with	  DEX.	  It	  has	  also	  been	  indicated	  that	  the	  effects	  of	  DEX	  may	  vary	   depending	   on	   the	   species	   origin,	  maturation	   stage	   of	   the	   cells	   as	  well	   as	  culture	  conditions	  [57,	  58].	  In	  a	  similar	  study	  it	  was	  shown	  that	  mice	  and	  rats	  are	  different	  in	  their	  response	  to	  the	  cell	  proliferation	  effects	  of	  DEX	  [59].	  It	  showed	  that	   instead	   of	   increasing	   the	   number	   of	   calcified	   nodules	   as	   seen	   in	   rat	   cells,	  calvarial	  osteoblasts	  from	  mice	  produced	  fewer	  calcified	  colonies	  in	  the	  presence	  of	  dexamethasone.	  The	  data	   further	   indicated	   that	  DEX	  might	  not	  be	  beneficial	  for	   the	   growth	   and	   differentiation	   of	   bone	   marrow	   stromal	   cells	   culture	   as	  reported	   for	   rat	   cells	   or	   human	   MSCs.	   It	   is	   interesting	   to	   note	   these	   strong	  differences	   in	   the	   two	  species	   responses	   to	  a	  biochemical	   agent	   since	  mice	  are	  the	   most	   common	   source	   of	   transgenic	   and	   knockout	   animals	   for	   biomedical	  research.	   The	   mechanism	   by	   which	   DEX	   and	   mechanical	   stimuli	   induce	  osteogenic	  differentiation	  in	  human	  MSC	  cells	  is	  poorly	  understood.	  However,	  it	  has	  been	  proposed	  that	  one	  of	  the	  potential	  signal	  transduction	  pathways	  which	  could	  direct	   the	  human	  MSC	  cells	   towards	  a	  osteogenic	   lineage	   is	   the	  mitogen-­‐activated	   protein	   kinase	   (MAPK)	   pathway	   [60].	   Extracellular	   signal	   related	  kinase	   (ERK,	   a	   member	   of	   the	   MAPK	   family)	   stimulates	   the	   differentiation	   of	  human	  MSCs	  into	  osteoblasts	  via	  phosphorylation	  of	  the	  osteogenic	  transcription	  factor	  RUNX2/Cbfa1	  [60].	  	  	  Metabolic	  assays	  such	  as	  MTS,	  MTT	  or	  alamar	  blue	  are	  widely	  used	  to	  assess	  cell	  viability	  and	  cell	  proliferation.	  Furthermore,	  assays	  such	  as	  ALP,	  sirius	  red	  and	  alizarin	  red	  staining	  are	  used	  to	  evaluate	  cell	  differentiation	  in	  2D	  and	  3D	  culture	  [61].	  Although	   the	  non-­‐dynamic	  model	  showed	  acceptable	  results	  with	  regards	  to	   mouse	   MSC	   proliferation	   as	   seen	   by	   alamar	   blue	   analysis	   (fig	   3.2),	   the	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distribution	   of	   cells	   was	   not	   homogenous.	   Confocal	   images	   (fig	   3.3)	   revealed	  more	  cells	  on	   the	   top	  and	  bottom	  surface	   than	   in	   the	  cross-­‐section	  of	   the	  glass	  scaffold.	  Alternative	  techniques	  such	  as	  application	  of	  flow	  can	  induce	  fluid	  into	  the	   culture	   system	   to	   improve	   growth,	  migration	   and	  distribution	   of	   cells	   [62-­‐70].	  During	   the	   assay	  protocol	   it	  was	  noticed	   that	  not	   all	   the	   solutions	  may	  be	  able	  to	  diffuse	  out	  of	  the	  interior	  of	  scaffolds	  whether	  its	  the	  quantification	  of	  cell	  number	   by	   dissolving	   MTS	   or	   measuring	   calcium	   deposition	   by	   alizarin	   red	  staining.	  In	  the	  case	  of	  MTT,	  the	  assay	  relies	  on	  the	  cells	  metabolising	  a	  solution	  of	   a	   colored	   substrate.	   Studies	   have	   shown	   that	   the	   accuracy	   of	   assays	   in	   3D	  scaffolds	   is	   dependent	   on	   the	   efficiency	   of	   solution	   diffusion	   into	   and	   out	   of	  constructs	   [71,	   72].	   Therefore	   in	   later	   chapters	   it	   was	   decided	   that	   scaffolds	  would	   be	   separated	   into	   several	   sections	   to	   maximise	   diffusion	   out	   of	   the	  interior.	  	  	  Results	  from	  this	  chapter	  suggest	  that	  the	  application	  of	  flow	  to	  both	  mouse	  MSC	  and	   hES-­‐MP	   cells	   promoted	   cell	   proliferation	   as	   indicated	   by	   higher	  MTS	   over	  time	   and	   general	   increase	   in	   DNA	   content.	   This	   observation	   has	   also	   been	  reported	   by	   others	   culturing	   hMSCs	   under	   dynamic	   conditions	   in	   bioreactor	  systems	   [73,	   74].	   Perfusion	   systems	   are	   known	   to	   affect	   cell	   proliferation	  through	   two	  main	  mechanisms,	   enabling	  mass	   transport	   and	   applying	   a	   fluid-­‐driven	  mechanical	  stimulation.	  Similarly,	  the	  increase	  in	  cell	  proliferation	  in	  this	  study	   maybe	   due	   to	   the	   short	   increase	   in	   nutrient	   transport	   and	   fluid	   shear	  stress	   associated	   with	   flow	   perfusion	   [75].	   On	   the	   other	   hand,	   it	   has	   been	  reported	  by	  Lynch	  et	  al,	  that	  upon	  osteogenic	  differentiation	  and	  bone-­‐like	  tissue	  formation	   in	   vitro,	   cells	   undergo	   programmed	   cell	   death	   [76].	   In	   the	   present	  study	   it	   was	   unclear	  whether	   the	   increase	   in	   DNA	   content	   is	   due	   to	   an	   actual	  increase	   in	   proliferation	  or	   reduced	   cell	   death.	  However	   in	   the	   current	   system	  there	  is	  no	  continuous	  perfusion	  so	  effects	  of	  nutrient	  transport	  are	  likely	  to	  be	  small.	  	  In	   this	   investigation	   cell	   morphology	   did	   not	   seem	   to	   alter	   with	   respect	   to	  location	  on	  glass	  scaffolds	  as	  hES-­‐MP	  cells	  demonstrated	  an	  elongated	  fibroblast-­‐like	   shape	   at	   the	   top,	   cross-­‐section	   and	   bottom	   part	   of	   the	   scaffold	   (fig	   3.3).	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Extracellular	  matrix	   (ECM)	   stiffness	  has	   also	  been	   shown	   to	  play	   an	   important	  role	   in	   a	   variety	   of	   cell	   behaviours	   such	   as	   migration,	   proliferation,	   and	  differentiation	  in	  both	  osteogenic	  and	  non-­‐osteogenic	  cells	  [77-­‐79].	  Engler	  et	  al.,	  demonstrated	   that	   MSC	   differentiation	   along	   different	   phenotypic	   lineages	   is	  partially	   dependant	   on	   substrate	   stiffness.	   It	   was	   shown	   that	   MSCs	   would	  differentiate	   into	   osteoblast-­‐like	   cells	   when	   cultured	   on	   collagen	   coated	  polyacrylamide	  substrates	  that	  would	  mimic	  the	  stiffness	  of	  osteoid	  (25–40	  kPa).	  Furthermore,	   cells	  would	   take	   the	   characteristics	   of	   neurons	  when	   cultured	   in	  subtrates	   with	   stiffness	   values	   similar	   to	   brain	   (1	   kPa).	   MSCs	   cultured	   on	  matrices	  with	  stiffness	  range	  of	  8-­‐17	  kPa	  became	  spindle-­‐shaped	  in	  morphology,	  similar	   to	   myoblasts	   [80].	   In	   these	   studies	   the	   stiffness	   of	   the	   struts	   of	   the	  scaffold	  were	   not	  measured,	   however	   the	   glass	   scaffold	  would	   have	   been	   very	  stiff,	  well	  above	  the	  range	  tested	  by	  Engler’s	  group	  and	  therefore	  it	  is	  not	  really	  possible	   to	   compare	   these	   results	   with	   theirs.	   It	   would	   be	   interesting	   in	   the	  future	   to	   investigate	  whether	   the	  differences	   in	   stiffness	  between	  glass	  and	  PU	  have	  any	  effect	  on	  cell	  differentiation,	  however	  it	  would	  be	  difficult	  to	  separate	  stiffness	  effects	  from	  chemical	  effects	  in	  these	  two	  very	  different	  materials.	  	  In	   this	   study,	   two	   different	   cell	   seeding	   densities	   were	   chosen	   due	   to	   the	  difference	   in	   scaffold	   size.	   Glass	   scaffolds	   (12	  mm	   x	   3	  mm)	  were	   seeded	  with	  250,000	  cells	  while	  PU	  scaffolds	  (10	  mm	  x	  10	  mm)	  having	  a	  larger	  volume	  were	  seeded	   with	   500,000	   cells,	   as	   per	   a	   previously	   established	   protocol	   in	   the	  laboratory.	  The	  separation	  distance	  of	  cells,	  as	  controlled	  by	  cell	  seeding	  density,	  has	  been	  shown	  to	  play	  a	  key	  role	  in	  the	  differentiation	  of	  osteogenic	  cells	  during	  
in	  vitro	   cell	   culture	  experiments	  due	   to	  changes	   in	  paracrine	  signaling	  distance	  among	  the	  cells.	  Kim	  et	  al.	  established	  the	  importance	  of	  seeding	  density	  for	  the	  differentiation	  of	  BMSCs	  into	  osteoblasts	  on	  2D	  culture	  plates.	  It	  was	  shown	  that	  ALP	  activity	  in	  rat	  bone	  marrow	  stromal	  cells	  was	  higher	  when	  cells	  were	  seeded	  at	  a	  lower	  initial	  seeding	  density	  (3x104	  per	  cm2)	  in	  comparison	  to	  a	  high	  seeding	  density	   (14.9x104	   cm2)	   [81].	   Cell	   seeding	   density	   has	   been	   shown	   to	   influence	  osteoblast	  proliferation	  and	  matrix	  mineralisation	  in	  3D	  constructs	  in	  vitro	  [82].	  It	  was	  demonstrated	  that	  bone	  formation	  was	  increased	  when	  a	  higher	  number	  of	  goat	  bone	  marrow	  cells	  (47.8x106	  cells/cm3)	  were	  seeded	  on	  to	  HA	  scaffolds	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(2.8x3.6x5.2	   mm3)	   [83].	   Therefore,	   choosing	   a	   suitable	   seeding	   density	   is	  important	  as	  cell-­‐cell	  interactions	  may	  be	  controlled	  by	  this	  factor	  which	  would	  eventually	  induce	  a	  specific	  cell	  differentiation	  needed	  for	  each	  tissue	  type.	  Due	  to	   the	   limited	   number	   of	   glass	   scaffolds	   available	   it	   was	   not	   possible	   to	  extensively	   examine	   density	   effects	   however	   this	   would	   be	   an	   interesting	  variable	  to	  include	  in	  future	  studies.	  	  ALP	   activity	   is	   used	   as	   a	  marker	   of	   osteogenic	   differentiation	   and	  plays	   a	   vital	  role	   in	   the	   early	   phases	   of	   mineralisation	   of	   newly	   formed	   bone	   [84].	   In	   this	  study	  the	  activity	  of	  ALP	  in	  constructs	  was	  slightly	  different	  when	  cultured	  under	  static	   and	   dynamic	   conditions.	   Higher	   ALP	   activity	   was	   observed	   for	   scaffolds	  under	  static	  conditions	  compared	  to	  dynamic	  conditions.	  This	  difference	  may	  be	  due	   to	   the	   cell	   lysate	  not	  diffusing	  well	  out	  of	   the	   inner	   core	  of	   the	   constructs.	  Another	  reason	  could	  be	  complex	  biological	  factors	  underlying	  gene	  expression	  and	  protein	  synthesis	  [85].	  Interestingly,	  ALP	  exists	  as	  membrane-­‐bound	  and	  as	  a	  released	  enzyme,	  therefore	  the	  application	  of	  fluid	  flow	  may	  contribute	  to	  the	  removal	   of	   the	   released	   isoform	   and	   resulting	   in	   an	   underestimation	   of	   its	  activity	   [86].	   ALP	   is	   generally	   upregulated	   in	   the	   early	   phase	   of	   osteoblast	  differentiation	   and	   the	   positive	   correlation	   between	   ALP	   activity	   and	   matrix	  mineralisation	  indicates	  a	  relationship	  between	  the	  two	  markers.	  This	  has	  been	  supported	  by	  many	  other	  authors	  [68,	  87-­‐90]	  and	  is	  suggested	  that	  greater	  ALP	  activity	   would	   result	   in	   bone-­‐like	   formation.	   Once	   this	   level	   is	   reached,	   an	  upregulation	   in	   ALP	   activity	   will	   not	   result	   in	   an	   increase	   in	   matrix	  mineralisation.	  However	  this	  relationship	  was	  not	  observed	  in	  this	  study,	  and	  it	  may	   be	   speculated	   that	   there	   would	   be	   a	   specific	   level	   of	   ALP	   activity	   that	   is	  required	   to	   induce	   bone	   formation.	   Since	   calcium	   deposition	   was	   higher	   for	  samples	   subjected	   to	   fluid	   flow	   in	   comparison	   to	   static	   controls,	   it	   can	   be	  speculated	   that	   the	   peak	   in	   ALP	   activity	   could	   have	   occurred	   either	   before	   or	  after	  day	  7.	  Thus,	  highlighting	  the	  complex	  biology	  underlying	  gene	  expression,	  as	  well	  as	  the	  possibility	  that	  additional	  components	  control	  its	  regulation.	  This	  has	   also	   been	   observed	   in	   other	   studies	  whereby	   a	   significant	   decrease	   in	   the	  ALP	   activity	   occurs	   at	   a	   later	   stage	   when	   osteoblastic	   cells	   mature	   and	   form	  mineralised	  extracellular	  matrix	  [91,	  92].	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Osteogenic	  differentiation	  of	  hES-­‐MP	  cells	  was	  further	  assessed	  by	  investigating	  the	   collagen	   and	   calcium	   production	   on	   day	   14	   of	   culture.	   It	   is	   evident	   that	  matrix	   production	   was	   higher	   for	   constructs	   under	   dynamic	   conditions	  compared	  to	  static	  conditions.	  In	  a	  recent	  study,	  rat	  stromal	  cells	  were	  seeded	  on	  a	   titanium	  scaffold	  and	  placed	   in	  a	  perfusion	  bioreactor.	   It	  was	  shown	   that	   the	  rate	  of	  osteoblastic	  differentiation	  and	  calcium	  deposition	  significantly	  increased	  [87].	  As	  calcium	  is	  deposited	   in	   the	   late	  stages	  of	  osteoblastic	  differentiation,	   it	  was	  suggested	  that	  the	  application	  of	  flow	  greatly	  enhanced	  the	  differentiation	  of	  stem	   cells	   into	   mature	   osteoblasts.	   It	   was	   proposed	   that	   the	   cells	   were	  responding	  to	  the	  fluid	  shear	  stress	  caused	  by	  the	  fluid	  movement	  into	  and	  out	  of	  the	   scaffold.	   This	   will	   eventually	   cause	   a	   cascade	   of	   events	   that	   would	   finally	  result	   in	  an	  upregulation	  of	  survival	  and	  matrix	  producing	  genes.	  Furthermore,	  an	   improved	   nutrient	   supply	   only	   for	   a	   short	   time	   could	   contribute	   to	   the	  mechanosensative	   response	   however	   the	   mechanical	   stimuli	   subjected	   to	   the	  cells	  would	  also	  play	  a	  key	  role	  as	  has	  been	  demonstrated	  in	  2D	  monolayers	  [93,	  94].	  	  	  The	  use	  of	  PU	  scaffolds	  for	  tissue	  engineering	  purposes	  are	  limited	  due	  to	  their	  lack	  of	  biodegradation	  during	  long-­‐term	  in	  vivo	  culture	  [95].	  However	  these	  have	  good	  mechanical	   properties	   and	   allows	   them	   to	  withstand	   in	   vitro	  mechanical	  loading,	  while	   at	   the	   same	   time	  being	   cost-­‐effective	  and	  highly	   reproducible.	   It	  was	  previously	  shown	  that	  PU	  scaffolds	  supported	  MLO-­‐A5	  mouse	  osteoblastic	  cell	  growth	  [51]	  and	  therefore,	  it	  was	  predicted	  that	  this	  scaffold	  would	  also	  be	  biocompatible	  with	  MSCs.	  Furthermore,	  it	  was	  demonstrated	  that	  PU	  foams	  can	  support	  MSC	  adhesion,	  proliferation	  and	  differentiation	  into	  osteoblastic	  cells	  by	  observing	  the	  CaP	  deposition	  in	  in	  vitro	  static	  culture	  [96].	  	  A	  wide	  variety	  of	  both	  natural	  and	  synthetic	  materials	  are	  being	  investigated	  for	  the	   design	   and	   construction	   of	   scaffolds	   for	   bone	   tissue	   engineering.	   Scaffolds	  made	  from	  calcium	  phosphate	  have	  been	  used	  for	  bone	  engineering	  application	  for	   more	   than	   two	   decades.	   Hydroxyapatite	   and	   other	   calcium	   phosphates	  including;	   tricalcium	   phosphate	   (β-­‐TCP),	   have	   been	   widely	   used	   as	   bone	  substitutes	  in	  the	  clinical	  area	  due	  to	  their	  osteoconductive	  properties.	  Cancedda	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et	   al.	   demonstrated	   that	   marrow	   derived	   osteoprogenitor	   cells	   seeded	   onto	  hydroxyapatite	  (HA)	  scaffolds	  provided	  better	  bone	  repair	  over	  a	  short	  period	  of	  time	   in	   comparison	   to	   cell-­‐free	   HA	   scaffolds	   [97].	   Even	   with	   the	   promising	  results	   gained	   from	   using	   synthetic	   calcium-­‐based	   ceramics,	   their	   use	   in	   the	  clinical	   area	   is	   limited	   since	   they	   do	   not	   combine	   good	  mechanical	   properties	  with	   an	  open	  porosity	   and	  have	  been	   shown	   to	  be	  prone	   to	   fragile	   failure	   [98,	  99].	  The	   combination	   of	   bioactive	   ceramics	   in	   combination	   with	   polymers	   have	  shown	  to	  improve	  the	  mechanical	  properties	  of	  scaffolds.	  In	  vitro	  culture	  studies	  have	  shown	  promising	  results	  when	  osteoblastic	  cells	  were	  seeded	  on	  to	  Highly	  porous	  PLLA	  and	  PLLA-­‐HA	  scaffolds.	  Osteoblasts	  penetrated	  deep	  into	  the	  PLLA–HA	  scaffolds	  and	  demonstrated	  uniform	  distribution	  with	  a	  higher	  cell	   survival	  count	  when	   compared	   to	  PLLA	   scaffolds.	   In	   addition,	   cells	   seeded	  on	  PLLA-­‐HA	  scaffolds	   showed	   higher	   expression	   of	   bone-­‐speciﬁc	   markers	   [100].	   Similar	  synthesised	  collagen	  derived	  gelatin–HA	  nanocomposites	  were	   investigated	   for	  osteoblastic	   cellular	   responses;	   the	   scaffolds	   retained	   less	   crystallised	   and	  smaller-­‐sized	   apatite	   crystals	   and	   a	   more	   well-­‐developed	   pore	   conﬁguration	  than	   the	   conventional	   ones	   [101].	   Kim	   et	   al.,	   synthesised	   collagen-­‐derived	  gelatin/hydroxyapatite	   (HA)	  nanocomposites	  for	   tissue	  engineering	  purposes.	  MG63	   osteoblastic	   cells	   seeded	   on	   nanocomposites	   were	   shown	   to	   attach	   and	  proliferate	  to	  a	  much	  higher	  degree	  when	  compared	  to	  conventional	  composite	  scaffolds.	  Furthermore,	   the	  ALP	  activity	  and	  osteocalcin	  produced	  by	  the	  MG63	  cells	  were	  significantly	  higher	  on	  the	  nanocomposite	  scaffolds	  in	  comparison	  to	  conventional	  composite	  scaffolds	  [101].	  hES-­‐MP	   cells	   utilised	   in	   this	   study	   were	   used	   as	   a	   model	   for	   human	   MSCs	  however	   it	   also	   possible	   they	   have	   future	   clinical	   applications.	   As	   mentioned	  previously,	  human	  mesenchymal	  stem	  cells	   (hMSCs)	  are	  a	  promising	  candidate	  for	   musculoskeletal	   regeneration	   and	   tissue	   engineering.	   In	   a	   study	   that	  compared	  the	  osteogenic	  potential	  of	  human	  MSCs	  with	  hES-­‐MP	  cells,	  de	  peppo	  et	  
al.,	   demonstrated	   faster	  mineralisation	   of	  matrix	   produced	   by	   hES-­‐MP	   cells	   in	  comparison	  to	  hMSCs.	  In	  addition	  hES-­‐MP	  cells	  displayed	  good	  proliferation	  and	  high	  mineralisation	  potential	   after	   protracted	   expansion.	  ALP	   activity	  was	   also	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observed	   from	  week	  1	  with	  peak	  of	   intracellular	  ALP	  activity	  measured	  after	  6	  weeks.	   Interestingly,	   hES-­‐MP	   cells	   displayed	   a	   significantly	   lower	   ALP	   activity	  with	   greater	   mineralisation	   ability	   than	   hMSCs.	   It	   was	   suggested	   that	   when	  considering	   hES-­‐MP	   cells,	   ALP	   activity	   may	   not	   be	   crucial	   for	   matrix	  mineralisation	  as	  different	  cells	  may	  be	  subjected	  to	  different	  signaling	  pathways	  and	  dynamics	  in	  relation	  to	  their	  differentiation	  towards	  the	  osteogenic	  lineage	  [21].	  	  	  Another	   study	   successfully	   incorporated	   hES-­‐MP	   cells	   with	   Electron	   beam	  melting	  (EBM)	  fabricated	  cp-­‐Ti	  and	  Ti6Al4V	  scaffolds	  under	  in	  vitro	  conditions.	  It	  was	  shown	  that	  hES-­‐MPs	  distributed	  uniformly	  within	  the	  geometrical	   features	  of	   both	   scaffolds.	   It	   demonstrated	   that	   increasing	   cell	   density	   inhibits	   cell	  proliferation,	   as	   cell-­‐cell	   communication	   is	   essential	   for	   tissue	   formation.	   In	  addition,	   the	   expression	   of	   RUNX2,	   OPN	   and	   OC	   increased	   after	   2	   weeks	   of	  culture	  in	  both	  scaffolds	  [102].	  	  In	  a	  follow	  up	  study,	  the	  researchers	  investigated	  the	  behaviour	  of	  hES-­‐MP	  and	  hMSC	   cells	   cultured	   in	   coral	   scaffolds	   (3x3x3	  mm,	   volume	   porosity:	   49%–2%,	  pore	  diameter	  150–400	  μm)	  under	  dynamic	  conditions.	  The	  data	  demonstrated	  a	  significant	   increase	   in	   cell	   proliferation	   for	  both	   cell	   types	   subjected	   to	   flow	   in	  comparison	   static	   culture.	   Interestingly,	   ALP	   activity	   was	   higher	   for	   hES-­‐MP	  constructs	   cultured	   in	   static	   conditions	   compared	   to	   dynamic	   conditions.	  Suggesting	  that	  this	  difference	  may	  in	  part	  be	  due	  to	  technical	  limitations	  and	  in	  part	  to	  complex	  biological	  factors	  underlying	  gene	  expression	  or	  may	  result	  from	  a	  washout	  effect	  as	  a	  result	  of	  fluid	  flow.	  Furthermore,	  it	  was	  shown	  that	  hES-­‐MP	  constructs	  subjected	  to	  flow	  deposited	  nodules	  of	  calcium	  phosphate	  deep	  inside	  the	  scaffold	  pores	  in	  comparison	  to	  static	  conditions	  [22].	  	  	  
3.8	   Conclusion	  	  In	   this	   chapter	   it	  was	   shown	   that	  hES-­‐MP	  and	  mouse	  MSC	  cells	   can	  attach	  and	  proliferate	  on	  an	   industrial	   grade	  PU	  and	  a	  novel	   glass	   scaffold.	  Glass	   scaffolds	  possessed	   good	   properties	   including	   an	   adequate	   pore	   size	   to	   provide	   enough	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Chapter	   4:	   Mechanical	   stimulation	   of	  
mesenchymal	   stem	   cells	   in	   a	   3D	   glass	  
scaffold	   using	   oscillatory	   and	   unidirectional	  
flow	  
	  
4.1	   Introduction	  
	  The	  combination	  of	  hMSCs	  and	  3D	  scaffolds	  has	  become	  an	  attractive	  approach	  to	  creating	  functional	  constructs	  for	  therapeutic	  outcomes	  and	  correcting	  critical	  bone	  defects	  [1].	  For	  this	  reason	  bioreactors	  play	  a	  vital	  role	  in	  the	  development	  of	   3D	   constructs	   as	   they	   provide	   an	   instructive	   stimulus	   and	   regulate	   the	   cell	  growth	  environment	   [2].	  Bioreactors	   such	   as	   rotating	  wall	   vessels	   and	   spinner	  flasks	  have	  been	  extensively	  reviewed	  and	  investigated	  in	  the	  field	  of	  bone	  tissue	  engineering	  [3].	  These	  bioreactors	  increase	  homogeneity	  of	  nutrient	  distribution	  only	   on	   the	   surface	   of	   constructs.	   Bioreactors	   which	   subject	   direct	   perfusion	  through	  the	  constructs	  have	  the	  ability	  to	  expose	  cells	  throughout	  the	  scaffold	  to	  the	  interstitial	  fluid	  flow	  as	  opposed	  to	  cells	  only	  on	  the	  exterior	  of	  the	  construct	  [2].	   The	  outcome	   is	   that	   these	   flow	   configurations	   create	  different	   cellular	   and	  biochemical	  microenvironments	  in	  the	  3D	  constructs	  [4-­‐6].	  	  	  Bone	  cells	  in	  vivo	  are	  believed	  to	  be	  subjected	  to	  two	  forms	  of	  fluid	  shears	  stress	  at	   the	   cellular	   level;	   an	   outward	   radial	   unidirectional	   flow,	   driven	   by	   a	  hydrostatic	  pressure	  drop	  across	  the	  cortex	  [7]	  and	  an	  oscillatory	  flow	  induced	  by	  mechanical	   loading	   [8].	  2D	   flow	  chamber	  studies	  have	  shown	  an	  osteogenic	  response	  of	  bone	   cells	  when	  subjected	   to	  unidirectional	   flow	  by	   increasing	   the	  amounts	  of	  ALP	  [9]	  and	  expression	  of	  osteocalcin	  [10].	  	  	  3D	  constructs	  have	  also	  been	  subjected	  to	  unidirectional	  fluid	  flow	  whereby	  the	  media	   is	   forced	   through	   the	   interconnected	   pores	   of	   the	   scaffold,	   which	  continuously	  removes	  waste	  and	  introduces	  fresh	  nutrients,	  as	  well	  as	  applying	  a	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physical	   stimulus	   by	   the	   shear	   stress	   [11].	   Studies	   that	   incorporated	  unidirectional	   flow	   have	   had	   a	   positive	   effect	   on	   osteogenic	   differentiation	   by	  increasing	  the	  amount	  of	  PGE2	  [12]	  and	  mineralised	  matrix	  production	  [13]	  on	  MSCs	   in	   3D	   scaffolds.	   Botchwey	   et	   al.,	   cultured	   cells	   on	   3D	   scaffold	   and	  demonstrated	   that	   subjecting	   constructs	   to	   unidirectional	   flow	   (interior	   flow	  velocity	   1x10-­‐3	   and	   1x10-­‐2	   cm/s)	   significantly	   increased	   cell	   growth	   in	   the	  interior	  aswell	  as	  retaining	  osteoblastic	  phenotype	  as	  measured	  by	  ALP	  actibity	  [14].	  
	  
Wang	  et	  al.,	  investigated	  the	  osteogenic	  differentiation	  of	  bone	  marrow-­‐derived	  osteoblasts	  (BMOs)	  in	  porous	  ceramics	  (dimensions:	  5x5x5	  mm3,	  porosity:	  75%,	  pore	  size:	  100	  to	  400	  μm)	  under	  dynamic	  conditions.	  Constructs	  were	  subjected	  to	  a	  continuous	  flow	  rate	  of	  2	  ml/hr	  by	  a	  peristaltic	  pump	  and	  the	  ALP	  activity	  and	  OCN	  content	  were	  measured	  at	  the	  end	  of	  1,	  2,	  3,	  and	  4	  weeks	  of	  subculture.	  The	  results	  demonstrated	  that	  levels	  of	  ALP	  activity	  and	  OCN	  in	  groups	  subjected	  to	  flow	  were	  significantly	  higher	  in	  comparison	  to	  static	  culture	  [15].	  Sikavitsas	  
et	  al.,	   seeded	   rat	   bone	  marrow	   stromal	   cells	   in	   3D	  porous	   titanium	   fiber	  mesh	  disk	  scaffolds	  (diameter	  =	  10	  mm,	  thickness	  =	  0.8	  mm,	  porosity	  =	  86%,	  average	  pore	   size	   =	   250	   μm)	   and	   cultured	   for	   up	   to	   16	   days	   in	   a	   flow	   perfusion	  bioreactor.	   The	   study	   involved	   perfusing	   culture	  media	   of	   different	   viscosities	  through	  the	  construct,	  whilst	  maintain	  a	  constant	  flow	  rate	  of	  0.3	  ml/min.	  It	  was	  shown	  that	  increasing	  the	  viscosity	  led	  to	  an	  increase	  in	  mineral	  deposition	  with	  a	   better	   spatially	   distributed	   extracellular	   matrix	   inside	   the	   3D	   scaffolds	   in	  comparison	  to	  static	  conditions	  [16].	  	  Previous	   2D	   experiments	   have	   shown	   that	   the	   application	   of	   oscillatory	   fluid	  flow	  has	  biological	  effects	  on	  cultured	  bone	  cells	  such	  as	   increased	  osteopontin	  expression	  [17-­‐21].	  However	  few	  studies	  have	  examined	  the	  effect	  of	  oscillatory	  flow	  on	  cell-­‐seeded	  scaffolds	  and	  fewer	  have	  also	  directly	  compared	  the	  two	  flow	  types	   with	   respect	   to	   cell	   distribution,	   cell	   proliferation	   and	   osteogenic	  differentiation.	  Where	   this	  has	  been	  studied	   it	  has	  mostly	  been	  using	  bone	  cell	  lines	   such	   as	  MC3T3.	  O’Brien	  et	  al.,	   designed	   a	   novel	   flow	  perfusion	  bioreactor	  that	   can	   hold	   up	   to	   six	   constructs	   and	   can	   be	   cultured	   simultaneously.	  Osteoblast-­‐seeded	  collagen-­‐GAG	  scaffold	  discs	  (diameter	  =	  12.7	  mm,	  thickness	  =	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3.5	   mm,	   pore	   diameter	   =	   95	   μm,	   porosity	   ∼99%)	   were	   subjected	   to	   steady,	  pulsatile	   and	   oscillatory	   flow	   (0.1-­‐2.0	  ml/min).	   It	   was	   demonstrated	   that	   cell-­‐seeded	   scaffolds	   under	   dynamic	   culture	   maintained	   cell	   viability	   and	   that	  mechanical	   stimulation	   led	   to	   an	   800-­‐1200%	   increase	   in	   PGE2	   production	   in	  comparison	   to	   static	   culture	   [22].	   In	   a	   follow	   up	   study,	   O’Brien	   et	   al.,	   and	  researchers	   investigated	  the	  effects	  of	   intermittent	  steady	  (1	  ml/min),	  pulsatile	  (0–1.0	  mL/min	   at	   2	   Hz),	   and	   oscillatory	   (±1.0	  mL/min	   at	   1	   Hz)	   ﬂuid	   ﬂow	   on	  MC3T3-­‐E1	   activity	   with	   the	   same	   collagen-­‐GAG	   scaffold.	   Cell-­‐seeded	   scaffolds	  were	   analysed	   after	   1,	   25	   and	   49	   hours	   of	   continuous	   flow	   or	   static	   culture.	  Results	  indicated	  that	  scaffolds	  subjected	  to	  fluid	  flow	  (regardless	  of	  flow	  profile)	  had	  a	  40%	  to	  52%	  decrease	  in	  cell	  number.	  However,	  cellular	  spatial	  distribution	  was	  much	  improved	  for	  cell-­‐seeded	  scaffolds	  subjected	  to	  fluid	  flow.	  In	  addition,	  the	  mechanical	  stimulation	  induced	  the	  production	  of	  early	  stage	  bone	  formation	  markers	   including	  COX-­‐2,	  PGE2	  and	  OPN.	   It	  was	  also	  suggested	   that	  oscillatory	  and	   pulsatile	   fluid	   flow	   could	   be	   more	   stimulatory	   for	   long-­‐term	   bioreactor	  culture	   compared	   to	   steady	   flow	   however	   there	   were	   no	   strong	   differences	  between	  oscillatory	  and	  pulsatile	  flow	  [23].	  	  In	   a	   similar	   study,	  mouse	   osteoblast-­‐like	  MC3T3-­‐E1	  were	   seeded	   onto	   porous	  ceramic	   scaffolds	   (diameter	   =	   10	   mm,	   height	   =	   8	   mm,	   porosity	   =	   75%)	   and	  cultured	   in	  vitro	   for	  6	  days	  under	  oscillatory	  (0.5	  and	  1	  ml/min),	  unidirectional	  (1	   ml/min)	   and	   static	   conditions.	   The	   results	   demonstrated	   that	   cells	  proliferated	   on	   the	   scaffold	   surface	   in	   static	   culture.	   The	   proliferation	   for	  samples	   subjected	   to	   unidirectional	   flow	   was	   significantly	   higher	   than	   other	  groups	  but	  was	  very	  inhomogeneous.	  	  Only	  samples	  subjected	  to	  oscillatory	  fluid	  flow	  displayed	   a	  uniform	  distribution	  of	   cells	   throughout	   the	   scaffolds	  with	   an	  increase	  in	  ALP	  activity	  [24].	  	  	  Since	   an	   important	   function	   of	   a	   bioreactor	   system	   is	   to	   create	   a	   suitable	  microenvironment	   for	   the	   development	   of	   functional	   3D	   constructs,	  understanding	  the	  effects	  of	  flow	  on	  hMSC	  phenotype	  can	  provide	  further	  insight	  for	  engineering	  3D	  bone	  constructs.	  For	  this	  reason	  the	  aim	  of	  this	  chapter	  was	  to	   investigate	  the	  effect	  of	  different	  flow	  regimes,	  oscillatory	  and	  unidirectional	  flow,	   for	   stimulating	   proliferation	   and	   osteogenic	   differentiation	   of	   Human	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4.2	   Dynamic	  culture	  of	  hES-­‐MP	  cells	  on	  glass	  scaffold	  
	  
	   4.2.1	   Methodology	  









 	  	  	  
 
(a)	   	   	   	   	   	   (b)	  
	   	  
	  	  
	   	  
	  
Fig	  4.1;	  Scaffolds	  where	  subjected	  to	  fluid	  flow	  whilst	  positioned	  in	  two	  different	  planes.	  (a)	  Horizontal	  plane	  (parallel	   flow,	  whereby	  the	  direction	  of	  flow	  is	  parallel	   to	  scaffold	  surface),	  (b)	   vertical	   plane	   (transverse	   flow,	   whereby	   direction	   of	   flow	   is	   perpendicular	   to	   scaffold	  surface).	  Arrows	  indicate	  direction	  of	  flow.	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Figure	   4.2;	   The	   experimental	   time	   line.	   (a)	   Short	   term	   dynamic	   culture,	   samples	   were	  subjected	   to	   flow	   on	  day	  4	   of	   culture	   and	   assayed	   for	   cell	   viability	   (MTS,	  MTT),	   totsal	   DNA	  content	  andALP	  activity	  on	  day	  7.	  (b)	  Long	  term	  dynamic	  culture,	  samples	  were	  subjected	  to	  flow	  on	  days	  4,	  7	   and	  10	  and	  assayed	   for	   cell	   viability	   (MTS),	  collagen	  production	   (SR)	  and	  calcium	  deposition	  (AR)	  on	  day	  14. 
	   	   146	  
4.3	   Results	  	   4.3.1	   Cell	  viability	  as	  assayed	  by	  MTT	  –	  Day	  7	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Fig	  4.3;	   hES-­‐MP	  cells	   cultured	  on	   glass	   scaffolds	  and	   subjected	   to	  3,	   5	   and	  10	  ml/min	   fluid	  flow	  (unidirectional	  and	  oscillatory)	  on	  day	  4.	  On	  day	  7	  of	  culture,	  samples	  were	  analyzed	  for	  cell	  viability	  (MTT)	  for	  cell-­‐seeded	  scaffolds	   subjected	  to	  (a)	  transverse	  oscillatory	  flow,	  (b)	  transverse	   unidirectional	   flow,	   (c)	   parallel	   oscillatory	   flow	   and	   (d)	   parallel	   unidirectional	  flow.	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4.3.2	   Cell	  viability	  as	  assayed	  by	  MTS	  –	  Day	  7	  &	  14	  	  From	  figure	  4.4a	  and	  4.5a	  it	  is	  evident	  that	  on	  day	  7	  of	  culture,	  samples	  subjected	  to	  transverse	  oscillatory	  flow	  exhibited	  much	  higher	  (p<0.05)	  cell	  viability	  than	  static	   culture.	  More	   specifically,	   cell-­‐seeded	   scaffolds	   subjected	   to	   a	   transverse	  oscillatory	   flow	   of	   5	  ml/min	   demonstrated	   a	   siginifacnly	   (P<0.05)	   higher	  MTS	  value	   than	   other	   samples	   subjected	   to	   transverse	   oscillatory	   flow.	   hES-­‐MP-­‐constructs	   subjected	   to	   a	   transverse	   unidirectional	   flow	   of	   3	   ml/min	   also	  exhibited	   a	   much	   higher	   (P<0.05)	   cell	   viability	   than	   static	   and	   other	   samples	  subjected	   to	   transverse	   unidirectional	   flow.	   Furthermore,	   cell-­‐seeded	   scaffolds	  subjected	   to	   a	   transverse	   oscillatory	   flow	   of	   5	   ml/min	   showed	   significantly	  higher	   (P<0.05)	   cell	   viability	   than	   samples	   subjected	   to	   a	   transverse	  unidirectional	  flow	  of	  5	  ml/min.	  	  	  On	   day	   14	   of	   culture	   (fig	   4.4a	   and	   4.5a),	   cell	   viability	  was	   significantly	   higher	  (P<0.05)	  for	  cell-­‐seeded	  scaffolds	  subjected	  to	  a	  transverse	  oscillatory	  flow	  of	  5	  and	   10	   ml/min	   in	   comparison	   to	   static	   and	   samples	   subjected	   to	   3	   ml/min	  transverse	   oscillatory	   flow.	   hES-­‐MP-­‐constructs	   under	   transverse	   unidirectional	  flow	  of	  3	  and	  10	  ml/min,	  displayed	  a	  10%	  and	  12	  %	  decrease	  in	  cell	  viability	  in	  comparison	   to	   static	   conditions.	   Samples	   subjected	   to	   a	   transverse	   oscillatory	  flow	   rate	   of	   3,	   5	   and	   10	   ml/min,	   displayed	   significantly	   higher	   (P<0.05)	   cell	  viability	   than	   samples	   under	   transverse	   unidirectional	   flow	   of	   3,	   5	   and	   10	  ml/min	  respectively.	  	  	  Scaffolds	  subjected	  to	  parallel	  flow	  did	  not	  demonstrate	  such	  high	  cell	  viability	  as	  with	   the	   transverse	   flow	   group	   (fig	   4.4b	   and	   4.5b).	   On	   day	   7	   of	   culture,	   cell-­‐seeded	   scaffolds	   subjected	   to	   a	   parallel	   oscillatory	   flow	   of	   3	   and	   10	   ml/min	  displayed	  significantly	  higher	  (P<0.05)	  cell	  viability	  than	  samples	  under	  parallel	  unidirectional	   flow	   of	   3	   and	   10	  ml/min	   respectively.	   On	   day	   14	   of	   culture	   (fig	  4.4b	  and	  4.5b),	  samples	  in	  all	  flow	  groups	  did	  not	  show	  any	  significant	  increase	  in	  cell	  viability	  with	  respect	  to	  samples	  in	  static	  conditions.	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   4.3.3	   Total	  DNA	  content	  –	  Day	  7	  
	  From	   figure	  4.6a,	   it	   is	   clear	   that	   cell-­‐seeded	  scaffolds	   subjected	   to	  a	   transverse	  oscillatory	  flow	  of	  3	  and	  5	  ml/min	  had	  a	  much	  higher	  (p<0.05)	  DNA	  content	  than	  those	   of	   static	   culture.	   It	   is	   also	   evident	   that	   the	   same	   samples	   subjected	   to	  transverse	   oscillatory	   flow	   of	   3	   and	   5	   ml/min,	   showed	   significantly	   higher	  (P<0.05)	   total	   DNA	   content	   than	   samples	   under	   3	   and	   5	   ml/min	   transverse	  





	   	   150	  






	  4.3.4	   ALP	  activity	  –	  Day	  7	  
	  In	   general,	   cell-­‐seeded	   scaffolds	   subjected	   to	   transverse	   perfusion	   (oscillatory	  and	   unidirectional)	   exhibited	   higher	   ALP	   activity	   than	   static	   culture.	   More	  specifically,	  scaffolds	  subjected	  to	  transverse	  oscillatory	  and	  unidirectional	  flow	  of	   5	   ml/min	   demonstrated	   significantly	   (P<0.05)	   higher	   ALP	   activity	   in	  comparison	  to	  static	  culture	  (fig	  4.7a).	   	  Scaffolds	  subjected	  to	  parallel	   flow	  also	  
	   	   	   	  	   	   	   	  
Fig	  4.6;	   hES-­‐MP	  cells	   cultured	  on	  glass	   scaffolds	  and	   subjected	   to	  3,	   5	   and	  10	  ml/min	   fluid	  flow	   (unidirectional	   and	   oscillatory)	   on	   day	   4.	   On	   day	   7	   of	   culture,	   total	   DNA	   content	  (normalised	  to	  static	  conditions)	  was	  measured	  for	  cell-­‐seeded	  scaffolds	  under	  (a)	  transverse	  flow	  and	  (b)	  parallel	   flow.	  *=	  Significantly	  different	  compared	  to	  static	  culture	  (dashed	   line)	  and	  ♯=Significantly	  different	  to	  corresponding	  flow	  rate.	  All	  data	  is	  mean	  ±	  SD	  (n=6).	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had	   a	   higher	   ALP	   activity	   than	   static	   culture.	   Although	   not	   significant,	   but	   the	  highest	  value	  of	  ALP	  activity	  was	  13%	  more	  than	  the	  static	  group	  and	  was	  seen	  in	  constructs	  subjected	  to	  a	  unidirectional	  flow	  of	  3	  ml/min	  (fig	  4.7b).	  	  	  
	  	  
4.3.5	   Collagen	  production	  (Sirius	  red	  staining)	  –	  Day	  14	  
	  In	   general,	   transverse	   perfusion	   increased	   collagen	   production	   for	   samples	  subjected	  to	  a	  flow	  rate	  of	  3	  and	  5	  ml/min.	  More	  specifically,	  hES-­‐MP-­‐constructs	  subjected	   to	   transverse	   oscillatory	   flow	   of	   5	   ml/min	   produced	   significantly	  higher	  (P<0.05)	  collagen	  in	  comparison	  to	  static	  culture	  (fig	  4.8a).	  From	  the	  data	  it	   is	   clear	   that	   a	   large	   variance	   exists	   in	   collagen	   production	   for	   samples	  subjected	   to	   transverse	   unidirectional	   flow.	   Similary,	   cell-­‐seeded	   scaffolds	  subjected	   to	   parallel	   oscillatory	   flow	   also	   produced	   more	   collagen	   than	   static	  culture.	   Samples	   under	   parallel	   oscillatory	   flow	   of	   5	   ml/min	   produced	   much	  higher	  (P<0.05)	  collagen	  in	  comparison	  to	  static	  conditions	  (fig	  4.8b).	  	  
	   	   	   	  
	   	   	   	  
Fig	  4.7;	  hES-­‐MP	  cells	  cultured	  on	  glass	  scaffolds	  and	  subjected	  to	  3,	  5	  and	  10	  ml/min	  fluid	  flow	   (unidirectional	   and	   oscillatory)	   on	   day	   4.	   On	   day	   7	   of	   culture,	   ALP	   activity	  (normalised	   to	  DNA)	  was	  measured	   for	   cell-­‐seeded	   scaffolds	  under	   (a)	   transverse	   flow	  and	  (b)	  parallel	   flow.	  *=	  Significantly	  different	   compared	   to	   static	   culture	   (dashed	   line)	  and	  ♯=Significantly	  different	  to	  corresponding	  flow	  rate.	  All	  data	  is	  mean	  ±	  SD	  (n=6).	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Fig	  4.8;	  hES-­‐MP	  cells	  cultured	  on	  glass	  scaffolds	  and	  subjected	  to	  3,	  5	  and	  10	  ml/min	  fluid	  flow	  (unidirectional	  and	   oscillatory)	   on	   day	   4,	   7	   and	   10.	   On	   day	   14	   of	   culture,	   samples	   were	   analysed	   for	   collagen	   production	  (Sirius	  red)	   for	  constructs	  under	  (a)	  transverse	  flow	  and	  (b)	  parallel	  flow.	  Cell-­‐seeded	  scaffolds	  stained	  with	  Sirius	  red	  provide	  a	  qualitative	  measure	  of	  collagen	  production	  for	  different	   flow	  conditions.	  *=	  Significantly	  different	  compared	  to	  static	  culture	  (dashed	  line)	  and	  ♯=Significantly	  different	  to	  corresponding	  flow	  rate.	  All	  data	  is	  mean	  ±	  SD	  (n=6).	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4.3.6	   	  	  	  Calcium	  deposition	  (Aliarin	  red	  staining)	  –	  Day	  14	  
	  It	   is	   interesting	   to	   note	   that	   the	   pattern	   for	   calcium	   deposition	   for	   both	   flow	  types	  (oscillatory	  and	  unidirectional)	  was	  very	  similar	  for	  all	  flow	  groups	  when	  subjected	   to	   either	   transverse	   or	   parallel	   flow.	   More	   specifically,	   scaffolds	  subjected	  to	  a	  transverse	  oscillatory	  flow	  of	  3	  and	  5	  ml/min	  deposited	  119%	  and	  370%	  more	  calcium	  than	  static	  cultures	  (p<0.05)	  (fig	  4.9a).	  Scaffolds	  subjected	  to	   a	   transverse	   unidirectional	   flow	   of	   5	  ml/min	   also	   deposited	   a	  much	   higher	  amount	   of	   calcium	   (p<0.05)	   than	   static	   conditions.	   Furthermore,	   Samples	  subjected	   to	   a	   transverse	   oscillatory	   flow	   rate	   of	   3	   and	   5	   ml/min,	   displayed	  significantly	  higher	  (P<0.05)	  calcium	  deposition	  than	  samples	  under	  transverse	  unidirectional	  flow	  of	  3	  and	  5	  ml/min	  respectively.	  	  	  Similarly,	  cell-­‐seeded	  scaffolds	  subjected	  to	  a	  parallel	  oscillatory	  flow	  of	  3	  and	  5	  ml/min	   deposited	   154%	   and	   377%	   more	   calcium	   (p<0.05)	   in	   comparison	   to	  static	   conditions	   respectively	   (fig	   4.9b).	   Furthermore,	   samples	   subjected	   to	   a	  parallel	   oscillatory	   flow	   rate	   of	   3	   and	   5	  ml/min,	   displayed	   significantly	   higher	  (P<0.05)	  calcium	  deposition	  than	  samples	  under	  parallel	  unidirectional	  flow	  of	  3	  and	  5	  ml/min	  respectively.	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Fig	   4.9;	   hES-­‐MP	   cells	   cultured	   on	   glass	   scaffolds	   and	   subjected	   to	   3,	   5	   and	   10	   ml/min	   fluid	   flow	  (unidirectional	   and	   oscillatory)	   on	   day	   4,	   7	   and	   10.	   On	   day	   14	   of	   culture,	   samples	   were	   analysed	   for	  calcium	   deposition	   (Alizarin	   red)	   for	   constructs	   under	   (a)	   transverse	   flow	   and	   (b)	   parallel	   flow.	   Cell-­‐seeded	  scaffolds	  stained	  with	  Alizarin	  red	  provide	  a	  qualitative	  measure	  of	  calcium	  content	   for	  different	  flow	   conditions.	   *=	   Significantly	   different	   compared	   to	   static	   culture	   (dashed	   line)	   and	   ♯=Significantly	  different	  to	  corresponding	  flow	  rate.	  All	  data	  is	  mean	  ±	  SD	  (n=6).	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4.3.7	   	  	  Day	  14:	  Live/dead	  staining	  
	  A	  live/dead	  staining	  technique	  (described	  in	  chapter	  2)	  was	  used	  to	  compare	  the	  location	   and	   attachment	   of	   viable	   and	   dead	   cells	   on	   three	   different	   sections	  within	   the	   glass	   scaffold	   for	   the	   different	   experimental	   setups.	   Images	   were	  taken	  from	  the	  top,	  cross-­‐section	  and	  bottom	  of	  the	  constructs	  (fig	  4.10).	  There	  were	  more	  dead	  cells	  visible	  (stained	  as	  red)	  in	  the	  cross	  section	  cells	  grown	  in	  static	   conditions.	   As	   where	   this	   does	   not	   seem	   to	   be	   apparent	   for	   scaffolds	  subjected	  to	  flow.	  In	  the	  unidirectional	  perfusion	  system,	  cells	  spread	  uniformly	  but	  living	  cells	  favored	  the	  top	  surface	  of	  the	  scaffold	  and	  more	  dead	  cells	  were	  visible	   at	   the	   bottom	   surface.	   Constructs	   subjected	   to	   oscillatory	   fluid	   flow	  displayed	  a	  uniform	  cell	  distribution	  with	  fewer	  dead	  cells	  visible	  in	  the	  bottom	  surface	  of	  the	  scaffold.	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Fig	  4.10;	  hES-­‐MP	  cells	  cultured	  on	  glass	   scaffolds	  and	  distribution	  was	  analysed	  using	  Live/Dead	   imaging	  technique	  for	   samples	  under	  static,	   transverse	  oscillatory	   flow	  of	  5	  ml/min,	   and	  transverse	  unidirectional	  flow	  of	  5	  ml/min	  on	  day	  14	  of	  culture.	  Images	  were	  taken	  from	  the	  top,	  middle	  and	  bottom	  location	  of	  cell-­‐seeded	  scaffolds.	  Live	  cells	  are	  stained	  as	  green	  and	  dead	  cells	  are	  stained	  as	  red.	  Representative	  images	  are	  shown	  (n=2).	  Sclae	  bar	  =	  200	  μm.	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4.4	   Discussion	  
	  Numerous	  studies	  have	  investigated	  the	  effect	  of	  fluid	  flow	  on	  cell	  cultures.	  The	  effect	  of	  mechanical	  stimulation	  has	  been	  analysed	  in	  2D	  [9,	  18,	  19,	  25-­‐27]	  and	  in	  3D	  [11,	  12,	  16,	  28,	  29]	  in	  vitro	  conditions.	  	  The	   aim	   of	   this	   study	  was	   to	   examine	   flow	   type	   and	   scaffold	   orientation	   on	   a	  human	  mesenchymal	   stem	   cell	   line	   (hES-­‐MP)	   seeded	  on	   a	   novel	   glass	   scaffold.	  Constructs	  were	  subjected	  either	  to	  oscillatory,	  unidirectional	  or	  no	  flow	  upto	  a	  period	  of	  14	  days	  to	  compare	  the	  biological	  outcomes	  for	  each	  condition.	  To	  this	  end	   it	   was	   shown	   that	   short	   bouts	   of	   transverse	   oscillatory	   flow	   ensures	   cell	  survival,	   proliferation	   and	   osteogenic	   differentiation	   of	   hES-­‐MP	   cells	   inside	   a	  porous	  glass	  scaffold.	  	  	  Although	   short	   bouts	   of	   flow	   were	   beneficial	   for	   cell	   growth	   and	   survival,	  transverse	   flow	   seems	   to	   accelerate	   the	   early	   stages	   of	   bone	   formation	   in	  comparison	   to	   parallel	   flow.	  Due	   to	   a	   simple	  mechanical	   design	   of	   the	   system,	  transverse	   flow	   forces	   fluid	   through	   the	   construct	   thus	   creating	   a	   more	  homogenous	  environment,	  rather	  than	  just	  improving	  convection	  at	  the	  scaffold	  surface.	  The	  reason	  could	  be	  that	  this	  setup	  will	  allow	  a	  biomechanical	  stimulus	  to	  be	  applied	   to	  cells	   throughout	   the	  entire	  structure	  of	   the	  scaffold.	  Therefore	  the	  applied	  shear	  stress	   leads	   to	  a	  better	  cell	  survival	  and	  proliferation	  of	  hES-­‐MP	  cells.	  	  
	  Overall,	   cell-­‐seeded	   scaffolds	   subjected	   to	   transverse	   flow	   appeared	   more	  uniformly	  distributed	  than	  samples	  subjected	  to	  parallel	  flow	  as	  seen	  by	  the	  MTT	  staining	  on	  day	  7	  of	  culture	  (fig	  4.3).	  Although	   from	  the	   images	   it	   is	  difficult	   to	  make	  a	  direct	  comparison	  between	  oscillatory	  and	  unidirectional	  flow	  samples,	  it	  does	  appear	  that	  hES-­‐MP-­‐constructs	  subjected	  to	  5	  ml/min	  transverse	  flow	  seem	  to	  have	   the	  highest	   cell	   viability	  as	   indicated	  by	  a	   stronger	  purple	   staining	   (fig	  4.3a	  &	  4.3b).	  On	  the	  other	  hand,	  samples	  subjected	  to	  10	  ml/min	  transverse	  flow	  (fig	  4.3b)	  had	  a	  very	  light	  purple	  staining	  implying	  that	  the	  shear	  stress	  created	  might	  have	  been	  too	  high	  and	  as	  a	  result	  cells	  were	  washed	  from	  the	  scaffold,	  as	  seen	   by	   other	   research	   groups	   for	   different	   scaffold	   type	   [11].	   Samples	   under	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static	   conditions	   appeared	   to	   have	   an	   inhomogeneous	   cell	   distribution	   with	   a	  high	  density	  of	  cells	  in	  the	  core	  part	  of	  the	  scaffold	  and	  very	  few	  cells	  in	  the	  outer	  regions.	   During	   the	   seeding	   phase	   cells	   were	   directly	   pipetted	   onto	   the	   glass	  scaffolds,	  which	  probably	  led	  to	  a	  higher	  density	  of	  cells	  in	  the	  centre/core	  of	  the	  scaffold	  than	  the	  periphery.	  	  	  From	  the	  MTS	  data	  it	  appears	  that	  scaffold	  orientation	  (TF	  vs	  PF)	  had	  an	  effect	  on	   cell	   viability.	   In	   transverse	   flow,	   it	   is	   evident	   that	   samples	   subjected	   to	  oscillatory	  flow	  had	  much	  higher	  cell	  viability	  than	  static	  and	  unidirectional	  flow	  groups	   (fig	   4.4a	   and	   4.5a).	   More	   specifically,	   it	   appears	   that	   cell	   activity	   was	  highest	   for	   samples	   under	   oscillatory	   flow	   rate	   of	   5	  ml/min.	   The	   cell	   viability	  data	   for	   cell-­‐seeded	   scaffolds	   under	   transverse	   oscillatory	   flow	   were	   also	   in	  agreement	   with	   the	   total	   DNA	   content	   (fig	   4.6a),	   implying	   that	   the	   metabolic	  activity	   and	   total	   cell	   number	   are	   correlated	   in	   this	   system.	   MTS	   was	   slightly	  higher	  at	  day	  14	  than	  day	  7	  indicating	  that	  the	  cells	  also	  proliferated	  over	  time	  in	  culture,	   however	   the	   change	   between	   day	   7	   and	   day	   14	   was	   rather	   small,	  probably	  because	  of	  the	  high	  initial	  seeding	  density.	  The	  higher	  cell	  numbers	  in	  oscillatory	  transverse	  flow	  groups	  compared	  to	  their	  static	  counterparts	  on	  day	  7	  indicates	  that	  oscillatory	  flow	  either	  increased	  the	  proliferation	  rate	  or	  reduced	  cell	  death	  during	  that	  first	  week	  of	  culture.	  A	  more	  specific	  assay	  such	  as	  the	  cell	  proliferation	   assay	   bRDU	   would	   be	   needed	   to	   determine	   which	   of	   these	   had	  occured.	   Other	   research	   groups	   have	   also	   reported	   on	   the	   same	   findings	  whereby	   the	   application	   of	   flow	   has	   increased	   cell	   viability,	   however	   these	  groups	  used	  longer	  flow	  durations,	  different	  loading	  times	  and	  different	  scaffolds	  [13,	  30,	  31].	   It	   is	   interesting	   that	   such	  short	   times	   in	  dynamic	  culture	   (3	  hours	  within	  a	  14	  day	  culture	  period)	  also	  has	  a	  significant	  effect	  on	  cell	  viability.	  The	  effect	  of	   flow	  on	  viability	  was	  more	  apparent	  at	  day	  7	  than	  day	  14	  for	  example	  only	   samples	   subjected	   to	   transverse	   oscillatory	   flow	   of	   5	   and	   10	  ml/min	   had	  higher	  MTS	  values	   than	  static	  controls.	  Whereas	   the	   low	  flow	  rate	  of	  3	  ml/min	  had	   been	   sufficient	   to	   induce	   higher	   cell	   numbers	   by	   day	   7	   in	   transverse	   flow	  both	  oscillatory	  and	  unidirectional,	  those	  cell	  numbers	  did	  not	  increase	  between	  day	  7	  and	  14	  and	  therefore	  cell	  numbers	  equalised	  with	  static	  controls.	  This	  7-­‐14	  day	   period	   resembles	   later	   osteoblastic	   differentiation	   and	   matrix	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mineralisation.	   Other	   studies	   such	   as	   one	   that	   subjected	  marrow	   stromal	   cells	  cultured	  on	  titanium	  fiber	  mesh	  scaffolds	  to	   flow	  perfusion	  also	  showed	  the	  an	  effect	   on	   cell	   number	   only	   occurred	   in	   the	   early	   stages	   of	   cell	   culture,	   here	   it	  seems	  this	  effect	  is	  also	  flow	  rate	  dependant	  [13,	  32].	  	  
Bancroft	   et	   al.,	  seeded	  marrow	   stromal	   osteoblasts	   on	   3D	   titanium	   fiber	  mesh	  scaffolds	   (diameter=10	  mm,	   thickness=8	  mm,	   porosity=	   86%,	   pore	   size	  ~	   250	  μm)	   to	  study	   the	  effects	  of	  different	   flow	  rates	   (static,	  0.3,	  1	  and	  3	  ml/min)	  on	  osteoblast	  differentiation.	  Samples	  were	  subjected	   to	  continuous	  unidirectional	  flow	  for	  a	  period	  of	  upto	  16	  days	  and	  analysed	  on	  day	  4,	  8	  and	  16	  of	  culture.	  The	  results	   demonstrated	   that	   with	   an	   increase	   in	   flow	   rate,	   mineralised	   matrix	  production	  was	  also	  increased	  in	  comparison	  to	  static	  conditions.	  Furthermore,	  it	  was	  suggested	  that	   long-­‐term	  culture	  was	  beneficial	   in	  order	   to	  enhance	  and	  create	   a	   uniform	   distribution	   of	   cells	   throughout	   the	   scaffolds	   [13].	   Similarly,	  
Olivier	  et	  al.,	  investigated	  the	  efficiency	  of	  a	  new	  bioreactor	  system	  for	  the	  in	  vitro	  development	  of	   large	  bone	  substitutes.	  Human	  MG63	  osteoblast-­‐like	  cells	  were	  seeded	  on	  beta	  tricalcium	  phosphate	  (β-­‐TCP)	  cylinders	  (33	  mm	  in	  length	  and	  14	  mm	   in	   diameter,	   macroporosity	   with	   spherical	   pores	   of	   500–630	   µm)	   and	  subjected	   to	   unidirectional	   flow	   of	   3	  ml/min	   for	   upto	   28	   days.	   In	   general,	   the	  results	   demonstrated	   that	   long-­‐term	   culture	   enhances	   the	   bone	   matrix	  production	  of	  MG63	  osteoblast-­‐like	   cells	   and	   improves	   their	  distribution	   in	  3D	  scaffolds	  [31].	  	  	  	  On	   the	   other	   hand,	   samples	   subjected	   to	   parallel	   flow	   displayed	   contradictory	  results	  with	   respect	   to	   cell	   viability	   (MTS)	   and	   total	  DNA	   content.	   	   The	   results	  show	  that	  cell	  viability	  for	  samples	  subjected	  to	  parallel	  oscillatory	  flow	  (fig	  	  4.4b	  and	   4.5b)	   are	   relatively	   the	   same	   as	   static	   conditions,	   however	   the	   total	   DNA	  content	   was	   significantly	   higher	   for	   the	   same	   comparison	   (fig	   4.6b).	   The	  differences	  in	  DNA	  content	  compared	  to	  metabolic	  activity	  as	  measured	  by	  MTS	  may	  be	  due	  to	  dead	  cells	  remaining	  within	  the	  scaffold.	  The	  MTS	  data	  does	  shows	  the	  predicted	   effect	   as	   subjecting	  hES-­‐MP-­‐constructs	   to	  parallel	   flow	  may	   limit	  the	  amount	  of	  media	  entering	  the	  scaffold	  due	  to	  its	  orientation.	  The	  limited	  flow	  of	   media	   into	   the	   scaffold	   might	   lead	   to	   a	   non-­‐uniform	   distribution	   of	   cells.	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Reports	  in	  the	  literature	  indicate	  that	  insufficient	  oxygenation	  in	  the	  core	  of	  the	  scaffold	   could	   correlate	   to	   nonuniform	   distribution	   of	   cells	   and	   as	   a	   result	  nonuniform	  bone	  matrix	  deposition	  can	  occur	   [33,	  34].	   In	  general,	  uniform	  cell	  distribution	   is	   very	   important	   for	   uniform	   formation	   of	   bone	   matrix.	  Unfortunately,	   due	   to	   limited	  numbers	   of	   glass	   scaffolds	   it	  was	  not	   possible	   to	  undertake	   live-­‐dead	   staining	   on	   the	   samples	   subjected	   to	   parallel	   flow	   which	  would	  have	  helped	  address	  this	  question.	  	  In	  this	  study	  live	  cells	  were	  present	  deep	  within	  the	  core	  of	  the	  glass	  scaffolds	  for	  groups	  subjected	  to	  transverse	  fluid	  flow	  (fig	  4.10).	  It	  was	  shown	  that	  scaffolds	  cultured	  in	  either	  static	  or	  unidirectional	  flow	  had	  more	  dead	  cells	  compared	  to	  samples	   subjected	   to	   oscillatory	   flow.	   Moreover,	   static	   cultured	   constructs	  contained	   a	   large	   number	   of	   dead	   cells	   in	   the	   core	   and	   bottom	   surface	   of	  scaffolds.	  This	  is	  also	  in	  confirmation	  with	  other	  studies	  whereby	  the	  application	  of	   flow	   has	   shown	   to	   improve	   cell	   distribution	   [13,	   29].	   It	   is	   interesting	   that	  unidirectional	   flow	   alone	   does	   not	   improve	   cell	   survival	   indicating	   that	   cell	  survival	  is	  not	  enhanced	  simply	  by	  improved	  nutrient	  flow	  but	  is	  an	  effect	  of	  the	  specific	  mechanical	  stimulus	  of	  oscillatory	  flow.	  Others	  have	  shown	  live	  cells	  to	  be	  present	  within	  the	  periphery	  of	  cell-­‐seeded	  scaffold	  (200-­‐300	  um)	  [35]	  or	  live	  cells	  at	  millimeter	  depths	  depending	  on	  scaffold	  geometry	  [36].	  Confocal	  images	  from	  this	  study	  demonstrate	  that	  flow	  conditions	  (in	  particular	  oscillatory	  fluid	  flow)	  allow	  for	  a	  better	  distribution	  of	  live	  hES-­‐MP	  cells	  inside	  the	  glass	  scaffold	  than	  static	  culture	  conditions.	   In	  a	  similar	  study,	  Du	  et	  al.,	  studied	  the	  effects	  of	  different	   flow	   profiles	   (unidirectional	   and	   oscillatory)	   on	   3D	   porous	   cellular	  constructs.	   Mouse	   osteoblast-­‐like	   MC3T3-­‐E1	   cells	   were	   cultured	   on	   Porous	   b-­‐TCP	  ceramic	  scaffold	  disks	  (10	  mm	  in	  diameter	  and	  8	  mm	  in	  height,	  porosity	  of	  75%)	  in	  vitro	  for	  6	  days	  under	  static,	  oscillatory	  (0.5	  ml/min)	  and	  unidirectional	  flow	  (1	  ml/min).	  The	  results	  demonstrated	  that	  proliferation	  of	  cells	  was	  highest	  for	  cells	  subjected	  to	  unidirectional	  flow	  in	  comparison	  to	  other	  groups	  but	  was	  very	  inhomogeneous.	  However,	  it	  was	  seen	  that	  samples	  subjected	  to	  oscillatory	  flow	   allowed	   cells	   to	   proliferate	   in	   a	   uniform	   manner,	   (even	   with	   a	   scaffold	  thickness	   of	   8	   mm)	   and	   also	   increased	   ALP	   activity	   when	   compared	   to	   other	  groups	  [37].	  The	  reason	  for	  the	  findings	   in	  this	  study	  can	  be	  explained	  through	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the	  simple	  mechanical	  design	  of	  the	  perfusion	  system.	  The	  scaffolds	  positioned	  in	  the	  vertical	  plane	  (TF)	  are	  placed	  in	  such	  a	  manner	  that	  media	  is	  forced	  through	  the	  whole	  internal	  structure	  of	  the	  scaffold	  in	  both	  oscillatory	  and	  unidirectional	  systems,	   creating	   a	   more	   homogenous	   microenvironment	   which	   has	   lead	   to	  better	  survival	  and	  proliferation	  of	  hES-­‐MP	  cells.	  	  	  As	  mentioned	   in	   chapter	   1,	   ALP	   is	   an	   enzyme	   involved	   in	   the	   early	   phases	   of	  mineralisation	   of	   newly	   formed	   bone	   tissue	   [38].	   Results	   in	   this	   study	   (4.7a)	  showed	  a	  high	  activity	  of	  the	  enzyme	  on	  day	  7	  of	  culture	  for	  samples	  subjected	  to	  transverse	  flow	  when	  compared	  to	  parallel	  flow.	  In	  the	  transverse	  configuration,	  cell-­‐seeded	  scaffolds	  under	  oscillatory	  and	  unidirectional	  flow	  had	  a	  higher	  ALP	  activity	   in	   comparison	   to	   their	   static	   control.	   However	   this	   is	   not	   the	   case	   for	  scaffolds	   arranged	   in	   parallel.	   Goldstein	   et	   al.,	   showed	   an	   increase	   in	   ALP	  expression	  when	  marrow	  stromal	  osteoblasts	  were	   seeded	   in	  3D	  porous	  PLGA	  scaffolds	   (12.7	  mm	  diameter,	   6.0	  mm	   thick,	   78.8%	  porous)	   and	   cultured	   for	   7	  days	   in	   a	   continuous	   flow	  perfusion	  bioreactor	   [39].	   	  Mai	  et	  al,	   also	   confirmed	  that	  one	  single	  load	  of	  oscillatory	  fluid	  flow	  (1	  h,	  1.2	  Pa)	  subjected	  to	  MC3T3-­‐E1	  cells	  seeded	  on	  a	  parallel	  plate,	  was	  capable	  of	  inducing	  terminal	  differentiation	  by	  up-­‐regulating	  osteogenic	  genes,	  elevating	  ALP	  and	  inducing	  secretion	  of	  type	  I	  collagen	  [40].	  The	  findings	  in	  this	  chapter	  are	  in	  confirmation	  with	  other	  studies	  [5,	   11,	   38]	   and	   some	   have	   found	   that	   on	   days	   14	   and	   21	   the	   ALP	   activity	   in	  perfused	  samples	  was	  three	  times	  the	  corresponding	  amount	   in	  static	  cultures.	  However	   variable	   levels	   of	   ALP	   have	   been	   observed	   in	   other	   studies	   of	  MSCs.	  
Peter	  et	  al.,	  [41]	  demonstrated	  the	  differentiation	  of	  rat	  MSCs	  on	  poly(propylene	  fumarate)	  disks	  and	  noticed	  that	  ALP	  activity	  was	  not	  enhanced	  until	  day	  21	  for	  static	   conditions.	   The	   high	   expression	   of	   ALP	   in	   both	   oscillatory	   and	  unidirectional	  flow	  groups	  suggests	  that	  continuous	  perfusion	  is	  not	  required	  in	  order	   to	   upregulate	   ALP	   activity	   or	   matrix	   production	   of	   hES-­‐MP	   cells.	   Short	  bouts	  of	   fluid	  flow	  (in	  particular	  oscillatory	  flow)	  can	  increase	  ALP	  activity	  and	  mineralisation	  of	  hES-­‐MPs	  in	  porous	  scaffolds.	  It	  seems	  this	  could	  be	  possible	  if	  flow	  is	  directed	  through	  the	  scaffold	  hence	  stimulating	  cells	  in	  the	  core/centre	  of	  the	  construct	  however	  in	  parallel	  arrangement	  this	  would	  not	  be	  the	  case	  since	  flow	  is	  mainly	  restricted	  to	  the	  periphery	  of	  the	  scaffold.	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It	   is	   interesting	   to	   note	   that	   scaffold	   orientation	   (TF	   vs	   PF)	   did	   not	   have	   any	  significant	   effect	   on	   matrix	   deposition	   as	   measured	   by	   collagen	   and	   calcium	  assays.	  Despite	  not	  having	  an	  ALP	  response	   to	   flow	  at	  day	  7,	   cells	   subjected	   to	  parallel	   oscillatory	   flow	   did	   produce	   as	   much	   matrix	   as	   cells	   subjected	   to	  transverse	  oscillatory	  flow	  at	  day	  14.	  As	  discussed	  in	  the	  previous	  paragraph	  this	  may	   be	   related	   to	   the	   peak	   of	   ALP	   expression	   occurring	   at	   different	   times	   in	  different	  culture	  conditions.	  From	  the	  data	  (fig	  4.8	  &	  4.9)	  it	  seems	  that	  flow	  type	  plays	  a	  key	  role	  in	  mineral	  production	  of	  hES-­‐MP	  cells.	  From	  these	  results	  it	  appears	  that	  subjecting	  cells	  to	  oscillatory	   flow	   offers	   a	   greater	   benefit	   than	   placing	   them	   in	   a	   unidirectional	  perfusion	   system	   for	   producing	   and	   depositing	   the	   most	   matrix.	   Although	   5	  ml/min	  unidirectional	   flow	  has	   an	   effect	   (60	  %	  higher)	   on	  mineral	   deposition,	  this	   was	   much	   less	   than	   the	   effect	   observed	   for	   samples	   subjected	   to	   an	  oscillatory	   flow	   of	   5	   ml/min	   (370%).	   Effect	   of	   5	   ml/min	   oscillatory	   was	   also	  stronger	  in	  comparison	  to	  samples	  subjected	  to	  an	  oscillatory	  flow	  of	  3	  ml/min	  (fig	   4.9).	   The	   presence	   of	   newly	   formed	   mineral	   in	   glass	   scaffolds	   further	  confirms	  mature	  osteoblast-­‐like	  characteristics	  of	  hES-­‐MP	  constructs.	  	  It	   is	   difficult	   to	   make	   direct	   comparisons	   with	   these	   results	   and	   others.	   For	  example	  Bancroft	  et	  al.,	  investigated	  the	  effects	  of	  different	  perfusion	  rates	  on	  rat	  marrow	  stromal	  osteoblasts	  and	  found	  that	  higher	  flow	  rates	  enhanced	  calcium	  deposition	   in	   a	   dose	   dependent	   manner	   [13].	   A	   recent	   study	   investigated	   the	  effects	  of	   intermittent	  steady,	  pulsatile,	  and	  oscillatory	   fluid	   flow	  on	  MC3T3-­‐E1	  activity	   within	   a	   collagen-­‐GAG	   scaffold.	   The	   results	   demonstrated	   that	   an	  oscillatory	   flow	   of	   1	  ml/min	   for	   49	   hours	   resulted	   in	   uniform	   cell	   distribution	  and	   enhanced	   the	   production	   of	   early	   stage	   bon	   formation	  markers	   [23].	   The	  inconsistency	  between	  this	  study	  and	  other	  studies	  may	  be	  explained	  in	  terms	  of	  differences	   in	   cell	   types.	   However,	   differences	   in	   system	   geometries,	   scaffold	  material	   and	   scaffold	   architecture	   further	   makes	   direct	   comparisons	   difficult	  since	   similar	   volumetric	   rates	   can	   result	   in	   highly	   different	   shear	   stresses	  imparted	  to	  the	  cells.	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The	   production	   of	   a	   mineralised	   matrix	   is	   considered	   the	   end-­‐point	   of	   full	  maturation	  of	  differentiating	  marrow	  stromal	  cells,	  and	  flow	  perfusion	  culture	  at	  this	   range	   appeared	   to	   have	   accelerated	   this	   differentiation	   [13].	   Others	   have	  described	   oscillatory	   flow	   being	   the	   dominant	   flow	   type	   in	   physiological	   bone	  conditions,	   it	  maybe	  because	  of	   this	   reason	   that	   the	   results	   in	   this	   study	   show	  oscillatory	  flow	  as	  a	  much	  more	  efficient	  flow	  type	  than	  unidirectional	  flow	  [42].	  	  
	  The	   results	   presented	   in	   this	   study	   suggest	   that	   shear	   stresses	   created	   by	  oscillatory	   ﬂow	   might	   be	   more	   beneficial	   than	   shears	   stresses	   created	   by	  unidirectional	   ﬂow	   for	   directing	   hES-­‐MPs	   towards	   an	   osteogenic	   lineage.	   A	  wealth	   of	   literature	   exists	   focusing	   on	   the	   effects	   of	   fluid	   shear	   stress	   on	  osteoblastic	   differentiation	   that	   have	   shown	   that	   the	   application	   of	   fluid	   flow	  affects	   osteogenic	   signal	   expression	   of	   mesenchymal	   stem	   cells	   [2,	   43-­‐46].	  Predicting	   shear	   stress	   distribution	   for	   different	   scaffold	   architecture,	   in	  combination	   with	   the	   knowledge	   of	   how	   these	   local	   stresses	   affect	   cell	  attachment	   and	   cell	   growth	   can	   ultimately	   lead	   to	   scaffold	   design	   procedures	  that	   would	   maximise	   cell	   and	   tissue	   growth.	   In	   this	   study	   (chapter	   2,	   section	  2.2.15),	  Wang	  and	  Tarbell’s	  model	  was	  used	   to	  approximate	   the	  average	  stress	  values	  subjected	  to	  the	  cells	  by	  unidirectional	  flow.	  It	  was	  found	  that	  flow	  rates	  of	  3,	  5	  and	  10	  ml/min	  produced	  average	  stress	  values	  of	  0.111,	  0.647	  and	  1.398	  Pa	   respectively.	   Since	   oscillatory	   flow	   has	   a	   back	   and	   forth	  motion,	   it	  was	   not	  possible	   to	  use	   the	  same	  model	   to	  predict	   shear	  stress	  values.	  The	  variation	   in	  cell	   types,	   3D	   scaffold	   geometry	   and	   bioreactor	   setup	   has	   increased	   the	  complexity	   of	   defining	   the	   optimum	   shear	   stress.	   Nevertheless,	   up	   to	   now	   the	  bodies	   of	   work	   suggest	   that	   osteogenic	   differentiation	   can	   be	   achieved	   with	  shear	   stresses	   in	   the	   range	   of	   1x10-­‐4-­‐1.2	   Pa,	   showing	   a	   good	   correlation	   with	  levels	  of	  shear	  stress	  expected	  to	  occur	  in	  bone	  (0.8-­‐3	  Pa)	  [8].	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Chapter	   5:	   Mechanical	   stimulation	   of	  
mesenchymal	   stem	   cells	   seeded	   on	  peptide-­‐
coated	  glass	  scaffolds	  
	  
	   5.1	   Introduction	  
	  Human	   and	   animal	   cells	   are	   grown	   in	   serum	   in	   order	   to	   enable	   growth	   and	  proliferation.	  The	  most	  commonly	  used	  serum	  for	  cell	  culture	  is	  fetal	  calf	  serum.	  Serum,	  which	  is	  extracted	  from	  blood,	  is	  an	  extremely	  complex	  mixture	  of	  many	  small	   and	   large	   molecules	   with	   different	   physiologically	   balanced	   growth	  promoting	  and	  growth	  inhibiting	  activities.	  Serum	  provides	  an	  enormous	  variety	  of	   substances	   necessary	   for	   cultivating	   a	   wide	   variety	   of	   animal	   cells,	   such	   as	  hormones,	   growth	   factors,	   transport	   proteins	   and	   attachment	   factors.	  Advantages	  of	  using	  serum	  in	  media	  is	  to	  provide	  basic	  nutrients	  in	  soluble	  or	  in	  protein-­‐bound	   forms	  and	  also	   contains	   albumin,	   hormones,	   vitamins,	  minerals,	  fatty	   acids	   which	   promote	   proliferation	   of	   cells.	   However,	   Batch	   testing	   is	  necessary	   due	   to	   variability	   and	   Specific	   cell	   lines	   require	   specific	   fetal	   calf	  serum.	  Recent	   developments	   in	   formulating	  media	   show	   that	   a	   variety	   of	   cells	  can	   be	   cultured	   in	   the	   absence	   of	   a	   serum	   supplement,	   provided	   various	  combinations	   of	   hormones,	   nutrients	   and	   purified	   proteins	   are	   added	   to	   the	  medium	  to	  replace	  serum	  [1].	  Some	  reasons	  for	  using	  serum-­‐free	  media	  include	  the	  avoidance	  of	   serum	  toxicity	  and	   in	   the	  absence	  of	   serum,	   the	  phenotype	  of	  cell	   can	  be	  better	   controlled.	  However,	   Serum-­‐free	  media	  are	  highly	   specific	   to	  one	   cell	   type,	   as	   cell	   type	   from	   each	   species	   has	   its	   own	   characteristics	   and	  requirements	   and	   reliable	   serum-­‐free	   media	   are	   not	   readily	   available	  commercially.	  	  Many	  factors	  contribute	  to	  the	  maintenance	  of	  a	  biomimetic	  microenvironment	  for	  cell	  growth	  in	  vitro	   including	  consistency	  of	  the	  growth	  medium,	  addition	  of	  supplements	  and	   the	  surface	   in	  which	  cells	  attach	  and	  grow.	  The	  nature	  of	   the	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surface	   to	  which	   cells	   attach	   and	   are	   cultured	   is	   important	   for	   their	   ability	   to	  proliferate,	   migrate	   and	   function.	   Components	   of	   the	   ECM	   have	   recently	   been	  used	  to	  coat	  glass	  or	  plastic	  surfaces	  to	  enhance	  and	  promote	  cell	  attachment	  in	  
vitro.	   These	   fragments	   represent	   binding	   sites	   that	   are	   known	   to	   allow	   cell	  attachment	   and	   can	   be	   immobolised	   on	   surfaces	   in	   order	   to	  mimic	   the	   effects	  seen	  by	  the	  binding	  sites	  on	  whole	  molecules	  [2].	  	  Tenascin	  C	  is	  known	  to	  be	  a	  hexameric	  glycoprotein	  and	  each	  of	   its	  disulphide-­‐linked	  subunits	  consists	  of	  a	  series	  of	  domains	  with	  homology	  to	  other	  proteins	  including	   fibrinogen,	   fibronectin,	  and	  epidermal	  growth	   factors	  [3,4].	  The	  multi	  domain	   structure	   of	   tenascin	   C	   demonstrates	   the	   many	   potential	   sites	   of	  interaction	  with	  cells	  and	  other	  matrix	  proteins.	  A	  variety	  of	  functions	  have	  been	  associated	   with	   tenascin	   C	   on	   the	   basis	   of	   in	   vitro	   findings.	   In	   the	   developing	  nervous	  system,	   tenascin	  C	  has	  been	  shown	  to	  stimulate	  granule	  cell	  migration	  and	  neurite	  outgrowth	  [5,	  6].	  Tenascin	  C	  also	  inhibits	  milk	  protein	  synthesis	  by	  mammary	  epithelial	  cells	   [7,	  8]	  and	   inhibits	  T	   lymphocyte	  activation	  [9].	   In	   the	  developing	  skeleton,	  tenascin	  C	  encourages	  chrondrogenic	  differentiation	  in	  limb	  and	   mesenchymal	   cell	   culture	   [10].	   Cells	   of	   the	   osteoblast	   lineage	   have	   been	  shown	  to	  express	  tenascin	  C	  from	  the	  onset	  of	  ossification,	  however	  tenacin	  C	  is	  undetectable	   in	  mineralised	   bone.	   The	   expression	   of	   tenascin	   C	   appears	   to	   be	  enhanced	   at	   sites	   of	   remodeling	   and/or	   bone	   formation	   [10-­‐12].	   In	   a	   recent	  study,	   tenascin	  C	  was	   found	   to	   stimulate	  ALP	   activity	   of	   osteosarcoma-­‐derived	  osteoblast-­‐like	  cell	   lines	  and	  anti-­‐tenascin	  C	   resulted	   in	  a	   reduction	   in	   collagen	  synthesis	  and	  ALP	  activity	  [13].	  	  Osteopontin	   (OPN)	   is	   an	   extracellular	   matrix	   protein	   and	   it	   has	   been	  demonstrated	  to	  play	  a	  key	  role	   in	   inflammation	  and	  immunological	  responses,	  [14]	   as	   well	   as	   remodeling	   of	   mineralised	   tissue.	   In	   vitro	   experiments	   have	  shown	   that	   OPN	   binds	   to	   the	   cells	   via	   cell	   adhesion	   sequences	   that	   recognise	  	  integrins	  including	  αvβ1,3,5,6	  [15].	  In	  rat	  calvarial	  osteoblast	  cells,	  OPN	  expression	  is	  increased	  during	  the	  initial	  stages	  of	  differentiation	  and	  has	  also	  upregulated	  ALP	   activity	   [16].	   Therefore,	   OPN	   has	   been	   proposed	   not	   only	   as	   a	   linker	  between	  hydrophobic	  surfaces	  and	  the	  cell,	  but	  as	  an	  activator	  on	  the	  surfaces.	  In	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a	   recent	   study,	   osteoblastic	   MG63	   cells	   were	   seeded	   on	   to	   surfaces	   that	   were	  covered	  with	  recombinant	  osteopontin	  (rOPN17-­‐169)	  fragments	  (containing	  the	  cell	  adhesion	  motifs).	  The	  results	  demonstrated	  that	  rOPN17-­‐169	  precoated	  on	  the	  hydrophobic	  surface	  can	  promote	  cell	  adhesion,	  generate	  mitogen	  activated	  protein	  kinases	  (MAPK)	  and	  cytokine	  activation	  for	  osteoblastic	  cells	  [17].	  
 Bone	  morphogenetic	  protein-­‐2	  (BMP-­‐2)	  is	  a	  member	  of	  the	  transforming	  growth	  factor	   (TGF)	   β	   superfamily	   and	   is	   an	   essential	   factor	   for	   enhancing	   osteogenic	  differentiation.	   Recombinant	   BMPs	   can	   offer	   the	   early	   stage	   signals	   for	  pluripotent	   cells	   in	   order	   to	   differentiate	   into	   mineral	   depositing	   osteoblasts	  [18].	  Under	  the	  influence	  of	  locally	  administered	  BMPs,	  stem	  cell	  differentiation	  is	  accelerated	  and	  functional	  properties	  of	  regenerated	  bone	  tissue	  are	  enhanced	  [19-­‐22].	  A	  previous	  study	  demonstrated	  the	  repair	  of	  a	  20-­‐mm	  long	  rabbit	  radial	  bone	   defect	   by	   using	   a	   BMP-­‐2	   derived	   peptide	   combined	   with	   porous	   α-­‐tricalcium	   phosphate	   (TCP)	   scaffold.	   In	   vivo	   experiments	   showed	   that	   a	  combination	  of	  BMP-­‐2	  derived	  peptide	  and	  α-­‐TCP	  scaffold	  promoted	  calcification	  in	   the	   implanted	  area	   [23].	  Another	   study	  demonstrated	  bone	  marrow-­‐derived	  mesenchymal	  stem	  cell	  (BMMSC)	  adhesion	  on	  chitosan-­‐grafted	  titanium	  (Ti-­‐CS)	  coated	  with	   immobilised	   BMP-­‐2.	   Furthermore,	   it	  was	   shown	   that	   Ti-­‐CS-­‐BMP-­‐2	  enhanced	  ALP	  activity	  and	  had	  higher	  level	  of	  transcription	  activity	  of	  the	  bone	  transcription	  factor	  Runx2,	  compared	  with	  that	  of	  bone	  cell-­‐derived	  osteoblasts.	  Alizarin	   red	   staining	   also	   confirmed	   calcium	   deposition,	   suggesting	   that	   the	  BMMSCs	  were	  actively	  differentiating	  into	  osteoblasts	  [24].	  	  	  Studying	   the	   effects	   of	   peptide-­‐coated	   surfaces	   should	   give	   further	   insight	   into	  cell	  attachment,	  cell	  migration	  and	  cell	  function	  on	  biomaterials.	  For	  this	  reason	  it	   is	  of	   interest	  to	   investigate	  cell	  responses	  to	  a	  combination	  of	  peptide	  coated	  scaffolds	  cultured	  in	  different	  serum	  conditions.	  In	  this	  chapter,	  the	  hypothesis	  is	  that	   the	   combination	   of	   peptide-­‐coated	   scaffolds	   and	   application	   of	   fluid	   flow	  (established	   in	   chapter	   4)	   will	   have	   a	   synergistic	   effect	   on	   hES-­‐MP	   cell	  distribution,	  proliferation	  and	  osteogenic	  differentiation	  in	  3D	  dynamic	  culture.	  To	  test	  this	  hypothesis,	  the	  experiments	  were	  divided	  into	  2	  stages:	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5.2	   Investigating	  the	  effects	  of	  serum-­‐containing	  and	  serum-­‐free	  media	  
on	  hES-­‐MP-­‐peptide-­‐coated	  constructs	  with	  respect	  to	  cell	  attachment,	  cell	  
viability	  and	  matrix	  mineralisation	  in	  static	  culture.	  	  	   5.2.1	  	  	  	  	  	  Methodology	  	  Peptide	   coating	   was	   performed	   by	   the	   commercial	   company	   Orla	   Protien	  Technologies.	   The	   peptide	  motifs	   derived	   from	  Tenascin	   C	   (VFDNVKL),	   BMP-­‐2	  (IPKASSVPTELSAISTLY)	  and	  Osteopontin	  (VVYGLRGSGSGSS)	  were	  modified	  first	  by	   silanisation	   then	   treated	   with	   colloid	   gold,	   which	   gives	   the	   scaffolds	   an	  invisible	   gold	   coating	   across	   the	   entire	   exposed	   surface.	   All	   the	   proteins	   used	  have	   a	   single	   exposed	   cysteine	   on	   the	   bottom	   of	   the	   molecule	   and	   it	   is	   the	  binding	  of	  the	  SH	  group	  in	  the	  cysteine	  to	  the	  gold	  that	  gives	  scaffolds	  the	  ability	  to	   form	   oriented	   protein	   monolayers	   on	   substrates,	   simply	   by	   placing	   the	  substrate	  in	  an	  aqueous	  Orla	  protein	  solution.	  Neutron	   reflection	   data	   demonstrates	   that	   the	   proteins	   dimensions	   are	  estimated	  as	  5nm	  x	  2.5nm	  making	  the	  theoretical	   thickness	  of	   the	  coating	  5nm	  [25].	  There	  is	  no	  easy	  way	  to	  show	  that	  the	  coating	  of	  each	  material	  has	  worked	  without	   in	   effect	   destroying	   the	   coating.	   Therefore	   confidence	   in	   the	   coating	  process	   comes	   from	   the	   control	   tests	  Orla	  perform	   in	   their	   labs.	  These	   include	  analytical	  tests	  such	  as	  surface	  plasmon	  resonance	  (SPR),	  surface	  acoustic	  wave	  (SAW)	  or	  quartz	  crystal	  microbalance	  (QCM)	  chips,	  combined	  with	  the	  biological	  effects	   and	   changes	   in	   wettability	   observed	   on	   coated	   2D/3D	   surfaces.	   These	  assays	  were	  all	  performed	  by	  Orla	  Protein	  Technologies,	  in	  house.	  	  The	  aim	  of	  this	  experiment	  was	  to	  investigate	  the	  effects	  of	  growing	  hES-­‐MP	  cells	  in	  serum-­‐containing	  and	  serum-­‐free	  media	  on	  hES-­‐MP-­‐peptide-­‐coated	  scaffolds	  with	   resepect	   to	   cell	   viability	   and	   matrix	   production.	   Peptide-­‐coated	   scaffolds	  were	   sterilised	   using	   70%	   ethanol	   rather	   than	   0.1%	   peracetic	   acid	   (as	  recommended	  by	  Orla	  Protein	  Technologies	  to	  avoid	  any	  damage	  to	  the	  surface	  coatings)	   and	   washed	   with	   PBS	   several	   times.	   hES-­‐MP	   cells	   were	   statically	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5.2.2	   Results	  























Fig	   5.1;	   MTS	   absorbance	   of	   hES-­‐MP	   cells	   cultured	   on	   gelatin	   and	   peptide-­‐coated	   glass	  scaffolds	  in	  serum-­‐free	  (-­‐serum)	  and	  serum-­‐containing	  (+serum)	  media	  at	  day	  7	  of	  static	  culture.	  All	  data	  is	  mean	  ±	  SD	  (n=4).	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5.2.2.2	  	  	  	  	  Live/dead	  staining	  –	  Day	  7	  
	  According	   to	   the	   previous	   results	   (fig	   5.1),	   constructs	   cultured	   in	   serum-­‐containing	  media	   showed	   better	   cell	   viability	   than	   samples	   cultured	   in	   serum	  free	  media.	  Therefore	  a	   live/dead	   staining	   technique	  was	  used	   to	  visualise	   cell	  proliferation	  and	  uniformity	  on	  day	  1,	  3	  and	  7	  for	  samples	  statically	  cultured	  in	  serum-­‐containing	   media.	   The	   images	   reveal	   that	   on	   day	   1,	   gelatin	   coated	  scaffolds	   contained	   more	   dead	   cells	   (red	   dots)	   than	   other	   peptide-­‐coated	  scaffolds.	   By	   day	   7,	   very	   few	   dead	   cells	   seem	   to	   be	   present	   however	   a	   much	  higher	  number	  of	   live	   cells	   (green	  dots)	   seem	   to	  be	  present	  on	  peptide-­‐coated	  constructs,	  more	  specifically	  on	  those	  coated	  with	  osteopontin.	  hES-­‐MP	  cells	  also	  tended	   to	   have	   a	  much	  more	   uniform	   distribution	   on	   peptide-­‐coated	   scaffolds	  than	  gelatin	  coated	  samples,	  whereby	  cells	  had	  dominated	  and	  covered	  most	  of	  the	  surface	  area	  of	  a	  scaffold	  strut	  (fig	  5.2).	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5.2.3	   Collagen	  and	  calcium	  production	  –	  Day	  14	  

























































Fig	   5.3;	   Collagen	   production	   (SR)	   and	   calcium	   deposition	   (AR)	   was	   analysed	   on	   day	   14	   of	   static	  culture	   for	  hES-­‐MP	  cells	   seeded	  on	   gelatin	  and	  peptide-­‐coated	   scaffolds	   supplemented	  with	   serum-­‐free	  (-­‐serum)	  and	  serum-­‐containing	  (+serum)	  media.	  All	  data	  is	  mean	  ±	  SD	  (n=3).	  	  
(a)	  Collagen	  production	  
(b)	  Calcium	  deposition	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5.3	   Investigating	   the	   combination	   of	   fluid	   flow	   and	   hES-­‐MP-­‐peptide-­‐
coated	  constructs	  with	  respect	  to	  matrix	  mineralisation	  and	  expression	  of	  
genes	  associated	  with	  osteogenic	  differentiation.	  
	  	   5.3.1	   Methodology	  	  Although	  it	  was	  promising	  that	  cells	  could	  survive	  almost	  as	  well	   in	  serum-­‐free	  than	   serum-­‐containing	   media,	   the	   serum-­‐free	   media	   did	   inhibit	   collagen	   and	  calcium	  production.	   The	   effects	   of	   protein	   coating	  were	   still	   evident	   in	   serum-­‐containing	  media	  therefore	  it	  was	  decided	  to	  use	  serum-­‐containing	  media	  for	  the	  following	  experiments.	  The	  hES-­‐MP	  cells	  were	  used	  between	  passages	  8-­‐12	   for	  ALP	  activity	  and	  total	  DNA	  analysis.	  However,	  for	  all	  other	  assays	  the	  cells	  were	  used	  between	  passages	  3-­‐7.	  Glass	  scaffolds	  were	  seeded	  with	  250,000	  cells	  using	  the	   seeding	   and	   culture	  methods	   described	   in	   chapter	   2.	   Cell-­‐seeded	   scaffolds	  were	   cultured	   in	   standard	   culture	  media	   and	   supplemented	  with	   AA,	   βGP	   and	  DEX.	   Fluid	   flow	  was	   applied	   using	   the	   oscillatory	   pump	   (chapter	   2,	   figure	   2.3)	  and	   cell-­‐seeded	   scaffolds	   were	   arranged	   inside	   of	   the	   conduit	   as	   defined	   in	  chapter	  4.	  	  	  In	  short-­‐term	  dynamic	  culture,	  samples	  were	  subjected	  to	  oscillatory	   fluid	   flow	  (5	  ml/min,	  1	  Hz,	  1	  hour	  loading	  session)	  on	  day	  4	  and	  analysed	  for	  cell	  viability	  (MTS),	   total	  DNA	  content	  and	  ALP	  activity	  on	  day	  7	   (figure	  5.4a).	   In	   long-­‐term	  culture,	  samples	  were	  subjected	  to	  fluid	  flow	  on	  day	  4,	  7,	  10	  and	  analysed	  for	  cell	  distribution	   (DAPI	   and	   Phalloidin	   staining),	   collagen	   production,	   and	   calcium	  deposition	   on	   day	   14	   (figure	   5.4b).	   Between	   loading	   sessions,	   cell-­‐seeded	  scaffolds	   were	   cultured	   statically	   in	   an	   incubator	   in	   standard	   conditions.	   The	  experiment	   was	   conducted	   three	   times	   (N=3)	   with	   2	   scaffolds	   (n=2)	   for	   each	  condition.	  A	  one-­‐way	  ANOVA	  followed	  by	  Tukey’s	  post-­‐hoc	  test	  were	  performed,	  since	   there	  where	   comparisons	   of	  more	   than	   two	   sample	  means.	  Results	  were	  expressed	  as	  mean	  ±	  standard	  deviation.	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Figure	  5.4;	  The	  experimental	  time	  line.	  (a)	  Short	  term	  dynamic	  culture,	  samples	  were	  subjected	  to	  flow	  on	  day	  4	  of	  culture	  and	  assayed	  for	  cell	  viability	  (MTS),	  total	  DNA	  content	  and	  ALP	  activity	  on	  day	  7.	  (b)	  Long	  term	   dynamic	   culture,	   samples	   were	   subjected	   to	   flow	   on	   days	   4,	   7	   and	   10	   and	   assayed	   for	   collagen	  production	  (SR)	  and	  calcium	  deposition	  (AR)	  content	  on	  day	  14	  of	  culture. 
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5.3.2	   Results	  
	   5.3.2.1	  	  	  	  Cell	  Viability	  as	  assayed	  by	  MTS	  –	  Day	  7	  














Fig	   5.5;	   Cell	   viability	   (MTS)	   analysed	   on	   day	   7	   for	   hES-­‐MP	   cells	   cultured	   on	  gelatin	   and	   peptide-­‐coated	   scaffolds	   subjected	   to	   5	   ml/min	   oscillatory	   fluid	  flow.	   *=	   Significantly	   different	   compared	   to	   gelatin	   flow	   group	   and	  
♯=Significantly	  different	  to	  corresponding	  static	  culture.	  All	  data	  is	  mean	  ±	  SD	  (n=4).	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5.3.2.2	  	  	  	  Total	  DNA	  content	  –	  Day	  7	  


















Fig	  5.6;	  Total	  DNA	  content	  analysed	  on	  day	  7	  for	  hES-­‐MP	  cells	  cultured	  on	  gelatin	  and	   peptide-­‐coated	   scaffolds	   subjected	   to	   5	   ml/min	   oscillatory	   fluid	   flow.	   *=	  Significantly	  different	  compared	  to	  gelatin	  flow	  group	  and	  ♯=Significantly	  different	  to	  corresponding	  static	  culture.	  All	  data	  is	  mean	  ±	  SD	  (n=4).	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5.3.2.3	  	  	  	  	  ALP/DNA	  –	  Day	  7	  














	  5.3.2.4	  	  	  	  	  Dapi	  and	  phalloidin	  staining	  –	  Day	  14	  
	  Dapi	   and	   phalloidin	   staining	   was	   used	   on	   coated	   scaffolds	   to	   analyse	   cell	  distribution	  and	  cell	  uniformity,	   images	  were	   taken	   from	  the	   top,	   cross-­‐section	  
Fig	   5.7;	   ALP	   activity	   (normalised	   to	   DNA)	   analysed	   on	   day	   7	   for	   hES-­‐MP	   cells	  cultured	  on	  gelatin	  and	  peptide-­‐coated	  scaffolds	  subjected	  to	  5	  ml/min	  oscillatory	  fluid	   flow.	   *=	   Significantly	   different	   compared	   to	   gelatin	   flow	   group	   and	  
♯=Significantly	   different	   to	   corresponding	   static	   culture.	   All	   data	   is	   mean	   ±	   SD	  (n=4).	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5.3.2.5	  	  	  	  	  Collagen	  and	  calcium	  production	  –	  day	  14	  

























	   	   188	  	  
Fig	  5.9;	  Collagen	  production	  (SR)	  and	  calcium	  deposition	  (AR)	  analysed	  on	  day	  14	  for	  hES-­‐MP	  cells	  cultured	  on	  gelatin	  and	  peptide-­‐coated	  scaffolds	  subjected	  to	  5	  ml/min	  oscillatory	  fluid	  flow.	  *=	  Significantly	  different	  compared	  to	  gelatin	  flow	  group	  and	  ♯=Significantly	  different	  to	  corresponding	  static	  culture.	  All	  data	  is	  mean	  ±	  SD	  (n=4).	  	  	  
(a)	  Collagen	  production	  
(b)	  Calcium	  deposition	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5.4	   Discussion	  
	  The	  aim	  of	  this	  chapter	  was	  to	   investigate	  the	  response	  of	  hES-­‐MP	  cells	  seeded	  on	  peptide	  coated	  and	  standard	  coated	  glass	  scaffolds	  under	  dynamic	  conditions	  with	   respect	   to	   cell	   distribution	   and	   various	   markers	   of	   osteogenic	  differentiation.	  	  	  Short	  term	  static	  experiments,	  revealed	  that	  Tenascin	  C,	  BMP-­‐2	  and	  osteopontin	  coated	  scaffolds	  cultured	  in	  serum-­‐containing	  media	  enabled	  better	  adherence	  of	  hES-­‐MP	  cells,	  exhibited	  higher	  cell	  viability	  as	  assayed	  by	  MTS	  on	  day	  7	  of	  culture	  and	   produced	   more	   collagen	   and	   calcium	   compared	   to	   hES-­‐MPs	   seeded	   on	  gelatin	   coated	   scaffolds.	   Conventional	   media	   has	   been	   used	   for	   isolating	   and	  expanding	   human	   MSCs	   with	   supplementing	   FBS	   at	   10%.	   FBS	   contains	  nutritional	   and	   physiochemical	   compounds	   as	   well	   as	   a	   high	   content	   of	  attachment	   and	   growth	   factors	   required	   for	   cell	   growth	   and	   cell	  maintenance.	  However,	  due	  to	  the	  inherent	  problems	  associated	  with	  ill-­‐defined	  FBS	  there	  is	  a	  need	  for	  the	  development	  of	  defined	  serum-­‐free	  media.	  Efforts	  have	  been	  made	  to	  develop	   a	  defined	   serum-­‐free	  media	   for	   animal	   or	  human	  MSC	  growth.	   [26-­‐29].	  	  	  Additionally,	  cells	  exposed	  to	  serum	  during	  the	  isolation/expanding	  phase	  could	  lead	   to	   serum-­‐derived	   contaminants,	  which	  will	   probably	   be	   carried	  over	  with	  the	  cells	  when	  placed	  under	  serum-­‐free	  conditions	  and	  ultimately	  limiting	  their	  therapeutic	  use.	  Previous	   researchers	  developed	   a	  defined	   serum-­‐free	  medium	  (PPRF-­‐msc6)	  for	  hMSC	  isolation	  and	  expansion	  that	  contains	  key	  attachment	  and	  growth	   factors	   required	   for	   both	   primary	   and	   passaged	   cultures	   [30].	   It	   was	  shown	  that	  PPRF-­‐msc6	  medium	  supported	  hMCS	  generation	  from	  multiple	  bone	  marrow	   samples	   in	   a	   rapid	   and	   consistent	   manner	   whilst	   maintaining	   their	  multipotency	  and	  hMSC-­‐specific	  immunophenotype.	  Interestingly,	  in	  comparison	  to	   serum-­‐containing	   media,	   hMSCs	   cultured	   in	   PPRF-­‐msc6	   media	   exhibited	   a	  greater	   colony	   capacity,	   lower	   population	   doubling	   time,	   greater	   number	   of	  population	  doublings	  and	  a	  more	  homogeneous	  cell	  population.	  The	  serum	  free	  media	   used	   in	   this	   study	   has	   been	   optimised	   for	   adult	   MSC	   and	   contains	   an	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attachment	   substrate,	   which	   can	   mask	   and	   interfere	   with	   peptide-­‐coated	  scaffolds.	  This	  could	  explain	  the	  lower	  cell	  number	  in	  samples	  cultured	  in	  serum	  free	  media.	  A	  combination	  of	  peptide	  coatings	  may	  better	   resemble	   the	  critical	  ECM	  molecules	  needed	  for	  cell	  survival	  and	  proliferation	  and	  enable	  the	  cells	  to	  achieve	  as	  high	  a	  number	  as	  in	  serum	  containing	  medium.	  	  
In	  vivo	  studies	  have	  shown	  that	  the	  application	  of	  mechanical	  loading	  is	  a	  potent	  stimulus	   for	   new	   bone	   formation.	   Furthermore,	   the	   growth	   of	   cells	   in	   vitro	  requires	   the	   development	   of	   technologies	   to	   recreate	   some	   features	   of	   the	  natural	   microenvironment	   that	   cells	   experience	   in	   living	   tissues	   not	   only	   for	  optimal	   cell	   survival	   but	   also	   growth	   and	   function.	   Glass	   scaffolds	   coated	  with	  active	   peptide	   domain	   of	   proteins	   were	   used	   to	   examine	   the	   adherence	   of	  cultured	   cells	   to	   the	   surface	   under	   static	   and	   dynamic	   conditions.	   The	   results	  show	   that	   the	   combination	   of	   bioreactor	   culture	   and	   distinct	   ligand	   motifs	  further	  improved	  cell	  distribution	  and	  enhanced	  matrix	  production	  compared	  to	  gelatin-­‐coated	  scaffolds.	  	  A	   higher	   DNA	   content	   was	   observed	   in	   gelatin	   coated	   scaffolds	   compared	   to	  peptide-­‐coated	   scaffolds	   on	   day	   7	   of	   culture	   (fig	   5.6).	   However	   this	   was	   not	  reflected	  in	  the	  MTS	  data	  assayed	  on	  day	  7	  of	  culture	  (fig	  5.5).	  This	  has	  also	  been	  observed	   by	   other	   researchers	   [31-­‐33]	   and	   even	   with	   the	   reduction	   in	   DNA	  content	  for	  flow	  groups,	  cell	  distribution	  was	  much	  more	  homogeneous	  (fig	  5.8)	  and	   as	   also	   seen	   in	   other	   studies	   [34-­‐36].	   As	  mentioned	   in	   previous	   chapters,	  cells	  can	  be	  concentrated	  along	  the	  periphery	  of	  the	  constructs	  in	  static	  cultures	  in	   certain	   scaffolds.	  This	  phenomenon	   is	   less	  observed	   in	   the	  presence	  of	   fluid	  shear	  stress.	  However	  it	  is	  worth	  noting	  that	  despite	  the	  low	  DNA	  content	  in	  flow	  groups,	   there	   are	   still	   a	   high	   number	   of	   cells	   on	   the	   constructs	   by	   day	   14	   of	  culture	   (fig	   5.8).	   This	   could	   be	   due	   to	   a	   higher	   number	   of	   cells	   initially	   being	  attached	   to	   the	   peptide	   coated	   scaffold.	   The	   abundant	   cell	   adhesion	   on	   coated	  scaffolds	  is	  most	  likely	  mediated	  by	  the	  active	  peptide	  domains	  in	  comparison	  to	  gelatin-­‐coated	  scaffolds.	  Furthermore,	  the	  way	  in	  which	  cells	  adhere	  and	  interact	  with	  the	  surrounding	  matrix	  is	  known	  to	  not	  only	  influence	  cell	  shape	  but	  also	  to	  control	  cell	  response	  and	  gene	  expression	  [37].	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It	  is	  interesting	  to	  note	  that	  collagen	  and	  calcium	  production	  in	  static	  conditions	  for	   hES-­‐MP	   cells	   on	   gelatin-­‐coated	   scaffolds	   (fig	   5.3)	   were	   similar	   to	   static	  conditions	  in	  flow	  experiments	  (fig	  5.9)	  since	  these	  experiments	  were	  conducted	  at	  a	  similar	  time.	  However,	  there	  seems	  to	  be	  a	  discrepancy	  with	  regards	  to	  the	  collagen	  production	  and	  calcium	  deposition	  in	  samples	  cultured	  in	  static	  (fig	  5.9)	  and	   for	  similar	  results	  obtained	   in	  chapter	  4	  (fig	  4.8	  &	  4.9).	  The	   fact	   that	   these	  experiments	  were	   conducted	   at	   totally	   different	   time	   points	   could	   explain	   this	  variation.	  Although	  passage	  number	   of	   hES-­‐MP	   cells	  were	   very	   similar	   at	   both	  time	  points,	  other	   factors	   including	  age	  of	  media,	  age	  of	  supplements	  (AA,	  βGP,	  and	  DEX),	  and	  seeding	  density	  could	  all	  have	  an	  effect	  on	  the	  biological	  response.	  It	   has	   been	   demonstrated	   that	   increasing	   the	   density	   of	   human	   umbilical	   cord	  mesenchymal	   stromal	   cells	   in	   polyglycolic	   acid	   scaffolds,	   have	   resulted	   in	   an	  increase	  in	  collagen	  and	  calcium	  production	  [38].	  	  	  	  Cells	   seeded	  on	  gelatin	  and	  peptide-­‐coated	   scaffolds	  under	  dynamic	   conditions	  produced	   a	   significantly	   (p<0.05)	   higher	   amount	   of	   collagen	   and	   calcium	  compared	  to	  cell	  in	  respective	  static	  conditions	  (fig	  5.9).	  	  Furthermore,	  peptide-­‐coated	  scaffolds	  enabled	  a	  higher	  collagen	  and	  calcium	  production	   than	  gelatin	  coated	   scaffolds.	   It	   has	   been	   shown	   that	   osteopontin	   is	   involved	   in	   bone	   cell	  attachment	  to	  ECM	  and	  also	  acts	  as	  a	  chemoattractant	  for	  bone	  cells	  during	  the	  early	   stages	   of	   bone	   development	   [39].	   Early	   work	   demonstrated	   that	   the	  attachment	  of	  osteoblasts	  to	  osteopontin	  was	  dose	  dependant	  and	  mediated	  by	  a	  RGD	  peptide	  sequence	  [40].	  Furthermore	  it	  was	  found	  that	  osteopontin	  plays	  an	  important	   role	   in	   adhesion,	   remodeling	   and	   osseointegration	   at	   the	   interface	  between	  a	  biomaterial	  and	  bone	  [41].	  	  	  The	  ECM	  protein,	  Tenascin	  C	  is	  expressed	  in	  association	  with	  tissue	  remodeling	  during	   the	  development	   and	  pathogenesis	   in	   bone	   [42].	  Osteoblasts	   have	  been	  shown	  to	  express	  Tenascin-­‐C	  from	  the	  onset	  of	  bone	  formation	  and	  continue	  to	  do	   so	   in	   growing	   bone	   [10,	   43].	   In	   a	   recent	   study	   utilisng	   an	   osteosarcoma-­‐derived	  osteoblast-­‐like	  cell	   line,	  Tenascin	  C	  was	  found	  to	  stimulate	  ALP	  activity	  and	  antitenascin-­‐C	  showed	  a	  reduction	  in	  ALP	  activity	  and	  collagen	  production,	  suggesting	   that	   Tenascin-­‐C	   may	   play	   an	   important	   role	   in	   bone	   cell	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differentiation	  [13].	  In	  another	  study,	  heterogeneous	  bone	  marrow	  mononuclear	  cells	   showed	   a	   proliferative	   response	   in	   the	   presence	   of	   Tenascin	   C.	   Using	  recombinant	   fragments	  of	  human	  Tenascin	  C	   several	  mitogenic	  domains	  of	   the	  molecule	  was	  also	  identified.	  These	  effects	  suggest	  that	  Tenascin	  C	  plays	  a	  crucial	  role	   in	   proliferation	   and	   differentiation	   of	   hematopoietic	   cells	  within	   the	   bone	  marrow	  microenvironment	  [44].	  	  As	  mentioned	  previously,	  BMPs	  belong	  to	  the	  TGF-­‐β	  superfamily	  and	  are	  known	  to	   induce	   and	   promote	   the	   differentiation	   of	   undifferentiated	   MSCs	   into	  osteogenic	   and	   chrondrogenic	   cells	   [45].	   In	   vivo,	   undifferentiated	   MCSs	  proliferate	  from	  the	  bone	  marrow,	  periosteum,	  and	  muscle	  surrounding	  the	  site	  of	  fracture	  and	  begin	  to	  migrate.	  This	  will	  eventually	  lead	  to	  new	  bone	  formation	  as	   a	   result	   of	   their	   differentiation	   into	   chrondrogenic	   and	   osteogenic	   cells.	  Indeed	  BMPs	  have	  been	  demonstrated	  to	  be	  present	  at	  the	  initial	  stages	  of	  bone	  fracture	   healing	   and	   seem	   to	   play	   a	   key	   role	   in	   the	   events	   that	   results	   in	   the	  generation	   of	   new	   bone	   [46].	   The	   results	   presented	   in	   this	   study	  with	   BMP-­‐2	  coatings	  are	  in	  agreement	  with	  previous	  work	  that	  have	  shown	  a	  synthetic	  BMP-­‐2	   peptide	   was	   able	   to	   induce	   alkaline	   phosphatase	   activity	   in	   C2C12	   mouse	  osteoblast	  cells	  [47].	  Although	  the	  glass	  scaffolds	  utilised	  in	  this	  study	  cannot	  be	  used	  for	  in	  vivo	  tissue	  engineering	  purposes,	  researchers	  have	  shown	  delivering	  BMP-­‐2	   using	   PLGA	   scaffolds	   over	   several	   weeks	   following	   implantation	  enhanced	  higher	  bone	  formation	  in	  rats	  [48],	  a	  canine	  model	  [49]	  and	  sheep	  [50]	  when	   compared	   to	   using	   a	   scaffold	   alone.	   Immobilised	   BMP-­‐2	   has	   previously	  been	  shown	  to	  support	  osteogenic	  differentiation	  in	  vitro	  [51,	  52]	  using	  MC3T3-­‐E1	   cells.	   Liu	   et	   al.	   immobilised	   full-­‐length	   BMP-­‐2	   to	   PEG	   hydrogels	   and	  demonstrated	   an	   increase	   in	   osteogenic	   MSC	   differentiation	   [53].	   In	   another	  study,	   full-­‐length	  BMP-­‐2	  was	  covalently	   linked	  to	   titanium	  implants	   in	  a	  canine	  model,	   which	   resulted	   in	   enhanced	   appositional	   bone	   growth	   [54].	   The	   data	  presented	  in	  this	  study	  alongside	  previous	  studies	  indicate	  that	  BMP-­‐2	  remains	  biologically	   active	   when	   immoblised	   on	   3D	   glass	   scaffolds.	   The	   osteogenic	  differentiation	  processes	  promoted	  by	  modular	  peptides	  in	  this	  study	  were	  very	  similar	   to	  MSC	   differentiation	   promoted	   by	   soluble	   BMP-­‐2	   protein	   in	   previous	  studies.	  It	  was	  shown	  that	  BMP-­‐2	  alone	  was	  not	  sufficient	  to	  induce	  ALP	  activity	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by	   hMSCs	   however	   soluble	   BMP-­‐2	   promotes	   human	  MSC	   differentiation	  when	  presented	   to	   cells	   after	   pre-­‐treatment	   with	   dexamethasone	   [55].	   Due	   to	   the	  ability	  of	  BMPs	  to	  promote	  new	  bone	  formation,	  they	  have	  been	  widely	  used	  in	  bone	  tissue	  engineering	  applications	  [56,	  57].	  Human	  recombinant	  BMP-­‐2	  is	  an	  expensive	  growth	  factor	  which	  limits	  it’s	  clinical	  usefulness,	  therefore	  if	  a	  small	  BMP-­‐2	  peptide	  can	  be	  demonstrated	  to	  be	  as	  bioactive	  and	  full	  length	  BMP-­‐2	  this	  would	  be	  of	  strong	  interest	  to	  the	  bone	  graft	  substitute	  industry.	  This	  study	  also	  shows	  that	  hES-­‐MP	  cells	  seeded	  on	  BMP-­‐2	  coated	  glass	  scaffolds	  and	  stimulated	  by	   flow	   perfusion	   can	   be	   used	   as	   a	   useful	   model	   for	   in	   vitro	   research	   on	   the	  biological	   and	  mechanical	  mechanisms	   associated	  with	   cell	   differentiation	   and	  cell	  organisation.	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Chapter	  6:	  Primary	  cilia	  of	  bone	  cells	  and	  its	  
response	  to	  3D	  dynamic	  loading	  	  
	  
	  
6.1	   Introduction	  
	  As	  discussed	  in	  chapter	  1,	  bone	  tissue	  alters	  its	  mass	  and	  structure	  in	  response	  to	   mechanical	   and	   chemical	   stimulation	   both	   in	   vivo	   and	   in	   vitro.	   Therefore,	  increased	   loading	   results	   in	   greater	   bone	   formation,	   whereas	   reduced	   loading	  results	  in	  bone	  loss.	  	  The	  ability	  of	  bone	  to	  sense	  and	  translate	  the	  external	  force	  to	   biochemical	   signals	   depends	   on	   bone	   cells,	   including	   osteocytes,	   osteoblast	  and	  osteoclasts.	  Fluid	  flow	  in	  bone	  lacunar-­‐canalicular	  network	  is	  believed	  to	  be	  one	   of	   the	   potential	   stimuli	   that	   trigger	   mechanotransduction	   in	   bone.	  Osteocytes	  have	  been	  proposed	  as	  a	  prime	  candidate	  mechanosensor	  because	  of	  their	   location	   within	   the	   bone	   matrix.	   They	   have	   been	   shown	   to	   respond	   to	  mechanical	  stimuli	  both	  in	  in	  vivo	  [1]	  and	  in	  vitro	  [2].	  Osteoblasts	  and	  MSCs	  have	  also	  been	  shown	  to	  respond	  once	  subjected	  to	  an	  external	  force	  and	  also	  appear	  to	   play	   an	   important	   role	   in	   bone	   mechanostransduction	   [3,	   4].	   However	   the	  relative	  importance	  of	  different	  types	  of	  mechanical	  stimuli	  to	  which	  bone	  cells	  respond	  is	  still	  an	  active	  area	  of	  research.	  	  	  One	  mechanical	  stimulus	   that	  can	  be	  applied	   to	  cells	   in	  vitro	   is	  oscillatory	   fluid	  flow.	   It	   has	   been	   suggested	   that	   oscillatory	   fluid	   flow	   may	   be	   the	   most	  representative	   of	   physiological	   fluid	   flow	   in	   bone	   in	   vivo	   [5]	   and	   as	   shown	   in	  chapter	  4	  oscillatory	  fluid	  flow	  promotes	  hES-­‐MP	  cells	  commitment	  towards	  the	  osteogenic	   lineage.	  During	  dynamic	   loading	   of	   the	   bone,	   bending	  moments	   are	  created	  which	   lead	   to	   bone	  matrix	   deformation	   and	   pressure	   gradients.	   These	  pressure	  gradients	   force	   fluid	   flow	   from	  regions	  of	  high	  pressure	   to	   regions	  of	  low	  pressure	  within	  the	  canalicular	  network	  [6].	  The	  cells	  are	  subjected	  to	  shear	  stress	  over	  their	  surfaces,	  cell	  processes	  and	  cell	  body	  that	  have	  been	  estimated	  to	  be	  around	  0.8-­‐3.0	  Pa	  at	  the	  cell	  membrane	  [7].	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The	  mechanisms	   by	  which	   cells	   sense	   and	   translate	   external	   forces	   is	   still	   not	  known,	  however	  recent	  evidence	  suggests	  that	  the	  primary	  cilia	  is	  mechanically	  sensitive	   in	   many	   cell	   types	   [8].	   Interestingly,	   primary	   cilia	   have	   also	   been	  observed	   on	   osteocytes	   and	   osteoblasts	   [9-­‐11]	   and	   are	   implied	   to	   be	   potential	  mechanosensors	   in	   these	  cells.	  Primary	  cilia	  have	  previously	  been	  shown	  to	  be	  flow	  sensitive	   in	   renal	  epithelial	   cells	   in	  which	  bending	  of	   the	  cilium	  causes	  an	  increase	   in	   intracellular	   calcium	   [12,	   13].	   Moreover,	   chondrocytes	   in	   cartilage	  have	   also	  been	   shown	   to	   exhibit	  primary	   cilia.	   	   It	   appears	   that	   the	   cilia	   can	  be	  attached	   to	   the	   ECM	  of	   cartilage	   integrins	   such	   that	   deformation	   of	   the	  matrix	  induces	  cilia	  bending	  [14,	  15].	  	  	  
Malone	  et	  al.,	  applied	  continuous	   flow	  (0.036	  Pa)	   to	  MC3T3-­‐E1	  osteoblasts	  and	  demonstrated	  the	  bending	  of	  primary	  cilia.	  It	  was	  shown	  that	  subjecting	  MC3T3-­‐E1	   osteoblasts	   and	  MLO-­‐Y4	   osteocytes	   to	   oscillatory	   fluid	   flow	   increased	   OPN	  and	   COX2	   mRNA	   in	   comparison	   to	   no	   flow	   conditions.	   Furthermore,	   upon	  removal	   of	   the	   primary	   cilia	   (or	   inhibition	   of	   its	   formation),	   the	   fluid	   flow-­‐induced	   response	   was	   no	   longer	   observed	   [8].	   In	   another	   study,	   Hoey	   et	   al.,	  collected	   conditioned	  media	   from	  mechanically	   stimulated	   MLO-­‐Y4	   osteocytes	  and	   added	   it	   to	   MSCs.	   This	   resulted	   in	   a	   significant	   upregulation	   of	   OPN	   and	  COX2	   in	   MSCs	   in	   comparison	   to	   statically	   cultured	   conditioned	   media.	   The	  upregulation	   of	   osteogenic	   genes	   in	   the	  MSCs	  did	  not	   occur	   once	  primary	   cilia	  formation	  was	  inhibited,	  suggesting	  the	  primary	  cilia	  as	  a	  sensory	  mechanism	  for	  fluid	  flow	  in	  bone	  cells	  [16].	  
 It	   has	   been	   suggested	   that	   the	   primary	   cilia	   projecting	   from	   osteocytes	  might	  experience	   mechanical	   deformation,	   fluid	   flow	   shear	   stress,	   or	   pressure	  gradients	  depending	  on	  their	  size	  and	  orientation.	  Mechanical	  stimuli	  that	  might	  affect	   the	   primary	   cilia	   situated	   on	   preosteoblastic	   cells	   are	   less	   defined,	   since	  these	  cells	  are	  located	  on	  bone	  surfaces	  and	  within	  immature	  bone	  matrix	  rather	  than	  within	  the	  lacunae	  of	  the	  mature	  bone	  matrix.	  	  	  It	  has	  been	  shown	  that	  long	  exposure	  to	  chloral	  hydrate	  will	  completely	  remove	  the	  cilia	  in	  MDCK	  cells	  (rat	  kidney	  cells)	  [17,	  18],	  from	  the	  embryonic	  stem	  cells	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of	   early	   embryo	   phase	   of	   the	   sea	   urchin	   [19]	   and	   also	   bone	   cells	   [8].	   The	  mechanisms	   by	   which	   chloral	   hydrate	   destabilises	   the	   primary	   cilium	   is	   still	  unclear,	  however	  it	  has	  been	  proposed	  that	  it	  disrupts	  the	  junction	  between	  the	  cilium	  and	  basal	  body	  through	  disassembly	  of	  microtubules	  [19].	  	  	  MLO-­‐A5	  cells	  were	  chosen	  to	  study	  the	  role	  the	  primary	  cilia	  since	  experiments	  performed	   by	   Dr.	   Delaine-­‐Smith	   determined	   that	   they	   are	   very	   sensitive	   to	  different	   loading	   conditions	   by	   depositing	   a	   significant	   amount	   of	  matrix	   [20].	  Furthermore,	   the	  mineral	  deposited	  by	  MLO-­‐A5	  cells	  has	  been	  characterized	  to	  be	  more	   like	   the	  mineral	   found	   in	  bone	  compared	   to	   that	  synthesized	  by	  other	  osteoblast	  cells	  such	  as	  MC3T3-­‐E1	  cells	  [21].	  	  	  	  Dr.	  Delaine-­‐Smith	  has	   recently	   studied	   the	   role	   of	   the	  primary	   cilia	   in	  MLO-­‐A5	  responses	  to	  fluid	  shear	  stress	  [20].	  	  The	  experiments	  included	  seeding	  MLO-­‐A5	  cells	  on	  6-­‐well	  plates	  and	  subjecting	  them	  to	  back	  and	  forth	  rocking.	  In	  summary,	  he	   observed	   that	   subjecting	   MLO-­‐A5	   cells	   to	   fluid	   flow	   caused	   primary	   cilia	  length	   to	  shorten	  and	   that	   its	   removal	   (by	  application	  of	  CH)	   inhibited	  mineral	  deposition.	   Although	   the	   microtubule	   network	   seemed	   to	   be	   disrupted	   more	  with	   increase	   exposure	   time	   to	   CH,	   they	   returned	   to	   their	   normal	   state	   after	  24hrs	  in	  fresh	  media	  regardless	  of	  exposure	  time.	  However	  it	  is	  not	  known	  if	  the	  primary	  cilia	  can	  still	  operate	  as	  a	  mechanosensor	  in	  3D	  where	  the	  arrangement	  of	  cells	  is	  quite	  different	  from	  monolayer.	  In	  order	  to	  be	  able	  to	  compare	  the	  role	  of	   the	   cilium	   in	  3D	   to	   that	  previously	  demonstrated	   in	  2D,	   it	  was	  necessary	   to	  replicate	  the	  2D	  loading	  regime	  as	  closely	  as	  possible.	  	  	  Studies	   conducted	   on	   2D	   plates	   to	   investigate	   the	   role	   of	   primary	   cilia	   as	   a	  sensory	   organelle	   do	   not	   represent	   well	   the	   mechanical	   environment	  experienced	  by	  cells	  in	  real	  bone	  tissue.	  In	  previous	  chapters,	  it	  was	  shown	  that	  subjecting	  progenitor	  cell-­‐constructs	  to	  fluid	  shear	  stress	  significantly	  increased	  early	  markers	   of	   osteogenic	   differentiation	   and	  mineral	   deposition.	   Therefore,	  the	  aim	  of	  this	  chapter	  was	  to	  further	  understand	  mechanotransduction	  of	  cells	  in	  a	  3D	  environment.	   It	   is	  possible	   that	   the	  application	  of	   flow	  could	  affect	   the	  movement	   of	   the	   primary	   cilia	   embedded	   deep	   in	   cell-­‐seeded	   scaffolds.	   If	   the	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primary	   cilium	   is	   responsible	   for	   sensing	   mechanical	   forces	   (such	   as	   the	  application	   of	   fluid	   flow),	   then	   mature	   cells	   lacking	   a	   cilium	   would	   become	  unresponsive	  and	  therefore	  unable	  to	  deposit	  mineral	  in	  response	  to	  mechanical	  stimulation.	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6.2	   Methodology	  
	  MLO-­‐A5	   cells	   between	   passages	   25-­‐28	   were	   seeded	   at	   a	   density	   of	   300,000	  cells/scaffold	   on	   0.1%	   gelatin	   coated	   glass	   scaffolds.	   α-­‐MEM	   media	  supplemented	  with	  AA	  and	  βGP	  was	  added	  on	  day	  1	  and	  changed	  every	  2-­‐3	  days.	  Before	   subjecting	   the	   constructs	   to	   fluid	   flow,	   it	   had	   to	   be	   shown	   that	   the	  primary	   cilia	   does	   occur	   and	   project	   from	  MLO-­‐A5	   cells,	  where	   they	  would	   be	  capable	   of	   acting	   as	   a	  mechanosensor.	   This	  was	   the	   first	   attempt	   to	   image	   the	  primary	   cilia	   of	   MLO-­‐A5	   cells	   seeded	   on	   3D	   glass	   scaffolds	   and	   the	   technique	  used	  was	  to	  stain	  the	  protein	  tubulin	  with	  specific	  anti-­‐acetylated	  alpha	  tubulin	  antibody	  (described	  in	  chapter	  2).	  To	  study	  the	  involvement	  of	  primary	  cilia	  in	  a	  3D	  environment,	  MLO-­‐A5	  cells	  were	  exposed	  to	  4mM	  chloral	  hydrate	  (CH)	  for	  48	  hrs	  and	  72	  hrs	  followed	  by	  a	  recovery	  period	  in	  which	  cell-­‐seeded	  scaffolds	  were	  washed	  with	  PBS	  and	  cultured	  in	  fresh	  media	  (fig	  6.1).	  	  	  To	  study	  the	  response	  of	  primary	  cilia	  to	  mechanical	  loading,	  MLO-­‐A5-­‐constructs	  were	  subjected	  to	  oscillatory	  fluid	  flow	  (5	  ml/min,	  1	  Hz,	  1	  hour	  loading	  session)	  on	  day	  7	   and	  8,	   or	   cultured	   in	   static	   conditions.	  Media	  was	   collected	   for	   PGE2	  assay	  two	  hours	  after	  the	  first	  loading	  session	  (day	  7).	  Collagen	  production	  and	  calcium	   deposition	   were	   examined	   using	   Sirius	   red	   and	   alizarin	   red	   staining	  respectively	  on	  day	  12	  of	   culture.	  Cell	  viability	  was	  also	  quantified	  on	  day	  7	   to	  monitor	  any	  differences	  in	  cell	  activity.	  	  	  	  	  	  	  	  	  	  	  	  
Fig	  6.1;	  Experimental	  timeline	  used	  to	  study	  the	  effect	  of	  primary	  cilia	  damage	  on	  the	  fluid	  flow	  response	   of	  MLO-­‐A5	  cells.	  MLO-­‐A5	  cells	  were	  exposed	   to	   chloral	  hydrate	   (CH)	   for	  48	   and	   72	  hours	  on	  day	  3	  and	  4	  respectively.	  On	  day	  6	  of	  culture	  CH	  was	  removed	  and	  fresh	  media	  was	  added	  to	  samples.	  Cell-­‐seeded	  scaffolds	  in	  control	  conditions	  were	  not	  treated	  with	  CH.	  Samples	  were	   then	   subjected	   to	   oscillatory	   fluid	   flow	   (1	   hour	   at	   1	   Hz)	   on	   days	   7	   and	   8	   or	   cultured	  statically.	  Cell	  culture	  media	  was	  analysed	  for	  PGE2	  release	  2	  hours	  after	  first	  loading	  session	  (day	  7)	  and	  collagen	  production	  and	  calcium	  deposition	  was	  analysed	  on	  day	  12.	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6.3	   Results	  	   	  	   6.3.1	   	  	  	  Cell	  viability	  quantified	  using	  Alamar	  Blue	  	  Alamar	  Blue	  was	  utilised	  in	  this	  study	  to	  assess	  the	  effects	  of	  CH	  on	  MLO-­‐A5	  cell	  viability	   (fig	   6.2).	   Samples	   were	   assayed	   on	   day	   1	   (blue	   bar)	   prior	   to	   CH	  treatment	  and	  again	  on	  day	  7	  (green	  bar)	  prior	  to	  dynamic	  loading.	  Cell	  seeded	  scaffolds	   not	   treated	   with	   CH	   had	   slightly	   higher	   cell	   viability	   on	   day	   7	   in	  comparison	  to	  day	  1	  of	  culture.	  Samples	  treated	  with	  CH	  for	  48	  and	  72	  h	  did	  not	  show	   any	   significant	   difference	   between	   day	   1	   and	   day	   7	   of	   culture.	   Although	  there	  were	   slightly	   fewer	   cells	  on	  day	  7	  of	   culture	   in	   samples	   treated	  with	  CH,	  these	  results	  were	  not	  significant	  and	  suggest	  that	  the	  application	  of	  CH	  did	  not	  have	  any	  important	  effect	  on	  MLO-­‐A5	  cell	  viability.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Fig	  6.2;	  Alamar	  blue	  was	  used	  to	  quantify	  cell	  viability	  for	  samples	  treated	  with	  0,	  48	  and	  72	  hour	  CH	  treatment	  on	  days	  1	  and	  7	  of	  static	  culture.	  All	  data	  is	  mean	  ±	  SD	  (n	  =	  4).	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6.3.2	   	  	  	  CH	  treatment	  and	  MLO-­‐A5	  response	  to	  FSS	  	  On	   day	   7	   of	   culture,	   2	   hours	   after	   the	   first	   loading	   session,	   media	   from	   the	  samples	   was	   extracted	   and	   assayed	   for	   secreted	   PGE2.	   Cell	   seeded	   scaffolds	  subjected	   to	   fluid	   flow	   that	  were	  not	   treated	  with	  CH	  secreted	  more	  PGE2	  into	  the	  media	  compared	  with	  statically	  cultured	  cells	  (fig	  6.3).	  However,	  there	  were	  no	  significant	  differences	  in	  the	  levels	  of	  extracellular	  PGE2	  for	  samples	  treated	  with	  48	  and	  72	  h	  CH	  and	  subjected	  to	  fluid	  flow	  compared	  to	  their	  static	  controls.	  	  Furthermore	  the	  PGE2	  release	   from	  the	  CH	  treated	  cells	   in	   the	  FSS	  groups	  was	  significantly	  lower	  than	  for	  the	  non-­‐treated	  FSS	  group.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
	  
Fig	  6.3;	  Extracellular	  PGE2	  observed	  after	  2	  hours	  of	  loading	  on	  day	  7	  of	  culture	  for	  MLO-­‐A5	  constructs	  treated	  with	  0,	  48	  and	  72h	  CH.	  Data	  is	  mean	  ±	  SD	  (n	  =	  6).	  All	  data	  is	  mean	  ±	  SD	  (n	  =	  6).	  	  *P	  <0.05.	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6.3.3	  	  	  	  	  Primary	  cilia	  of	  MLO-­‐A5	  cells	  treated	  with	  CH	  and	  subjected	  to	  	  fluid	  flow	  	  MLO-­‐A5	  cells	   labeled	  with	  anti-­‐acetylated	  α	  tubulin	  can	  be	  seen	  in	  figure	  6.4.	   It	  can	  be	  noted	  that	  the	  microtubule	  network	  (highlighted	  in	  green)	  was	  visualised	  within	  the	  cell	  cytoplasm	  and	  was	  well	  organised	  and	  surrounding	  the	  nucleus	  in	  control	  conditions	  (no	  exposure	  to	  CH).	  	  It	  is	  very	  difficult	  to	  image	  and	  focus	  on	  the	  primary	  cilia	  of	  cells	  seeded	  on	  scaffolds	  because	  of	  the	  cells	  being	  clustered	  in	  3D	  and	   in	  multiple	   focal	  planes.	  As	  well	  as	   the	  microtubule	  network,	  a	  small	  bright	  protrusion	  was	  seen	  arising	  from	  cells	  which	  appeared	  to	  be	  the	  primary	  cilium.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Dr.	  Delaine-­‐smith	   imaged	  the	  same	  cell	   type	  but	  on	  6	  well	  plates	  and	   indicated	  that	   the	   primary	   cilium	   protrudes	   from	   the	   apical	   surface	   of	   the	   cell	   and	   is	  generally	  located	  on	  the	  side	  of	  the	  nucleus.	  When	  MLO-­‐A5	  cells	  were	  exposed	  to	  CH	  for	  48	  and	  72	  hrs,	  the	  microtubule	  network	  became	  increasingly	  disorganised	  
Fig	  6.4;	  Cell	  nuclei	  (DAPI-­‐blue)	  and	  anti-­‐acetylated	  α	  tubulin	  (green)	  staining	  of	  MLO-­‐A5	  cells	  with	  no	  CH	  treatment.	  The	  microtubule	  network	  can	  be	  seen	  surrounding	  the	  nucleus.	  Primary	  cilia	  seem	  to	   be	   projecting	   out	   of	   most	   cells	   and	   are	   located	   away	   from	   the	   cell	   nucleus	   indicated	   by	   the	  arrows.	  Images	  are	  representative	  of	  3	  experimental	  repeats.	  
(a)	  Static	  	  	   	   	   	   	   	   	  	  (b)	  Flow	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and	   the	   primary	   cilia	   were	   damaged	   or	   removed	   [20].	   	   Therefore	   it	   can	   be	  assumed	  that	  the	  cilia	  was	  also	  disrupted	  in	  the	  current	  3D	  model.	  	  
	  6.3.4	   	  	  	  Matrix	  production	  	  Collagen	  production	  and	  calcium	  deposition	  measured	  by	  Sirius	  red	  and	  alizarin	  red	  staining	  respectively,	  were	  significantly	  higher	  in	  the	  dynamic	  control	  group	  (cells	  which	  were	  not	  exposed	  to	  CH	  and	  thus	  retained	  their	  cilia).	  Furthermore,	  the	  application	  of	  flow	  caused	  significantly	  more	  mineral	  production	  in	  the	  non	  CH	   treated	   group	   compared	   to	   static	   conditions.	   This	   confirmed	   that	   MLO-­‐A5	  cells	  responded	  to	  flow	  in	  the	  same	  way	  as	  reported	  for	  hES-­‐MPs	  in	  the	  previous	  chapters.	  After	  exposure	  to	  chloral	  hydrate	  the	  ability	  of	  the	  cells	  to	  upregulate	  matrix	   in	   response	   to	   flow	   was	   reduced	   (fig	   6.5).	   In	   both	   groups	   exposed	   to	  chloral	   hydrate	   (48	   and	   72	   hrs)	   there	   was	   no	   significant	   difference	   in	   the	  collagen	  or	  calcium	  content	  between	  the	  static	  and	  flow	  groups.	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Fig	  6.5;	  Collagen	  production	  (SR)	  and	  calcium	  deposition	  (AR)	  on	  day	  12	  of	  culture	  for	  MLO-­‐A5	  cells	  treated	  with	  0,	  48,	  and	  72	  hour	  CH	  treatment.	  Fluid	  flow	  caused	  cells	  to	  produce	  more	  collagen	  and	  calcium	  for	  0	  hour	  CH	  treatment,	  and	  produce	  less	  matrix	  in	  response	  to	  fluid	  flow	  with	  increasing	  CH	  treatment	  time.	  All	  data	  is	  mean	  ±	  SD	  (n	  =	  6).	  	  *P	  <0.05.	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6.4	   Discussion	  	  This	   is	   the	   first	   time	  that	   the	  primary	  cilia	  of	  MLO-­‐A5	  cells	  seeded	  on	  a	  porous	  glass	   scaffold	   have	   been	   reported	   and	   imaged	   in	  vitro.	   In	   other	   studies,	   it	  was	  shown	  that	  mouse	  renal	  epithelial	  cells	  had	  the	  primary	  cilia	  extended	   into	  the	  duct	   lumen	   and	   hence	   the	   primary	   cilium	   was	   always	   located	   near	   the	   cell	  nucleus	  [21].	  In	  a	  recent	  study	  chondrocytes	  were	  seeded	  in	  a	  3D	  agarose	  culture	  and	  it	  was	  shown	  that	  the	  length	  of	  chondrocyte	  primary	  cilia	  was	  reduced	  when	  samples	   were	   subjected	   to	   cyclic	   compressive	   strain	   in	   comparison	   to	   free-­‐swelling	  culture	  [22].	  In	  another	  study,	  rat-­‐tail	  tendons	  were	  stress-­‐deprived	  and	  it	  was	  demonstrated	  that	  cilia	  length	  increased	  in	  comparison	  to	  fresh	  controls.	  However	   once	   these	   samples	   were	   subjected	   to	   24	   hrs	   of	   cyclic	   loading,	   cilia	  length	  returned	  to	  normal	  levels	  supporting	  the	  concept	  that	  cilia	  are	  involved	  in	  the	  mechanotransduction	  response	  of	  tendon	  cells	  [23].	  In	  this	  study	  there	  was	  some	   preliminary	   evidence	   based	   on	   confocal	   images	   that	   cells	   that	   had	   been	  subjected	   to	   fluid	   flow	   have	   slightly	   shorter	   cilia	   than	   those	   cultured	   in	   static	  conditions.	  However	  due	  to	  the	  irregular	  shape	  of	  the	  scaffold,	  it	  was	  difficult	  to	  obtain	  clear	   images	  of	   the	  primary	  cilia	  of	  MLO-­‐A5	  cells	   (fig	  6.4).	  However	   this	  could	   be	   further	   investigated	   in	   the	   future	   by	   using	   transmission	   electron	  microscopy	   (TEM),	   reducing	  background	   staining	  or	   even	  higher	  magnification	  objectives.	  	  MLO-­‐A5	   cells	   were	   chosen	   for	   this	   study	   since	   they	   have	   shown	   to	   be	   very	  sensitive	   to	  mechanical	   loading	   by	   producing	   a	   significant	   amount	   of	   collagen	  and	  calcium	  [20].	  Furthermore,	  by	  using	  MLO-­‐A5	  cells	  it	  was	  possible	  to	  compare	  the	   response	   in	   this	   3D	   model	   with	   Dr	   Delaine-­‐Smith’s	   2D	   system,	   who	   also	  noticed	   a	   reduction	   in	   MLO-­‐A5	   cilia	   length	   once	   cells	   were	   subjected	   to	   fluid	  shear	   stress	   when	   compared	   to	   static	   cultures	   [20].	   Uzbekov	   et	   al.,	   used	  transmission	  electron	  microscopy	  to	  study	  osteocyte	  centrosome	  morphology	  in	  relation	   to	   its	   mechanosensitive	   function.	   The	   spatial	   orientation	   of	   osteocyte	  centrosome	   was	   investigated	   and	   it	   was	   noticed	   that	   the	   primary	   cilium	   was	  mainly	   positioned	   perpendicular	   to	   the	   long	   axis	   of	   bone.	   Furthermore,	   it	  was	  observed	   that	  during	  osteocyte	  differentiation,	  mother	  and	  daughter	   centrioles	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changed	   their	   original	   mutual	   orientation	   [24].	   Due	   to	   the	   3D	   nature	   of	   the	  scaffold	  it	  was	  difficult	   identifying	  and	  obtaining	  focused	  images	  of	  the	  primary	  cilia	   however	   it	   was	   shown	   that	   the	   primary	   cilia	   of	   MLO-­‐A5	   cells	   on	   a	   glass	  scaffold	  was	  generally	  to	  the	  side	  of	  the	  nucleus	  and	  it	  was	  not	  possible	  to	  image	  any	   particular	   organisation	   pattern	   of	   the	   primary	   cilium	   (fig	   6.4).	   From	   the	  images	  it	  appears	  that	  the	  primary	  cilia	  are	  randomly	  organised	  in	  cultured	  cells.	  Therefore	  it	  maybe	  that	  type	  of	  mechanical	  stimulus,	  direction	  and	  force	  play	  an	  important	  role	  in	  cell	  migration	  and	  organisation.	  	  	  Most	   of	   the	   work	   analysing	   primary	   cilia	   as	   mechanosesnors	   has	   been	  demonstrated	   in	   the	  kidney	  and	   liver.	  Praetorius	  and	  Spring	  revealed	   that	   fluid	  flow	  within	  the	  kidney	  resulted	  in	  a	  deflection	  of	  the	  primary	  cilia	  which	  causes	  an	   extracellular	   calcium	   dependent	   increase	   in	   intracellular	   calcium	   [25].	   This	  response	  was	   lost	   after	   the	   removal	   of	   the	  primary	   cilia.	   This	  mechanosesning	  mechanism	  has	  also	  been	  reported	  in	  liver	  cholangiocytes.	  It	  was	  found	  that	  the	  PC1/2	  complex	  and	  the	  stretch	  activated	  ion	  channel	  TRPV4	  are	  situated	  at	  the	  primary	   cilium	   and	   sense	   fluid	   shear	   stress	   and	   osmotic	   pressure	   respectively	  [26].	   The	   application	   of	   flow	  not	   only	   resulted	   in	   an	   influx	   of	   calcium	  but	   also	  suppression	  of	  cAMP.	  	  In	  bone	  cells,	  primary	  cilia	  are	  needed	  for	  cytokine	  release	  and	  changes	  in	  gene	  transcription	  in	  response	  to	  a	  mechanical	  stimulus.	  Malone	  et	  al,	  removed	  cilia	  in	  MC3T3-­‐E1	  osteoblasts	  using	  both	  siRNA	  against	  Polaris	   (a	  protein	  required	   for	  ciliogenesis)	  and	  chloral	  hydrate	  treatment.	  The	  results	  demonstrated	  that	   that	  the	  presence	  of	  a	  primary	  cilium	  in	  MC3T3-­‐E1	  cells	  was	  essential	  for	  OPN	  gene	  expression	   and	   PGE2	   release	   by	   these	   cells	   when	   subjected	   to	   fluid	   flow,	  suggesting	   that	   primary	   cilia	   play	   an	   important	   role	   in	   transmitting	   the	   flow	  signal	   [8].	   Temiyasathit	   et	   al.	   also	   investigated	   the	   role	   of	   primary	   cilia	   as	  mechanosensors	  in	  bone.	  This	  was	  demonstrated	  by	  using	  Cre–lox	  technology	  by	  cross-­‐breeding	  mice	   that	   had	   floxed	  Kif3a	   gene	   (essential	   for	   ciliogenesis)	   and	  mice	   that	   express	   Cre	   under	   the	   control	   of	   the	   Col1α1	   promoter.	   The	   results	  showed	   that	   after	   3	   consecutive	   days	   of	   axial	   compressive	   ulna	   loading,	   bone	  formation	   and	   mineral	   apposition	   was	   significantly	   increased	   for	   both	   the	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knockout	  and	  control	  animals.	  However,	  in	  primary	  cilia	  knockout	  animals	  these	  increases	   were	   significantly	   reduced	   [27].	   Hoey	   et	   al.	   also	   demonstrated	   that	  signalling	   molecules	   released	   into	   culture	   media	   by	   MC3T3	   osteoblasts	   in	  response	   to	   fluid	   flow	   were	   primary-­‐cilia	   dependent,	   suggesting	   that	   primary	  cilia	   play	   a	   role	   in	   osteogenic	   responses	   to	   flow	   in	   both	   osteoblasts	   and	  osteocytes	  [16].	  	  In	   this	   chapter,	   it	   was	   shown	   that	   the	   primary	   cilium	   is	   needed	   for	   the	  upregulation	  of	  matrix	  production	  and	  PGE2	  release.	   In	  the	  absence	  of	  primary	  cilia,	  MLO-­‐A5	  cells	  were	  less	  responsive	  and	  deposited	  less	  collagen	  and	  mineral	  in	  response	  to	  flow.	  In	  monolayer	  the	  cilia	  projects	  into	  the	  fluid	  flowing	  over	  the	  cells	  but	  in	  a	  3D	  scaffold	  cell-­‐cell	  and	  cell-­‐matrix	  interactions	  may	  affect	  the	  cells	  position	  and	  ability	  to	  detect	  flow.	  Here	  it	  was	  demonstrated	  that	  even	  in	  a	  more	  complex	   environment	   of	   a	   3D	   scaffold	   the	   cilia	   mediate	   the	   matrix-­‐forming	  response	  of	  bone	  cells	  to	  fluid	  flow.	  	  	  PGE2	  has	  been	  shown	  to	  play	  an	  important	  role	  in	  osteoblast	  differentiation	  and	  in	   bone	   cell	   mechanostransduction.	   Bone	   cells	   in	   vivo	   subjected	   to	   fluid	   shear	  stress	   have	   been	   shown	   to	   induce	   PGE2	   secretion,	   which	   stimulates	   the	  production	  of	  new	  bone	  [28].	  In	  2D	  studies	  it	  was	  shown	  that	  PGE2	  was	  released	  when	  subjected	  to	  continuous	  and	  short-­‐term	  rest-­‐inserted	  fluid	  flow,	  a	  finding	  which	  is	  much	  the	  same	  in	  3D	  case	  studies	  [29].	  In	  this	  study,	  PGE2	  secretion	  by	  MLO-­‐A5	   cells	   subjected	   to	   FSS	   was	   significantly	   higher	   compared	   to	   static	  cultures.	  Dr	  Delaine-­‐Smith	  also	  presented	  the	  same	  findings	  for	  cells	  subjected	  to	  FFS	  in	  monolayer.	  In	  his	  studies	  the	  application	  of	  FSS	  combined	  with	  CH	  for	  only	  24	  hrs	  did	  not	  inhibit	  the	  PGE2	  response;	  	  there	  was	  a	  1.6-­‐fold	  increase	  in	  PGE2	  levels	   [20].	   Furthermore,	   in	   this	   3D	   system	   cell	   response	   was	   removed	   when	  samples	  were	  treated	  with	  48	  and	  72	  hrs	  CH	  suggesting	  that	  the	  primary	  cilium	  plays	   an	   important	   role	   in	   response	   to	   loading.	   In	   a	   similar	   study,	   the	   load-­‐induced	  PGE2	  production	  of	   immature	   osteoblasts	   (MC3T3-­‐E1)	   and	  osteocytes	  (MLO-­‐Y4)	  was	  removed	  when	  primary	  cilia	  formation	  was	  inhibited	  [8].	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The	  technique	  to	  remove	  primary	  cilia	  used	  in	  the	  present	  study	  was	  to	  expose	  MLO-­‐A5	  cells	  to	  chloral	  hydrate.	  There	  is	  evidence	  that	  chloral	  hydrate	  not	  only	  weakens	   the	   attachment	   of	   the	   primary	   cilium,	   it	   also	   causes	   substantial	  alterations	   in	   microtubules	   and	   associated	   processes	   [18],	   and	   also	   interferes	  with	   mitosis	   [30].	   The	   24	   hour	   recovery	   period	   should	   allow	   microtubule	  recovery	  as	  previously	  seen	  in	  2D	  culture,	  so	  that	  at	  the	  time	  of	  flow	  only	  the	  cilia	  and	  not	  the	  microtubules	  were	  damaged.	  Although	  the	  prolonged	  exposure	  times	  required	   to	   remove	   the	   cilia	   may	   cause	   undesirable	   side	   effects	   related	   to	  microtubule	   damage.	   at	   present	   chloral	   hydrate	   is	   the	   only	   pharmalogical	  technique	  for	  removal	  of	  MLO-­‐A5	  cilia.	  The	  treatment	  used	  in	  these	  experiments	  did	   not	   seem	   to	   adversely	   affect	   cell	   viability,	   probably	   because	   the	   cells	  were	  seeded	  at	  high	  density	  and	  there	  is	  not	  a	  large	  increase	  in	  cell	  number	  over	  time	  even	  in	  non-­‐treated	  cells	  in	  this	  culture	  condition.	  	  Other	  techniques	  used	  for	  the	  removal	  of	  primary	  cilia	   include	  siRNA-­‐mediated	  depletion	  of	   the	   intraflagellar	   transport	   (IFT)	   component	  polaris	   (a	  protein	   for	  primary	   cilia	  biogenesis	   and	   function)	   [8].	   In	   a	   recent	   study	   it	  was	   shown	   that	  after	   polaris	   siRNA	   treatment,	   only	   50%	   fewer	  MLO-­‐Y4	   cells	   had	   primary	   cilia	  than	   control	   cells	   and	   a	   complete	   loss	   of	   flow	   response	  was	   observed	   in	   these	  cells.	  This	  is	  because	  the	  efficiency	  of	  IFT	  will	  probably	  decrease	  upon	  reduction	  of	   polaris	   protein	   levels,	   which	   will	   prevent	   delivery	   of	   functional	   ciliary	  components	   to	   some	   fraction	   of	   the	   remaining	   cilia	   [8].	   In	   addition,	   this	  technique	  is	  expensive,	  more	  complicated	  and	  also	  needs	  to	  be	  optimised	  since	  it	  can	  inhibit	  other	  mechanosensory	  mechanisms	  [31].	  	  	  Other	   pathways	   exist	   in	   which	   mechanical	   stimulation	   is	   transduced	   and	  modulated.	   When	   a	   cell	   is	   subjected	   to	   some	   form	   of	   mechanical	   stimuli,	  alterations	   in	   the	   cytoskeleton	   can	   occur.	   These	   include	   actin	   reorientation,	  microtubule	   polymerisation/depolymerisation	   and	   reorganisation	   of	   focal	  adhesion	   sites	   [32,	   33].	   There	   is	   also	   evidence	   that	   the	   cell	   glycocalyx	   plays	   a	  sensory	  role	  in	  bone	  cells.	  In	  a	  previous	  study,	  Reilly	  et	  al	  inhibited	  the	  ability	  of	  osteocyte-­‐like	   cells	   to	   upregulate	   PGE2	   release	   in	   response	   to	   oscillatory	   fluid	  flow	  by	  removal	  of	  hyaluronan	  (HA,	  a	  key	  glycocalyx	  component)	  [34].	  In	  a	  more	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recent	  study,	  Morris	  et	  al	  used	  laminar	  flow	  on	  mature	  bone	  cells	  as	  a	  stimulus	  to	  increase	  collagen	  production,	  however	   this	   response	  was	  absent	  upon	  removal	  of	  HA	  [35].	  β1	  integrin	  has	  also	  been	  demonstrated	  to	  play	  an	  important	  role	  in	  both	   osteoblasts	   and	   osteocytes.	   Zimmerman	   et	   al.,	   demonstrated	   that	   the	  expression	  of	  an	  osteoblast-­‐specific	  dominant	  negative	  form	  of	  β1	  in	  long	  bones	  of	  mice	   lead	   to	   reduced	   bone	  mass	   and	   increased	   cortical	   porosity	   [36].	   Bone	  cells	  also	  express	  different	  ion	  channels	  which	  are	  involved	  in	  mechanosensitive	  pathways	   including;	   the	   gadolinium-­‐sensitive	   stretch-­‐activated	   cation	   channels	  [37],	   the	   multimeric	   voltage	   sensitive	   calcium	   channels	   (VSCC)	   [38,	   39],	   and	  transient	   receptor	   potential	   (TRP)	   channels	   [40].	   As	   a	   response	   to	  membrane	  strain,	   stretch-­‐activated	  cation	  channels	  cause	  a	  change	   in	  membrane	  potential	  leading	  to	  local	  depolarisation	  sufficient	  to	  activate	  VSCCs.	  Li	  et	  al.,	  demonstrated	  that	   VSCCs	   are	   mechanosensitive	   in	   rat	   tibia	   when	   mice	   treated	   with	   VSCC	  inhibitors	  exhibited	  significantly	  suppressed	   load-­‐induced	  bone	   formation	  [41].	  It	   may	   be	   possible	   that	   multiple	   mechanosensitive	   mechanisms	   are	   present	  within	  bone	  cells	  and	  they	  are	  activated	  at	  different	  levels	  of	  stimulus.	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Chapter	  7:	  Conclusion	  and	  Future	  Work	  
	  The	   main	   aim	   of	   this	   project	   was	   to	   investigate	   the	   effects	   of	   a	   perfusion	  bioreactor	   system	   on	   progenitor	   cell	   differentiation	   (towards	   an	   osteogenic	  lineage)	   and	   matrix	   mineralisation.	   The	   overall	   goal	   was	   to	   study	   which	  parameters	   within	   a	   bioreactor	   can	   accelerate	   cell	   differentiation	   and	   matrix	  production	   in	   order	   to	   direct	   cell	   phenotype	   and	   speed	   up	   development	   time.	  Here	   it	   was	   shown	   that	   direct	   perfusion	   in	   combination	   with	   oscillatory	   fluid	  flow	   improves	   cell	   distribution	   throughout	   the	   scaffold	   structure,	   enhances	  proliferation	   and	   upregulates	   the	   enzyme	   ALP	   and	   extracellular	   matrix	  components	   associated	  with	   osteogenic	   differentiation	   by	   hES-­‐MP	   cells	   seeded	  on	  a	  novel	  glass	  scaffold.	  The	  system	  designed	   in	   this	   report	  not	  only	  provides	  insight	   into	   cell	  mechanotransduction	   but	   also	   provides	   information	   regarding	  the	   relationship	   between	   fluid	   shear	   stress,	   cellular	   function	   and	   tissue	  development.	   The	   system	   was	   further	   used	   to	   investigate	   whether	   peptide-­‐coated	  scaffolds	  (developed	  by	  our	  industrial	  collaborators)	  would	  support	  cells	  and	   whether	   there	   was	   a	   synergistic	   effect	   of	   protein	   coating	   and	   fluid	   flow	  conditions.	  Furthermore	  the	  flow	  parameters	  shown	  to	  upregulate	  bone	  matrix	  were	   used	   to	   identify	   a	   potential	   mechanotransduction	  mechanism.	   The	   work	  presented	  in	  this	  thesis	  provides	  a	  useful	  3D	  model	  with	  which	  to	  understand	  the	  mechanical	  response	  of	  differentiating	  bone	  cells	  and	  can	  be	  applied	  to	  further	  in	  
vitro	   studies	   of	   bone	  mechanotransduction	   or	   be	   used	   to	   further	   develop	   and	  optimise	  bioreactor	  parameters	  for	  clinical	  bone	  tissue	  engineering	  applications.	  
	  
7.1	   Optimal	  culturing	  strategy	  
	  In	   this	   study	   it	  was	   shown	   that	   hES-­‐MP-­‐constructs	   subjected	   to	   short	   bouts	   of	  fluid	   flow	   can	   greatly	   enhance	   matrix	   production	   and	   genes	   associated	   with	  osteogenic	  differentiation.	  As	  suggested	  by	  a	  number	  of	  other	  research	  groups	  in	  the	  field,	  the	  reason	  for	  an	  upregulation	  in	  matrix	  production	  could	  be	  because	  of	  a	  better	  and	  more	  efficient	  nutrient	  transport,	  alongside	  biochemical	  cues	  which	  can	   ultimately	   create	   a	   suitable	   microenvironment	   for	   the	   development	   of	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functional	  3D	  constructs.	  However	  the	  improved	  nutrient	  flow	  would	  have	  only	  occurred	   for	   short	   time	   periods	   in	   this	   experimental	   set	   up	   since	   the	   samples	  were	   in	   static	   culture	   between	   flow	   sessions,	   which	   were	   of	   only	   1	   hours	  duration.	   Therefore,	   it	   seems	   likely	   there	  was	   a	   specific	   response	   to	   the	   shear	  stress	  that	   induced	  long-­‐term	  changes	  in	  the	  cells.	  However,	  a	  big	  question	  still	  remains	   regarding	   the	   ultimate	   strategy	   for	   directing	   the	   differentiation	   of	  progenitor	   cell	   lines	   through	   the	   use	   of	  mechanical	   cues	   such	   as	   shear	   stress.	  Many	   important	   parameters	   including	   flow	   type,	   insertion	   of	   rest	   periods,	  duration,	  frequency	  and	  magnitude	  of	  shear	  stress	  can	  all	  influence	  cell	  response.	  With	   respect	   to	   flow	   duration,	   there	   is	   evidence	   suggesting	   that	   constant	  stimulation	  of	  cells	  (irrespective	  of	  flow	  type)	  can	  lead	  to	  cellular	  desensitisation	  and	   switching	   off	   the	   cells	   response.	   In	   order	   to	   overcome	   this	   problem,	   rest	  insertions	   between	   loading	   sessions	   have	   been	   explored	   by	   a	   number	   of	  researchers.	   This	   appears	   to	   enhance	   the	   expression	   of	   certain	   genes	   such	   as	  osteopontin	   [1],	   bone	   sialoprotein	   [2]	   and	   PGE2	   [3].	   The	   timing	   of	  mechanical	  loading	   is	   also	   an	   important	   factor	   to	   consider.	   Cells	   tend	   to	   respond	   to	   the	  application	   of	   flow	  within	   seconds	   (influxes	   in	   calcium)	   to	  weeks	   (mineralised	  matrix	  deposition).	  In	  this	  investigation,	  fluid	  flow	  was	  subjected	  to	  samples	  on	  day	   4	   and	   analysed	   on	   day	   7	   of	   culture	   for	   short-­‐term	   experiments.	   For	   long-­‐term	  experiments,	   samples	  were	  subjected	   to	   loading	  on	  days	  4,	  7,	  and	  10	  and	  markers	   of	   osteogenesis	   were	   analysed	   on	   day	   14.	   These	   time	   points	   were	  chosen	   following	   a	   successful	   project	   conducted	   by	   a	   previous	   student	   [4].	  However,	  the	  duration	  and	  frequency	  of	  flow	  required	  to	  commit	  cells	  towards	  a	  specific	  lineage	  is	  still	  an	  active	  area	  of	  research.	  	  	  Future	  work:	  	  
• Measuring	  ALP	  activity	  at	  several	  time	  points	  (day	  5,	  6,	  etc)	  soon	  after	  the	  application	  of	  flow	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7.2	   Bioreactors	  for	  cell	  seeding	  
	  In	  this	  study	  cells	  were	  seeded	  onto	  glass	  and	  PU	  scaffolds	  by	  directly	  adding	  the	  cell	   suspension	   to	   the	   scaffold.	   Although	   this	   method	   is	   the	   simplest	   since	   it	  avoids	  the	  use	  of	  tubing,	  pumps	  and	  large	  volumes	  of	  media,	  it	  can	  result	  in	  non-­‐homogeneous	   cell	   distribution	   and	   low	   seeding	   efficiency.	   In	   previous	   studies	  that	  have	  utilised	  PU	  scaffolds	  (10	  mm	  x	  10	  mm),	  this	  seeding	  method	  seemed	  to	  cause	   cells	   to	   settle	   in	   the	   centre	   of	   the	   scaffold	   and	   be	   absent	   from	   the	  periphery.	   Low	   seeding	   efficiency	   can	   be	   improved	   by	   placing	   scaffolds	   in	  spinner	   flasks.	   However	   direct	   perfusion	   bioreactors	   have	   shown	   to	   further	  improve	   seeding	   efficiency	   [5-­‐9].	   It	   has	   been	   demonstrated	   that	   loading	  efficiency	   for	   bone	   marrow	   stromal	   cells	   and	   chondrocytes	   in	   a	   perfusion	  bioreactor	  was	  20%	  higher	   in	   comparison	   to	   static	   loading.	   Furthermore,	   cells	  were	   significantly	   more	   uniformly	   distributed	   [10].	   	   Studies	   that	   have	   utilised	  direct	   perfusion	   for	   cell	   seeding	   have	   also	   been	   shown	   to	   yield	   higher	   cell	  attachment	  compared	  to	  statically	  loaded	  cells.	  In	  another	  study,	  oscillatory	  flow	  was	  used	  to	  seed	  preosteoblastic	  cells	  onto	  polystyrene	  and	  PLLA	  scaffolds.	  As	  a	  result	  higher	  seeding	  efficiency	  and	  higher	  cell	  attachment	  was	  achieved	  under	  dynamic	   loading	   in	   comparison	   to	   statically	   loaded	   cells	   [11].	   The	   bioreactor	  system	   developed	   in	   this	   study	   can	   be	  modified	   to	   seed	   cells	   onto	   a	   range	   of	  scaffold	  shapes,	  however	  further	  experiments	  will	  need	  to	  be	  carried	  out	  in	  order	  to	  determine	  a	  flow	  rate	  for	  initial	  cell	  seeding.	  	  	  
7.3	   Bone	  tissue	  engineering	  scaffolds	  	  Scaffolds	   used	   in	   bone	   tissue	   engineering	   are	   typically	   made	   of	   porous	  degradable	   materials	   that	   supply	   the	   mechanical	   support	   during	   repair	   and	  regeneration	   of	   damaged	   or	   diseased	   bone.	   Ideally	   a	   scaffold	   for	   bone	   tissue	  engineering	   should	   be	   bioresorbable,	   biocompatible,	   have	   the	   mechanical	  properties	   to	  match	  host	  bone	  properties	  and	  have	  an	   interconnected	  porosity	  for	  successful	  diffusion	  of	  nutrients.	  Bioglass	  based	  bioresorbable	  scaffolds	  [12],	  polymeric	   scaffolds	   [13],	   composite	   scaffolds	   [14]	   and	   metallic	   scaffolds	   [15]	  have	   been	   demonstrated	   to	   enhance	   osteogenic	   differentiation	   of	   MSCs	   when	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used	  for	  bone	  repair	  in	  vivo.	  The	  borosilicate	  glass	  scaffolds	  utilised	  in	  this	  study	  are	  biocompatible	  in	  which	  cells	  can	  attach	  and	  proliferate,	  however	  they	  cannot	  be	  used	  for	  clinical	  applications.	  The	  reason	  glass	  scaffolds	  were	  utilised	  in	  this	  study	   is	   that	   they	   have	   good	   light	   transmissibility	   used	   for	   cell	   staining,	   are	  supplied	   uncoated	   or	   peptide	   coated	  which	   can	   both	   promote	   cell	   attachment	  and	  provide	  a	  foundation	  for	  studying	  various	  aspects	  of	  cell	  matrix	  interaction,	  mechanotransduction	  and	  cell	  behavior	  relevant	  in	  vitro	  three-­‐dimensional	  (3D)	  culture	  systems.	  	  Organisation	  of	  porosity	  has	  also	  been	  shown	  to	  play	  a	  key	  role	  in	  the	  quality	  of	  bone	   formation.	   In	   a	   recent	   study,	   an	   ordered	   and	   confined	   geometry	   of	  hydroxyapatite	   (HA)	   foams	   led	   to	   self-­‐assembly	  of	   collagen	   in	   the	  pores	  which	  resulted	   in	   compact	   lamellar	   bone	   [16].	   In	   comparison,	   when	   progenitor	   cells	  were	  loaded	  onto	  a	  HA/collagen	  composite,	  collagen	  fibres	  were	  distributed	  in	  a	  nematic	   phase	   and	   resulting	   in	   woven	   isotropic	   bone.	   Porosity	   for	   most	   bone	  tissue	   engineering	   scaffolds	   is	   uniformly	   distributed	   throughout	   scaffold	  structure.	  However,	   the	  scaffold	  may	  not	  be	  uniformly	  porous	  as	  demonstrated	  by	  the	  borosilicate	  glass	  scaffolds.	  Natural	  bone	  has	  higher	  porosity	   in	  the	  core	  with	  a	  strong	  and	  dense	  outer	  shell,	  hence	  it	  does	  not	  have	  a	  uniform	  distribution	  of	  porosity.	  Since	  the	  shear	  stress	  distribution	  can	  be	  affected	  by	  pore	  geometry,	  a	  parallel	  study	  comparing	  the	  glass	  scaffolds	  with	  other	  scaffolds	  with	  different	  pore	  architecture	  would	  further	  provide	  insight	  into	  osteoblastic	  differentiation	  and	  ECM	  mineralisation.	  	  	  
7.4	   Primary	  cilia	  of	  bone	  cells	  	  The	   data	   from	   chapter	   6	   supports	   the	   hypothesis	   that	   oscillatory	   fluid	   shear	  stress	   can	   mediate	   mechanosensation	   in	   MLO-­‐A5	   osteoblastic	   cells	   via	   the	  primary	   cilium.	   In	   summary	   it	  was	   shown	   that	  primary	   cilia	   translate	  dynamic	  fluid	   flow	   signals	   into	   upregulation	   of	   collagen,	   calcium	   and	   PGE2	   in	   MLO-­‐A5	  cells.	   However	   it	   is	   still	   unclear	   how	   the	   primary	   cilia	   transmits	   the	   external	  force	  to	  the	  inside	  of	  the	  cell	  and	  how	  it	  interacts	  with	  the	  mineralised	  matrix	  of	  bone.	  One	  possible	  reason	  could	  be	  the	  mechanical	  stimulus	  is	  converted	  into	  a	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chemical	   signal	   that	   initiates	   a	   cellular	   response	   such	   as	   a	   change	   in	   gene	  expression	  or	  cytokine	  release.	  However,	  as	  mentioned	  previously	  in	  chapter	  1,	  the	   only	   characterised	   mechanosensory	   mechanism	   in	   the	   cilium	   involves	   the	  polycystins	   [17].	   Adenylyl	   cyclases	   have	   also	   been	   found	   in	   the	   primary	   cilia,	  suggesting	   that	  cAMP	  could	  be	  a	  second	  messenger	   in	  ciliary	  signaling	   [18].	  As	  has	   been	   proposed	   for	   Shh	   signaling,	   IFT	   could	   also	   traffic	   activated	   signaling	  proteins	   from	   the	   ciliary	   compartment	   to	   the	   cytoplasm	   [19],	   all	   of	   which	  suggests	  that	  the	  primary	  cilium	  can	  be	  coupled	  with	  other	  signaling	  pathways.	  To	   further	   characterise	   the	   role	   of	   the	   primary	   cilium	   in	   bone,	   conditional	  knockout	   of	   genes	   required	   for	   primary	   cilium	   in	   osteocytes,	   osteoblasts	   and	  osteoclasts	   can	   be	   undertaken	   [20].	   Since	   the	   primary	   cilia	   play	   different	  signaling	   roles	   depending	   on	   developmental	   stage,	   in	   depth	   investigation	   of	  primary	   cilia	   function	   in	   these	   cells	   at	   different	   stages	   of	   differentiation	   could	  provide	   further	   insight	   into	   how	   cells	   sense	   and	   respond	   to	   environmental	  stimuli.	   	   Future	   studies	   could	   involve	   integrating	   ciliary	   signaling	   with	   other	  cellular	  sensory	  systems	  to	  provide	  a	  comprehensive	  picture	  of	  ciliary	   function	  in	   response	   to	   mechanical	   loading.	   Thus,	   for	   clinical	   applications	   it	   would	   be	  worth	  investigating	  mechanotransduction	  of	  osteoprogenitors	  considering	  that	  it	  was	  recently	  demonstrated	  by	  Hoey	  et	  al.,	   that	  the	  primary	  cilia	   is	  essential	   for	  load-­‐induced	  gene	  responses	  in	  MSCs	  [21]. 
	  
7.5	   Computational	  Modeling	  	  	  In	   the	   field	   of	   bone	   tissue	   engineering,	   growing	   interest	   has	   been	   given	   to	  analysing	  shear	  stress	  distribution	  in	  complex	  3D	  scaffolds.	   In	  this	  study	  it	  was	  shown	  that	   the	  action	  of	   fluid	   flow	  entering	   the	  scaffold	   is	  a	  potent	  mechanical	  stimulus,	  which	  can	  control	  the	  phenotype	  of	  the	  3D	  construct.	  It	  is	  evident	  that	  scaffold	   architecture	   and	   geometry	   determined	   by	   pore	   size,	   shape	   and	  distribution	   are	   key	   design	   parameters	   [22-­‐24].	   The	   combination	   of	   micro-­‐CT	  (fig	  7.1)	  and	  Computational	  Fluid	  Dynamics	  (CFD)	  can	  be	  very	  useful	  in	  order	  to	  obtain	   local	   shear	   stresses	   within	   porous	   structures.	   This	   can	   help	   determine	  loading	   conditions	   at	   the	   cellular	   level	   and	   provide	   further	   insight	   that	   relates	  mechanical	   stimuli	   with	   osteogenesis.	   Predictive	   models	   developed	   in	   this	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manner	   are	   a	   powerful	   tool	   for	   better	   understating	   constructs	   subjected	   to	  perfusion	   flow	  prior	   to	   transplantation.	   [25-­‐28].	   Flow	  patterns	  within	   the	   flow	  perfusion	  bioreactor	  need	   to	  be	  better	   characterised	   to	   further	  understand	   the	  relationship	  between	   fluid	   shear	   stress	   and	   cell	   differentiation	   for	   creating	   the	  ideal	  scaffold/culture	  combination.	  
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
 	  




7.6	   Mesenchymal	  Progenitors	  	  	  The	   choice	   of	   an	   optimal	   cell	   source	   is	   of	   great	   importance	   for	   the	   successful	  culture	   of	   functional	   constructs	   to	   be	   used	   for	   the	   repair	   of	   skeletal	   defects.	  Results	  from	  this	  project	  demonstrated	  that	  the	  use	  of	  a	  perfusion	  bioreactor	  in	  combination	  with	  hES-­‐MP	   cells	   on	  3D	  porous	   scaffolds,	   strongly	  promoted	   cell	  
Fig	  7.1;	  Micro-­‐CT	  images	  of	  the	  glass	  scaffold	  was	  obtained	  by	  placing	  the	  scaffold	  in	  a	  SKYSCAN	  1172	  micro-­‐CT	  machine.	  This	  resulted	  in	  a	  total	  of	  415	  images	  taken	  from	  top	  to	  bottom	  of	  glass	  scaffold.	  Images	  were	  compiled	  in	  ScanIP	  to	  create	  a	  3D	  model.	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proliferation	   and	   osteogenic	   differentiation.	   Other	   factors	   including	   surface	  chemistry	   and	   scaffold	   composition	   have	   also	   been	   identified	   to	   enhance	  MSC	  differentiation	   into	   a	   variety	   of	   tissue-­‐specific	   cells.	   This	   makes	   MSCs	   an	  attractive	  cell	  source	  for	  tissue	  engineering	  and	  regenerative	  medicine	  purposes.	  	  However,	  there	  are	  still	  a	  number	  of	  questions	  that	  need	  to	  be	  addressed	  before	  MSCs	   can	   be	   utilised	   in	   a	   clinical	   setting.	   Limited	   availability	   and	   poor	  proliferative	   properties	   are	   of	   major	   concern.	   Moreover	   the	   timing	   and	  differentiation	   process	   of	   MSCs	   to	   a	   specific	   cell	   is	   still	   unclear	   and	   requires	  further	   investigation.	  Even	   though	   it	  was	  shown	   that	   some	  osteogenic	  markers	  were	  upregulated	  in	  this	  study,	  further	  research	  regarding	  the	  differentiation	  of	  hES-­‐MP	  cells	  under	  perfusion	  is	  still	  required.	  These	  could	  include	  cytokines	  and	  expression	   of	   other	   osteogenic	   markers	   in	   order	   to	   confirm	   the	   existence	   of	  differentiated	  osteoblasts.	  Additionally,	  use	  of	  histological	  and	  mineral	  analysis	  (FTIR)	  can	  contribute	  to	  understanding	  the	  structural	  and	  mechanical	  properties	  of	  the	  hES-­‐MP/scaffold	  construct.	  In	  the	  meantime	  the	  stable,	  easily	  handled	  and	  highly	   osteogenic	   pluripotent	   stem	   cell	   derived-­‐mesodermal	   progenitors	   used	  here	  have	  a	  great	  potential	  as	  a	  cell	  source	  for	  the	  fabrication	  of	  bone	  substitutes	  in	  a	  clinical	  context.	  	  
	  
7.7	   Co-­‐culture	  of	  Osteoprogenitor	  Cells	  with	  Endothelial	  Cells	  	  	  The	   repair	   of	   skeletal	   defects	   involves	  many	   different	   events	   and	  multiple	   cell	  types.	  The	  main	   limitation	   in	   creating	   large	   scale	   implantable	   constructs	   is	   the	  lack	  of	  a	  vascular	  network.	  In	  particular,	  the	  survival	  of	  bone	  tissue	  relies	  on	  the	  development	  of	  blood	  vessels	  since	  they	  transport	  nutrients,	  oxygen	  and	  soluble	  factors	  to	  the	  tissue.	  Researchers	  have	  suggested	  to	  incorporate	  endothelial	  cells	  supplemented	  with	  angiogenic	   factors	  (vascular	  endothelial	  growth	  factor)	   into	  the	   tissue	   engineered	   construct	   in	   order	   to	   achieve	   a	   vascular	   network	   and	  understand	   more	   about	   the	   relationship	   between	   the	   vasculature	   and	   bone.	  Since	   osteoprogenitor	   and	   endothelial	   cells	   have	   been	   shown	   to	   be	  mechanosensitive,	  a	  coculture	  system	  could	  be	  developed	  to	  study	  the	  effect	  of	  fluid	  flow	  on	  the	  interactions	  between	  both	  cell	  types.	  Cultures	  can	  be	  analysed	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7.8	   Final	  Conclusions	  
	  
• In	  chapter	  3	  it	  was	  shown	  that	  hES-­‐MP	  and	  mouse	  MSC	  cells	  were	  able	  to	  survive	  and	  distribute	  throughout	  a	  PU	  foam	  and	  novel	  glass	  scaffold	  for	  up	  to	  14	  days	  in	  static	  culture.	  Furthermore,	  short	  bouts	  of	  fluid	  flow	  was	  shown	   to	   increase	   cell	   viability	   and	   calcium	  deposition	   of	   hES-­‐MP-­‐glass	  constructs.	  
• The	   effect	   of	   flow	   type	   (unidirectional	   Vs	   oscillatory)	   and	   scaffold	  orientation	   on	   human	   mesenchymal	   progenitor	   cell	   differentiation	   and	  matrix	  production	  was	  investigated	  in	  chapter	  4.	  It	  was	  shown	  that	  direct	  perfusion	   in	   combination	   with	   oscillatory	   fluid	   flow	   creates	   a	   more	  uniform	  cell	  distribution	  and	  an	  upregulation	  of	  ALP	  collagen	  and	  calcium	  associated	  with	  osteogenesis.	  	  
• The	   methods	   developed	   in	   chapter	   4	   were	   used	   to	   study	   the	   cell’s	  response	   to	   a	   combination	   of	   peptide	   coated	   scaffolds	   and	   bioreactor	  culutre.	  In	  chapter	  5	  it	  was	  shown	  that	  the	  combination	  of	  peptide	  coated	  scaffolds	   and	   oscillatory	   flow	   improves	   cell	   distribution	   and	   further	  enhances	  early	  and	  late	  markers	  of	  bone	  formation.	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